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Abstract 
In Europe, diseases of the heart and circulatory system are the main cause of death; 
48% of all deaths are from coronary heart disease, accounting for over 4.30 million 
deaths each year (European cardiovascular disease statistics 2008). Identifying stem 
cell types that can potentially contribute to the regeneration of cardiac tissue is one 
route to addressing this global problem. 
The follicular dermis has been proposed as a tissue containing cells with adult stem 
cell properties that could be used for regenerative medicine. This study showed that 
follicular dermal structures demonstrated spontaneous synchronised contractions in 
vitro, indicative of cardiomyocytic commitment. In contrast, isolated populations of 
follicular dermis, the dermal papilla and sheath, did not demonstrate spontaneous 
cardiomyocytic commitment in vitro. Co-culture of isolated follicular dermal 
populations with embryonic cardiomyocytes, a cell type previously reported to 
support cardiomyocytic commitment of mesenchymal stem cell types, induced 
expression of a panel of gene products indicative of cardiomyocytic commitment, but 
only when the inducing cell and the target cell were of the same species. The level of 
gene induction indicated that the number of cells affected were likely to be very 
modest. In order to better identify the stem cell types in the follicular dermis, this 
study used a novel mTert-GFP transgenic mouse to identify candidate stem cells on 
the basis of their expression of the stem cell phenotypic marker, telomerase. A small 
population of GFP-expressing non-haematopoietic cells present in the dermis (0.17-
0.49%) were identified and found associated with the follicular dermis and bulge 
region. This minor sub-population of GFP-expressing dermal cells contained all the 
detectable gene expression of four key markers of stem cells: Tert; Oct4; Nanog and 
Sox2, both at time of isolation and after 2 weeks in vitro culture. Intriguingly, non-
haematopoietic, GFP-expressing cells were also detectable in the adult heart at low 
levels (0.08%). After cryo-induced infarct, these non-haematopoietic GFP-expressing 
cells were associated with the epicardium, concentrated close to the infarct site, in a 
fashion consistent with other reports of candidate cardiac stem cells. This study 
indicates that the population of stem cells within the follicular dermis may be very 
modest. Further, it shows that phenotypic markers of stem cells from different organs 
may be a suitable approach for the investigation of the stem cell phenotype. 
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1 Dermal follicular cells as a model for investigation of 
somatic cell differentiation 
1.1 Stem Cell Identification 
Stem cells were described in 1990 by Potten and Loeffer as being undifferentiated cells 
which are capable of self-maintenance, proliferation with production of a large number 
of differentiated functional progeny and are responsible for regeneration of tissue after 
injury (Potten and Loeffer 1990). This remains an accurate description of stem cells; 
they are also considered to be primordial with their specific differentiation potential 
dependent upon their anatomical location. Stem cells have been described as being 
totipotent or multipotent. Totipotent cells have the potential to give rise to all the three 
germ layers, the placenta and extra-embryonic membranes and describe the early 
embryonic and germinal stem cells as has been demonstrated with embryonic stem cells 
(reviewed by Odorico et al., 2001). Multipotent cells give rise to all three germ layers 
and germ cells but not to the trophoblast and include the late embryonic stem cells and 
the neonatal stem cells, which are more differentiated than the early embryonic cells. 
Adult stem cells serve to maintain homeostasis of the organs they reside in, including 
repair after injury, and their potency is dependent upon the number of differentiated cell 
types they can give rise to. Adult stem cells have thought to be restricted in their 
differentiative and regenerative potential to the tissues in which they reside giving rise 
to a limited number of cell types in vivo for example haematopoietic stem cells (HSC) 
reconstituting blood after lethal irradiation. The stem cells give rise to new progeny that 
are less potent as the progenitor cells, however not yet as differentiated as the tissue 
cells; these are termed transit amplifying cells; Potten and Lajtha, in 1982, described the 
number of transit amplifying stages as being dependent upon the number of cells 
produced by that organ (Potten and Lajtha 1982). 
However, the differentiation of adult stem cell progeny being described as linear and 
irreversible has been challenged by a number of pieces of work where adult stem cells 
of specific tissues have been shown to contribute to another previously unrelated tissue, 
giving rise to the concept of plasticity and stem cells being defined by their 
functionality. Enriched bone marrow populations provide the best examples; HSC can 
differentiate into mature hepatocytes in the liver of rodents (Petersen et al., 1999; 
Theise et al., 2000) and humans (Theise et al., 2000, Alison et al., 2000), as well as 
microglia and macroglia (Eglitis and Mezey 1997); cell lineages unrelated to that of the 
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HSC. Therefore the concepts and models of stem cells are frequently revised in order to 
accommodate new data. 
The microenvironment, including contact with surrounding cells, the extracellular 
matrix (Hay 1991), oxygen concentrations (Studer et al., 2000) as well as growth and 
differentiation factors are likely to play a role in determining stem cell function; now 
termed the stem cell niche. The niche concept was introduced in 1978 (Schofield 1978) 
with spleen colony forming units; however, it was largely neglected until Drosophila 
studies provided a stimulus for its resurgence (as reviewed by Lin 2002); niche cells 
provide a sheltering environment, normally located deep within tissues, that sequesters 
stem cells from differentiation stimuli, apoptotic stimuli, and other stimuli that would 
challenge stem cell reserves and thereby enables them to maintain tissue homeostasis. 
The niche also safeguards against excessive stem cell proliferation that could lead to 
cancer (Moore and Lemischka 2006). Stem cells periodically activate to produce 
progenitor or transit amplifying cells that are committed to produce mature cell 
lineages; maintaining a balance of stem cell quiescence and activity is therefore a 
hallmark of a functional niche (Moore and Lemischka 2006). 
Identifying niches and determining how they are regulated is experimentally 
challenging. To look systematically for niches in a target tissue, stem cells first need to 
be identified by gene expression or cell surface antigen expression, for example, and 
these cells need to be marked and their progeny also tracked. When individual stem 
cells have been localized, evidence that they reside in a common microenvironment is 
sought by characterizing cellular neighbours, expression patterns of signalling 
molecules and local environmental factors such as extracellular matrices. If 
commonalities are found, then the microenvironment can be disturbed to determine 
which aspects, if any, affect stem cell behaviour. Evidence of cardiac stem cell clusters 
in the adult heart (Anversa et al., 2006A) suggests a potential stem cell niche. Although 
these clusters are scattered throughout the myocardium, their distribution appears to be 
conditioned by the distinct levels of wall stress where the frequency of cardiac stem cell 
clusters is inversely related to the hemodynamic load sustained by those anatomical 
regions. These clusters accumulate in the atria and apex and are less numerous at the 
base and mid-portion of the left ventricle (Leri et al., 2005). Stem cells and supporting 
cells in the niches interact structurally and functionally through specialised gap and 
adherent junction proteins, that mediate passage of small molecules and signals 
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involved in cell-to-cell communication; in the human heart these are connexin-40, 
connexin-43 and connexin-45 (Vozzi et al., 1999). Additionally, these gap junctions 
interfere with the activation, commitment, and migration of stem cells out of the niches. 
Survival factors traverse gap junctions to oppose cell death and favour cell growth (Leri 
et al., 2005) but the identity of these molecules at the moment is largely unknown. 
Any functional test or assay that would aim to demonstrate clonogenicity, self-renewal 
or multilineage differentiation could alter that cell by changing its characteristics or 
potency (Loeffer and Potten 1997). Therefore, complex cell surface markers are more 
often used to isolate a number of specific stem cell populations by FACS; as yet there is 
no one gene or marker that absolutely defines a stem cell from any tissue or 
developmental stage. Side population cells have been isolated from a number of adult 
tissues, including skeletal muscle, bone marrow, liver, lung, kidney, and brain and are 
associated with stem cell or progenitor cell populations. Tissue-derived side population 
cells are isolated by their efflux of the DNA binding dye, Hoechst 33342 (Goodell et 
al., 1996) which has proven useful for selecting stem cell populations including for 
example HSC and skeletal muscle stem cells however this is not particularly definitive 
(Liadaki et al., 2005). 
Current stem cell research is largely focusing on understanding the role of the stem cell 
in homeostasis and cell turnover and their regulation. This becomes the base for 
investigating their response to injury, regeneration and their potential for differentiating 
to unrelated cell types as a precursor for their potential in treatment of disease. This 
thesis investigates the dermal follicular cells of the skin, the dermal papilla (DP) and 
dermal sheath (DS), which have been attributed stem cell properties and may be capable 
of directed differentiation; their differentiation potential towards a cardiomyocytic 
linage is investigated here. The cardiac stem cell population of the heart is investigated 
in response to cryo-induced injury using a mouse model whereby potential stem cells 
are identified by their telomerase reverse transcriptase (TERT) expression. 
1.2 Significance of heart disease 
Diseases of the heart and circulatory system are the main cause of death in Europe; 48% 
of all deaths are from coronary heart disease, accounting for over 4.30 million deaths 
each year (European cardiovascular disease statistics 2008). It is thus a leading cause of 
death throughout the Western world and the main cause of both congestive heart failure 
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and sudden cardiac death (Lopez 2006). Myocardial infarction (MI) results from an 
acute reduction of blood to the myocardium, which leads to myocardial necrosis with 
overloading of the myocardium and gradual loss of large numbers of cardiomyocytes. 
These cardiomyocytes are removed, largely by macrophages, and replaced by scar 
tissue that may also be surrounded by poorly contractile surviving cardiomyocytes 
(Frangogiannis et al, 2002). Cardiac wall thinning and cardiac remodelling, among 
other factors, lead to diminished functional capacity of the heart and eventual heart 
failure and ultimately death of the patient follows. 
MI results in a number of necrotic cardiomyocytes; at this time of injury the cardiac 
cells appear unable to regenerate the tissue that is damaged. The early inflammatory 
phase is marked by the necrotic cardiomyocytes being replaced by granulation tissue, 
with stimulation of angiogenesis and recruitment of regulatory peptides and 
inflammatory cells, for example macrophages, to the MI site. This is followed by the 
fibrogenic phase where the granulation tissue is replaced by fibrillar, collagenous tissue 
largely due to the interstitial fibroblasts (Sun and Weber 2000). There is as yet no 
evidence that a potential cardiac stem cell population, which would be expected to be 
responsible for regenerating the cardiac tissue, is activated in response to an MI. 
Proposed reasons for this may include a delay in stem cell mobilisation or a lack of 
signalling to the cells to be mobilised due to the fibrotic scar tissue, the hypoxic 
environment of the scar being too hostile for cell survival for repair, cardiac stem cells 
in the area of the infarct also being necrotic or simply the cardiac stem cells are just not 
capable of regenerating such a large area of isolated tissue. 
In summary, the human myocardium is inadequate to compensate for the severe loss of 
functional cardiomyocytes, potentially due to limited intrinsic regenerative capacity 
(Angelini and Markwald 2005), in both MI and other heart diseases states with current 
treatment often only delaying the progression of the disease. Conventional therapies, for 
example drug treatment with P-blockers, an antihypertensive medication that limits the 
activity of epinephrine, and angiotensin-converting enzyme (ACE) inhibitors which 
inhibit the formation of angiotensin II responsible for artery constriction, slow the 
progression of the disease process in the myocardium, however they do not address the 
problem of cardiomyocyte loss or replacement of the myocardial scar within 
functioning contractile tissue. In principle three main strategies could be proposed to 
induce muscle regeneration following myocardial regeneration: 
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• The surrounding myocytes stimulated to migrate to the site of infarct and 
proliferate to repair the defect. 
There is a little evidence that this occurs naturally; with mammalian M I there is almost 
always the presence of a scar with evidence of infiltrating cardiomyocytes however this 
is not sufficient to fully repair the infarct. 
• The cardiac granulation tissue, that is rich in fibroblasts, induced to differentiate 
into myocytes rather than forming a scar 
With better understanding into cardiac differentiation it may be possible to induce the 
formation of new myocardium; it has been shown that cells in cardiac granulation tissue 
can be induced to differentiate into skeletal muscle by transfection with MyoD, a 
myogenic determination gene (Murry et al., 1996) however as yet there is no evidence 
for cardiomyocyte differentiation. 
• Cardiomyocytes, or cells that will differentiate into cardiomyocytes, 
transplanted into the area of injury 
There is preliminary data for a number of stem cell types that have potential to be used 
in this way; currently, it is the most promising of these three potential interventions. 
There is a large body of evidence suggesting that stem cells of several lineages can 
differentiate to cardiomyocytes and a number of them, for example bone marrow HSC, 
are in clinical trial phase. However, the defining criteria for successful differentiation 
vary from cardiomyocyte-associated gene expression to functional improvement of M I 
hearts; in addition a number of methods of induction of differentiation are used 
including, for example, co-culture. These methods will be discussed later in this section. 
The challenges with transplanting any cell type into the heart will lie in the ability of the 
transplanted cells to home to the myocardial tissue and i f they differentiate to 
cardiomyocytes, to remain within it. The long term fate of transplanted cells into the 
heart needs to be investigated; whether these cells remain viable and functional or 
whether they contribute to teratoma formation. Also the capability of the host tissue to 
promote differentiation of the engrafted cells and associated angiogenesis may be 
necessary for ischemic tissue to be replaced by functional cardiomyocytes. The ability 
of transplanted cells to differentiate to cardiomyocyte-like cells ( i f the cell type is not a 
differentiated cardiomyocyte) and the structural and functional integrity of the 
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implanted cells will need to be assessed to avoid arrhythmias due to uncoordinated 
electrical activity. 
A number of different cell types have been explored as a possible source of 
cardiomyocytes for myocardial repair with varying degrees of success; be it by direct 
(into the heart) or indirect (into the bloodstream) injection of a cell suspension. Another 
consideration is the application of undifferentiated stem cell population e.g. HSC or a 
differentiated cardiomyocyte population. 
A prospective donor cell would ideally have the following qualities: 
1. Easy to harvest/isolate and proliferative. It is important that the donor cell can be 
isolated with relative ease so that a significant number of cells can be harvested. I f the 
donor cell requires to be differentiated into a cardiomyocyte then having a large number 
of source cells minimises passage number in tissue culture. I f the cells need to be 
expanded in vitro before being used then it is important the donor cell is proliferative in 
culture, without evidence of transformation events that may cause the cells to have 
unlimited division when transplanted into the myocardium. 
I f the donor cell population need to be injected/applied to the heart without further 
manipulation then it is necessary to harvest a sufficient amount of cells from one or a 
limited number of donors. From a clinical perspective it would be advantageous for the 
method of cell isolation/harvest to be as simple as possible so it could potentially be 
transferable to a hospital environment. For any external, potential sources of 
cardiomyocytes, there wil l be a limited amount of cells that can be isolated. 
2. Non-immunogenie. When transplanting a cell population into a patient it is important 
to prevent tissue rejection, especially with an organ like the heart where immune 
rejection would have severe detrimental effects. I f a tissue source wil l be immunogenic 
then a patient can be administered immunosuppressants (Hosenpud 2005), however the 
degree of immunogenicity wil l need to be considered to ensure organ rejection would 
not occur. 
3. Ability to differentiate into cardiomvoevtes. The donor cell should be able to 
differentiate into a cardiomyocyte be it in vivo or in vitro. The cardiomyocyte must be 
functional; i f the cells are differentiated in vitro it is necessary that the differentiation is 
controlled to produce a specific population of cells and in vivo that the population of 
cells once in the patient's body will differentiate into cardiomyocytes and not a cell of a 
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different lineage leading to potential teratomas. Therefore a level of control is necessary 
be it in vitro by manipulation of the cells or in vivo by the resident cardiomyocytes or 
signalling pathways. 
4. Integration with the resident cardiomvocytes. The donor cell must integrate with the 
resident cardiomyocytes improving functionality of the damaged heart. One indication 
of communication is evidence of the donor cardiomyocyte establishing gap junctions 
with the neighbouring native cardiomyocytes, namely connexin-40 and connexin-43 
(Coppen et al., 2003), found between cardiomyocytes in vivo. 
5. Ability to survive. It is important that the donor cell survive in the heart long enough 
to improve the global cardiac function. It may not be necessarily a requirement of the 
donor cell to be able to survive the length of the life of the heart itself, as it may only be 
a temporary aid by providing for example a scaffold for resident cardiomyocytes to 
infiltrate. However, it is necessary that the cells survive in vivo. 
The challenge to date has been to find a cell type that has all these qualities; many of 
the cell sources investigated including differentiated, undifferentiated, progenitor, 
precursor and adult cells, have shown evidence of limitations in the number of these 
qualities they express. For example to date, donor (allogenic) cells are relatively easy to 
obtain but involve immunosupression for the patient. Autologous cells have no 
immunological problems but are more difficult to obtain and often hard to expand. 
Being able to generate a cardiac cell-based therapy may provide a source of functional 
cells that would replace normal scar formation. It has long been assumed that the reason 
for poor regeneration of the adult heart was the absence of endogenous progenitor cells; 
however this concept has been challenged with a number of pieces of evidence that 
support the theory of native cardiac stem cells and these will be discussed. 
1.3 Development and maintenance of the heart 
1.3.1 Cardiac development 
The commitment of unique cellular lineages to distinct regions of the heart guides the 
three-dimensional events of cardiac development (Buckingham et al., 2005). 
Understanding how stem and progenitor cells adopt cardiac-cell fate and subsequently 
assemble into the functional heart may lead to new approaches to repair or regenerate 
damaged heart muscle; insights into cardiogenesis from progenitor cells during 
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embryogenesis will compliment the investigation into reprogramming cells for 
therapeutic use. 
Two distinct mesodermal heart fields emerge from the primitive streak during 
gastrulation and contribute cells to the developing heart. The first heart field (FHF) 
derives cells from the anterior lateral plate mesoderm and forms a crescent shape at 
approximately embryonic (E) day 7.5 in the mouse embryo (week 2 of human 
gestation) (Srivastava 2006); by E8 (week 3 of human gestation) these cells coalesce 
along the ventral midline to form the primitive linear heart tube (Srivastava 2006). This 
structure consists of an interior layer of endocardial cells and an external layer of 
myocardial cells; separated by extracellular matrix which permits signalling between 
the layers. It is thought that the second heart field (SHF), marked by Isletl (Isll) 
expression and comprising the dorsal-medial aspect of the cardiogenic plate, migrate to 
the scaffold provided by the FHF and contribute to chamber formation (Cai et ai, 
2003). Interestingly Isll is expressed in the post-natal heart by cells in cardiac niches 
and is thought to denote undifferentiated cardiac progenitor cells (Laugwitz et ai, 2005; 
Moretti et ai, 2006), this is discussed later. As the heart tube forms, the SHF cells 
migrate to the pharyngeal mesoderm at the midline. Rightward looping occurs and the 
SHF cells cross into the anterior and posterior portions of the tube, thought to be 
attracted to migrate by factors secreted by the anterior portion of the tube; these cells 
populate a large portion of the outflow tract, and future right ventricle, and atria with 
the FHF making up the majority of the cells in the left ventricle with a small 
contribution from the SHF; the chamber configuration is apparent by E9.5 (Srivastava 
2006). Endocardial and epicardial signalling then encourages these cells to differentiate 
with chamber growth and expansion of the myocardium. Concurrently, the developing 
cardiac segments become subdivided by septa that initially are mesenchymal in 
composition and later in development become highly muscularised. Cardiac 
muscularisation is a result of two distinct mechanisms involving the growth and 
expansion of pre-existing myocardium and/or the recruitment of new cardiomyocytes 
from intracardiac and extracardiac mesenchyme located adjacent to the expanding 
myocardium (Srivastava 2006). Cells migrating from the neural crest septate the 
outflow tract of the developing heart and contribute to formation of arterial valves and 
the coronary arteries. These cells have been suggested to contribute to the development 
of the venous pole of the heart, but this process is poorly understood although there is 
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evidence it plays a role in nerve innervation (Hildreth et al., 2008). The development of 
the heart is shown in figure 1.1. 
A number of transcription factors are associated with early cardiomyocyte induction 
and commitment. These include Nkx2.5, GATA4, Mef2c and tbx5; four genes widely 
recognised as having roles in the developing embryonic heart as well as being 
expressed in the adult cardiomyocytes at lower levels. The initiation of cardiac 
differentiation has been vigorously investigated; however as yet there is no single 
transcription factor that appears responsible for the differentiation of lateral plate 
mesoderm into cardiac cells. The drosophila tinman gene encodes an NK-class 
homeodomain-containing transcription factor, identified Nkx2.5 in vertebrates (also 
known as Csx) and this is one of the earliest genes expressed in pre-cardiac mesoderm 
from both the FHF and the SHF; transcripts for murine Nkx2.5 are detected in early 
myocardiogenic progenitor cells at E7.5 (Srivastava and Olson 2000). Nkx2.5 is 
necessary for initiation of looping morphogenesis and chamber formation and its 
expression is maintained in the myocardium of embryonic and foetal hearts, as well as 
being linked to a number of downstream transcription factors (Lyons et al., 1995). 
The GATA family of zinc finger-containing transcription factors appear to be 
potentially critical in the progressive differentiation of pre-cardiac cells specifically in 
the formation of the linear heart tube when the FHF coalesce. GATA4 is detected at the 
same embryonic ages as Nkx2.5, E7.5, where it is confined to the cardiogenic crescents. 
GATA4 is co-expressed with Nkx2.5 in subsequent myocardial cells and by E9-10, is 
found in abundance in the atria, ventricles and proximal outflow where expression 
continues in the late foetal and adult heart. GATA4 is also responsible for controlling 
normal formation of the endoderm underlying the myocardial precursors (Srivastava 
and Olson 2000). Research into the inhibitory and activation domains indicates that 
Nkx2.5 undergoes conformational changes when interacting with other co-accessory 
factors, enabling it to become a more effective transcriptional activator (Sepulveda et 
al., 1998). Nkx2.5 has an upstream enhancer that has a binding site for GATA4 (Brown 
et al., 2004) and the C-terminus of Nkx2.5 has been shown to act as a transcriptional 
inhibitor; it is proposed that GATA4 may cause a conformational change in Nkx2.5 
such that the negative constraint is eliminated. 
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Figure 1.1: Morphogenesis of the mammalian heart 
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(Adapted from Srivastava 2006) 
Mammalian heart development. Myocardial progenitor cells originate in the primitive 
streak from where the first heart field (FHF) form the cardiac crescent; the second heart 
field (SHS) cells medial and anterior to the FHF (i.) where differentiated myocardial 
cells are now observed (mouse E7.5). The early cardiac tube forms through fusion of 
the cardiac crescent at the midline (E8). SHF cells lie dorsal to the straight heart tube 
and begin to migrate (arrows) into the anterior and posterior ends of the cardiac tube to 
form the right ventricle (RV), and part of the atria (A), known as looping («.). 
Following rightward looping of the heart tube, cardiac neural crest (CNC) cells also 
migrate into the outflow tract from the neural folds to septate the outflow tract and 
pattern the bilaterally symmetric aortic arch arteries (III, IV, and VI) (Hi.). Septation of 
the ventricles, atria, and atrioventricular valves ( A W ) results in the four-chambered 
heart (iv.). 
V, ventricle; LV, left ventricle; LA, left atrium; RA, right atrium; AS, aortic sac; PA, 
pulmonary artery. 
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GATA4, in complex with Nkx2.5, associates with tbx5 promoting cardiomyocyte 
development (Hiroi et al., 2001); together these are involved in atrial septation and left 
ventricular formation (Srivastava and Olson 2000). 
Mef2c, a MADS-BOX transcription factor, is expressed at the late cardiac crescent 
stage (E7.75) medial to the crescent as well as in the SHF and subsequently throughout 
the linear, looping, and multi-chambered heart (Srivastava and Olson 2000). It has been 
identified to be important in the looping of the heart tube at the stage where the tube 
forms the right ventricular chamber. Mef2c also appears to be a target of Isll as is 
indicated by an enhancer element within the Mef2c gene which is regulated by Isll as 
well as GATA4 (Dodou et al., 2004). GATA4 can also recruit Mef2 to GATA-
dependant regulatory elements to create specific active transcriptional complexes which 
are likely to confer degrees of tissue specificity during heart development (Morin et al., 
2000). Mef2c is also thought to associate with Nkx2.5 where the two genes up-regulate 
each other and are thought to initiate cardiomyogenesis (Skerjanc et al., 1998). 
T-box transcription factor 20 (tbx20) affects expansion of FHF- and SHF-derived cells 
and is necessary for outflow tract development, possibly by regulating Nkx2.5 and 
Mef2C (Srivastava 2006). In addition tbx5 appears to be a positive regulator of early 
cardiogenesis and chamber specification; GATA4, tbx5, and Nkx2-5 may form a 
complex required for proper cardiac septation (Srivastava 2006). 
These four transcription factors are central to the development of the functional, 
organised cardiomyocytes as is demonstrated by knock out studies; homozygous null 
alleles for each of these genes results in severe congenital heart malformations mostly 
associated with the heart tube looping morphogenesis (Lyons et al., 1995; Lin et al., 
1997; Molkentin et al., 1997). Early cardiomyocytes do form without the expression of 
these genes, however, their functionality and organisation is disrupted which results in 
embryo re-absorption. The expression of these genes are maintained in the adult heart, 
albeit at low levels, and has been associated with cardiac stem cells as will be discussed 
later in this chapter. Because these four genes are maintained in embryonic, as well as 
adult, cardiomyocytes they make ideal markers for investigating potential 
cardiomyocyte differentiation. 
There are a large number of genes associated with the functional cardiomyocyte, 
controlled by the transcription factors described, that are associated with sarcomere 
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formation. The sarcomere of the cardiomyocyte is composed of thick and thin 
filaments; the thick filaments extend from the centre of the sarcomere and are 
composed of myosin heavy and light chains and supported by binding to titin 
molecules. The thin filament is made up of actin, troponin and tropomyosin (Takeda 
2003); in the cardiomyocyte the cardiac specific sarcomere structural genes, alpha 
myosin heavy chain (a-MHC), myosin light chains specific to the atria (MLC1A) and 
ventricle (MLC1V), tropomyosin and cardiac actin are essential as well as genes 
associated with contractions including troponin I and titin (Wessels et al., 1991; Hill et 
al., 1992; Zammit et al., 2000). 
Myosin, essential for muscle contraction, is a multi-subunit protein that is made up of 
two heavy chains; two phosphorylated light chains and two non-phosphorylated light 
chains. Different myosin isoforms are found in cardiac, skeletal, smooth and non-
muscle cells where myosin heavy chain (MHC) is the major contractile protein in the 
heart; a-MHC and P-MHC are expressed in cardiomyocytes. The myosin composition 
of the heart is of physiological significance; the relative distribution of a-MHC and P-
MHC is in direct correlation with the contractile performance of the heart. a-MHC is 
associated with increased shortening of the cardiac velocity. In contrast; P-MHC is 
associated with hypocontractile states. a-MHC mRNA is expressed in the cardiac tube 
between days E7.5 and E8 but diminishes between days E8 and E9 as the ventricular 
chambers form (Haddad et al., 2003; Kolossov et al., 2005). It remains at low levels 
until just after birth, where P-MHC is the predominant myosin heavy chain isoforms in 
the ventricles during fetal development. At birth there is a dramatic increase in thyroid 
hormone and also a dramatic change in the expression of the myosin heavy chain 
isoforms; a-MHC levels increase to as much as 95% of the total MHC in the heart in 
humans, 90% in small mammals, and remain high throughout adult life (Haddad et al., 
2003). Within the a-MHC promoter are binding sites for Mef2c, GATA and KO of a-
MHC results in cardiac deformities (Jones et al., 1996). 
Tropomyosin is an essential thin filament protein that binds to cardiac actin and 
troponin I which regulate the calcium sensitive interaction of actin and myosin in the 
heart (Adhikari and Wang 2004). The tropomyosin 1 isoform specific to striated muscle 
consists of 10 exons and is designated a-tropomyosin and it is expressed mainly in the 
heart. During fetal development a-tropomyosin represents 80% of the total tropomyosin 
of the heart but in the adult heart 98% (Hill et al., 1992). 
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1.3.2 The evidence for the cardiac stem cell 
Increases in cardiac mass during foetal and embryonic life arise predominantly as a 
consequence of cardiomyocyte proliferation, however during neonatal life there is a 
transition from hyperplastic to hypertrophic growth that further increases the 
myocardial mass as cells withdraw from the cell cycle (MacLellan and Schneider 2000; 
Chien and Olson 2002). This lead to the long-held belief that the adult heart was a 
terminally differentiated organ. Hypertrophic growth is not typically accompanied by 
cardiomyocyte proliferation; in the adult myocardium it is generally believed that the 
vast majority of cardiomyocytes do not proliferate. This view is supported in part by 
clinical observations; functionally significant myocardial regeneration has not been 
documented in diseases or injuries where there is cardiomyocyte loss; the major 
response to myocardial damage was thought to be hypertrophy of still-viable 
cardiomyocytes that had exited the cell cycle (Barile et al., 2007). Furthermore, primary 
myocardial tumours are rarely observed in adults. These observations suggest that the 
proliferative capacity of adult cardiomyocytes is quite low, however they do not 
exclude the existence of a limited degree of hyperplasic growth in either the normal or 
diseased myocardium. 
A number of studies investigated the possibility of the cardiomyocytes having 
proliferative capacity, mostly by monitoring cardiomyocyte DNA synthesis as an 
approximation of cell division, as genome reduplication is a prerequisite for cell 
proliferation. One of the earliest approaches used to monitor genome reduplication was 
to score for the presence of mitotic figures which clearly identifies dividing nuclei 
(Sasaki et al., 1968; Rumyantsev and Marakjan 1968; Rumyantsev 1983) however the 
duration of the appearance of mitosis, the M phase, is short and in a low proliferative 
tissue capturing a time point to identify such mitotic figures can be problematic. Direct 
assessment of DNA, for example by incorporation of deoxyribonucleotide analogues 
such as tritiated thymidine (Kuhn et al., 1974; Wachtlova et al., 1977; Clubb and 
Bishop 1984; Erokhina and Rumyantsev 1986; Marino et al., 1991; Soonpaa et al., 
1996) and BrdU labelling in pulse chase experiments (Nakagawa et al., 1988; Reiss et 
al., 1993; Kajstura et al., 1994; Cheng et al., 1995; Li et al., 1996A; Soonpaa et al., 
1996; Machida et al., 1997), was employed in a number of studies to assess 
cardiomyocyte DNA synthesis. The reported values for cardiomyocyte DNA synthesis 
are in good agreement at the early stages of heart development, where a relatively large 
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percentage of cells are proliferating; a range of 10-46% according to mice and rat 
studies (reviewed by Soonpaa and Field 1998). The main discrepancies appear in the 
frequency of DNA synthesis in healthy and diseased hearts in late neonatal and adult 
animals where the level of cardiomyocyte DNA synthesis is, on average, markedly 
lower. A range of dividing cells have been reported in normal developmental adult 
hearts ranging from 0-3.5% with an average of 0.43% (reviewed by Soonpaa and Field 
1998); with ranges for injury slightly higher with averages of 2.53% for spark injury, 
13.22% for left ventricular infarct and 4.32% for coronary banding (reviewed by 
Soonpaa and Field 1998). However, these values are influenced by a number of 
potential factors such as nuclear misidentification, variation due to species, age of the 
animals (for example adolescent hearts may retain a degree of development-associated 
cardiomyocyte DNA synthesis), type of injury used etc., which may affect the 
percentage of cells demonstrating DNA synthesis as well as the possibility of these 
dividing cells being cell types other than cardiomyocytes, for example fibroblasts in 
response to injury. 
This small, but evident, percentage of dividing cells was suggestive of a population of 
cells capable of division and offered an alternative view of cardiac homeostasis. Initial 
evidence of cycling ventricular myocytes in the normal and pathologic adult 
mammalian heart (Beltrami et al., 2001; Kajstura et al., 1998) following the 
identification of dividing cardiomyocytes, added further speculation to the existence of 
a proliferative population of cardiomyocytes. This raised questions over the 
reconciliation of the well-documented irreversible withdrawal of cardiomyocytes from 
the cell cycle soon after birth and the presence of cycling myocytes in the adult heart. 
As a result, several independent studies described a cardiac stem cell or progenitor cells 
that may be responsible for the mitotically active cells and limited myocardial 
regeneration in response to injury. These studies took one of three approaches to isolate 
potential cardiac stem cells from the heart. The first was isolation of cells based upon 
their ability to efflux Hoechst dye, which is associated with side populations, or the 
presence of cell-surface markers, either c-kit, sca-1 or Abcg2 by magnetic cell sorting 
and flow cytometry The second was tissue culture of cardiac explants with spontaneous 
cardiosphere formation in vitro. The third was expression of the islet-1 gene as a 
potential marker of embryonically derived cardiac progenitor population. 
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Beltrami et al., isolated potential cardiac stem cells from adult rat hearts by their 
expression of the surface marker c-kit (Beltrami et al., 2003). In sex mismatched 
cardiac transplants in humans, the female hearts in male hosts had a significant number 
of Y chromosome-positive myocytes and coronary vessels (Quaini et al., 2002) 
potentially indicating male cells colonized the female heart after transplantation; cells 
of both donor and recipient origin were found to express c-kit, as well as sca-1 and 
moreover cells positive for these two cell surface antigens were detected in human 
control hearts (Quaini et al., 2002; Teyssier-Le Discorde et al., 1999). Beltrami 
identified c-kit+ve cells in the myocardium of 20-25 month old rats which were small 
cells, approximately one tenth the size of cardiac myocytes, arranged in clusters. These 
cells were negative for blood lineage markers including CD34, CD45, CD20, and CD8 
(lineage-ve) (Beltrami et al., 2003). FACS sorting indicated a number of these cells, 7-
10% of the c-kit+ve cells also expressed Nkx2.5, GATA4 and Mef2 and <0.5% 
expressed sarcomeric proteins. In culture the c-kit+ve lineage-ve cells were able to 
divide, as demonstrated by Ki67 expression even at passage 23, they were clonogenic 
and demonstrated multipotent heterogeneous differentiation generating cardiomyocytes, 
smooth muscle cells and endothelial cells. However, these cells were morphologically 
and functionally immature, with disorganised structure and no identifiable sarcomeres 
or contractions, potentially indicating they required the terminally differentiated 
myocardial cells for this. To investigate whether these cells could reach maturity in 
vivo, passage 2 cultured c-kit+ve, lineage-ve cells were labelled with BrdU and injected 
into the border zone of experimental MI rat hearts. A band of labelled cells was 
identified in regenerating myocardium in all 10 treated infarcts after 20 days, the 
labelled cells were small relative to mature cardiomyocytes, expressed sarcomeric 
proteins, exhibited visible striations and the gap junction connexin-43 (Beltrami et al., 
2003). Ventricular function was significantly improved and contribution of labelled 
cells to blood vessels was observed. This was confirmed to be attributed to by the c-
kit+ve, lineage-ve cells by repeating the injections with clonally derived cells. One 
potential caveat was the possibility that the c-kit+ve cells fused with existing host cells 
which would give the appearance of differentiation, however Beltrami confirmed the 
labelled myocytes were diploid. 
Around the same time it was reported a population of cardiac progenitor cells co-
purified with sca-1 expression made up 14-17% of cardiac cells, however these cells 
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were c-kit-ve. 0.03% of cells lacked expression of lineage markers CD45 and CD34 
(markers of endothelial progenitor cells), blood cell lineage markers (CD4, CD8, 
TER119), markers of vascular endothelium and lacked haematopoietic transcription 
factors (Lmo2, GATA2 and Tal) (Oh et al., 2003). Interestingly these cells were 
TERT+ve, a gene which has been associated with self-renewal potential. However, in 
contrast to the work of Beltrami these cells did not express early cardiac markers 
GATA4, Mef2, Nkx2.5 or sarcomeric proteins. It was reported these cells 
spontaneously differentiated in vitro however this was after treatment with 5-
azacytidine, with a fraction of cells them demonstrating sarcomeric a-actin, cardiac 
troponin I , Nkx2.5, and MHC. As with the cells Beltrami isolated, membrane dye-
marked sca-l+ve cells were injected into mice after ischemia and were identified in the 
border zone of the injured myocardium expressing sarcomeric a-actin, cardiac troponin 
I , and connexin-43 with evidence of fusion events as well as the presence of grafted 
cells entirely donor-derived (Oh et al., 2003). Unfortunately no functional analysis was 
reported. A year later Matsuura also reported isolation of sca-l-ve cells, however these 
cells were c-kit+ve albeit at low levels. Matsuura reported that sca-l+ve cells made up 
0.3% of the cardiac myocytes of which 40% expressed CD45 and 10% expressed CD34 
and c-kit (Matsuura et al., 2004B). These cells also expressed low levels of Nkx2.5 and 
GATA4. The sca-l+ve cells were treated with oxytocin in culture and spontaneous 
contractions were observed in approximately 1% of the cells, which also appeared 
spindle shaped, after 4 weeks. These cells also expressed higher levels of mRNA for 
Nkx2.5 and GATA4 as well as expression of Mef2c, a- and (i- MHC, myosin light 
chain 2A and 2V, cardiac a-actin, cardiac troponin T and tropomyosin with some 
evidence of connexin-43+ve gap junctions. However, these cultures contained cells 
which were CD45+ve and CD34+ve. In an attempt to ascertain i f the appearance of 
differentiation was attributed to the non-haematopoietic sca-l+ve cells, the sca-l+ve 
CD45+ve cells were cultured separate to the sca-l+ve CD45-ve cells with oxytocin 
treatment. The CD45+ve cells did not demonstrate evidence of cardiomyocyte 
differentiation while the CD45-ve cells expressed evidence of sarcomeres (Matsuura et 
al., 2004). In addition, the sca-l+ve cells were shown to be multipotent by appearance 
of early markers of osteogenesis and adipogenesis after treatment with inducers in 
culture however the cells were not sorted for CD45 expression first, leading to the 
question as to whether this differentiation was due to contaminating haematopoietic 
cells. 
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The bone marrow contains cells which are haematopoietic and are c-kit+ve, sca-l+ve, 
lineage negative and CD34-ive/low which contribute to multilineage reconstitution of 
the mouse blood system (Osawa et al., 1996). In addition there have been reports of c-
kit+ve bone marrow and MSC transdifferentiating into cardiomyocytes in vivo (Orlic et 
al., 2001; Gojo et al., 2003) which suggests c-kit is an important marker for multipotent 
bone marrow-derived cells. In addition, skeletal muscle-derived cells highly express 
CD34 and sca-1 but not c-kit and CD45 (Qu-Petersen et al., 2002; Torrente et al., 
2001). Therefore, the exclusion of CD45+ve cells is important in excluding potential 
bone marrow-derived contaminating cells. 
Messina et al., reported the isolation of undifferentiated cardiac cells that grew as self-
adherent clusters termed cardiospheres (Messina et al., 2004). Explants from human 
atrial and ventricular biopsies and mouse embryonic, foetal and adult hearts, were 
placed in culture. After 1-3 weeks, a fibroblastic layer of cells were generated over 
which small, quickly dividing, phase bright cells migrated. On collecting these cells and 
re-seeding, they formed clusters known as cardiospheres. Murine cardiospheres started 
contracting soon after generation, where human cardiospheres only contracted when co-
cultured with rat cardiomyocytes. Where the cardiospheres were labelled with GFP to 
distinguish them from cells of rat origin, Messina reported the presence of connexin-43 
which indicates communication between the two cell types most likely responsible for 
induced contractions. The cardiospheres were composed of clonally derived cells; when 
dissociated and re-plated the cells once again they generated contracting cardiospheres, 
at 1-10% efficiency, with expression of myosin and cardiac troponin T. The human 
cardiospheres were capable of self-renewal (Messina et al., 2004). The initial bright, 
small outgrowth cells were labelled with BrdU; in the cardiosphere these cells were 
located in the centre of the spheres with cardiac troponin T and MHC positive cells in 
the external layers. 10% of the cells of the newly developed cardiosphere were c-kit+ve, 
sca-l+ve, CD34+ve and also positive for the endothelial marker CD31 where in larger 
spheres, after a period in culture, these surface antigens were expressed mostly in the 
cells in the centre of the sphere, c-kit was expressed in approximately 30% of the cells 
by day 6, with no significant up-regulation of the other 3 markers examined (Messina et 
al., 2004). These cardiospheres were also negative for CD45 and MRD1 as well as a 
cocktail of blood lineage markers (Smith et al., 2007). 
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When cells were isolated from the heart by their ability to efflux the DNA binding dye 
Hoechst 33342 (Goodell et al., 1996; Goodell et al., 1997; Matsuzaki et al., 2004) i.e. 
the ability of side population cells, and encouraged to form cardiospheres in suspension 
culture, the cells were also CD45-ve with heterogeneous CD34, c-kit, flt-1 and sca-1 
expression (Tomita et al., 2005). Messina injected approximately 60 cardiospheres 
subcutaneously into mice; the cells spontaneously contracted and contained tubular 
formations, cardiac sarcomeres with cardiac troponin T, sarcomeric myosin and a-
smooth muscle actin expression. When injected into the viable myocardium of the 
border zone of the MI heart, they observed bands of regenerating myocardium 
throughout most of the infarct area with preservation of wall thickness and significant 
functional improvement. 
Tissue-derived side population cells isolated by their efflux of the DNA binding dye, 
Hoechst 33342 (Goodell et al., 1996) is dependent on the expression of Abcg2, a 
member of the family of ATP-binding cassette (ABC) transporters (Scharenberg et al., 
2002; Kim et al., 2002). Martin et al., used Abcg2 as a marker of the side progenitor 
cells during embryogenesis and in the adult mouse model to attempt to define a cardiac 
progenitor cell population. They initially investigated the cells expressing Abcg2 during 
embryogenesis where it was expressed, by immunohistochemistry and PCR, in the E8.5 
mouse heart expression was decreased by mid-gestational ages, E11.5-E13.5, to a 
subpopulation of cardiac cells (Martin et al., 2004). This suggests that these cells may 
contribute to the development of the heart and form a pool of cardiac progenitor cells. 
These cells did not express desmin, which is expressed early during cardiomyocyte 
differentiation suggesting these cells may remain in an embryonic progenitor-like state 
while cardiomyocyte differentiation occurs in other cells. 
The expression of Abcg2 was detected throughout cardiac development and persisted in 
the adult heart; these cells were sca-l+ve, c-kit+ve/low, CD34+ve/low and CD45+ve 
/low. In addition, endothelial cell-associated cell surface antigen Tie2 was not 
detectable in over 90% (6-9% were Tie2+ve) of the side population cells. The side 
population cells were investigated for their differentiation and proliferative capacity in 
vivo to determine if they could give rise to mesodermal derived cell populations and 
therefore may represent a cardiac stem cell population. The cells expressed a-actinin 
after co-culture with cardiac main population cells and formed haematopoietic colonies 
on methylcellulose media. Transcriptional analysis indicated these cells were negative 
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for the endothelial marker CD31 (Martin et al., 2004), in contrast to the cells isolated by 
Oh and Messina, and had expression of Mef2C associated with early cardiomyocyte 
differentiation. The findings of Pfister a year later complimented those reported by 
Martin; Pfister claimed the CD31-ve cells exhibited functional cardiomyogenic 
differentiation while the CD31+ve cells did not (Pfister et al., 2005). Of the side 
population cells, 84% expressed sca-1 and 75% expressed CD31 with <1% expressing 
CD45, CD34, CD44 and c-kit; however the low c-kit expression was attributed to 
enzyme cleavage during the digestion of the cardiac tissue. In addition the sca-l+ve 
cells also expressed Nkx2.5 and GATA4 as well as smooth muscle actin and desmin, 
both associated with early myofilament formation. Sca-l+ve, CD31+ve cells composed 
the majority of the total side population cells (~74%). The CD31-ve cells adhered to 
plastic in culture and spread out becoming spindle shaped, unlike the CD31+ve fraction 
which were non-adherent. In addition, after co-culture with adult cardiomyocytes, the 
CD31-ve cells expressed GATA4 and Mef2c and demonstrated electromechanical 
coupling with the cardiomyocytes with gap junction connexin-43 expression in the 
absence of cell fusion which was not reported with the CD31+ve cells (Pfister et al., 
2005). 
Islet-1 (Isll) is a transcription factor that is expressed in a number of cells in the right 
ventricle, regions of the left ventricle, the atria and the outflow tract in the developing 
embryonic heart (Cai et al., 2003). The population of cells that give rise to these organs 
are from the SHF, as discussed. In addition to Isll, these cells also expressed Nkx2.5 
and GATA4 and they remain undifferentiated until later in development, when Isll 
expression is lost with cardiomyocyte differentiation. Laugwitz et al., demonstrated that 
Isll+ve cells were identified in the mouse embryonic heart; their number decreases 
progressively from El2.5 to El8.5 and after birth an average of 500-600 Isll+ve cells 
were identified in the 1 -5 days old rat myocardium, indicating a very rare population. 
Their neonatal distribution matched that of the embryonic profile of Isll+ve cells of the 
SHF; clusters of cells were identified in the atria and single cells in the ventricles 
(Laugwitz et al., 2005). Laugwitz used a cre-recombinase triggered cell line tracing 
method to irreversibly label isll expressing cells and their differentiated progeny; when 
they induced cre-recombinase expression in embryos and investigated the neonatal 
heart; p-gal+ve cells were identified in their highest proportion in the right ventricle and 
made up 30-40% of the cells of the entire heart, with co-labelling of sarcomeric a-actin 
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with the differentiated P-gal+ve cells. Isl+ve cells isolated from the neonatal heart, and 
transferred into culture were analysed by FACS and were identified within the cardiac 
mesenchymal cell fraction where Isll+ve cells corresponded to 0.5% of this population. 
The cells expressed Nkx2.5 and GATA4 but when their cell surface antigens were 
investigated they were negative for sca-1 and c-kit. They also did not efflux Hoechst 
dye, indicting these cells are distinct from side population cells. Co-culture of the cells 
with neonatal cardiomyocyte induced cardiac a-actin and troponin T expression, there 
was also a subset of contractional cells with action potentials similar to that of the 
neonatal cardiac myocytes with evidence of connexin-43+ve gap junction formation, 
properties not attributed to by fusion events (Laugwitz et al., 2005). More recently, 
Moretti reported that these cells were multipotent, contributing to smooth muscle, 
pacemaker cells and vascular endothelium of the heart as well giving rise to smooth 
muscle and endothelial cells in vitro (Moretti et al., 2006). In summary, the isll+ve 
cells have only been isolated from very young samples; it remains to be seen whether 
these cells exist in the adult heart; indeed a single human sample analysed at 148 days 
demonstrated no Isll+ve cells. It is also noted that although a high percentage of cells 
expressed troponin I (25%) in the work described above, only 2.3% demonstrated 
calcium transients characteristic of cardiomyocytes. Isll+ve cells have also not been 
implicated in the failing heart and therefore their role in cardiac pathology is poorly 
understood. Therefore, although these initial results do not exclude the possibility that 
some Isll+ve cells may be present in the adult myocardium; their role here needs to be 
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In an effort to try to explain why there are conflicting gene expression profiles it was 
proposed by Anversa that there are four classes of cardiac immature cells which 
progress from a more primitive to a more differentiated phenotype: cardiac stem cells, 
progenitors, precursors and amplifying cells (Anversa et al., 2006A). By this 
classification the cardiac stem cells would be self-renewing as well as producing the 
cardiac progenitor cells, which express c-kit, MDR1 and sca-1 on their surface as well 
as the early cardiac associated gene GATA4. The cardiac progenitor would then divide 
to produce the endothelial progenitors with G A T A 4 expression, the smooth muscle 
progenitors with G A T A 4 and G A T A 6 expression, and the myocyte progenitors with 
GATA4, Nkx2.5 and Mef2c expression. Each progenitor then becomes precursors; 
endothelial precursors that express genes such as V W F and CD31, smooth muscle 
precursors that express alpha-smooth muscle actin and myocyte precursors expressing 
sarcomeric proteins. These precursors therefore possess stem cell antigens, transcription 
factors, and membrane and cytoplasmic proteins typical of myocytes, endothelial cells, 
and smooth muscle cells. Amplifying cells have nuclear, cytoplasmic, and membrane 
proteins of cardiac cell lineages but are negative for stem cell antigens. The transient 
amplifying stem cells therefore act as a means of protection for the progenitor cells. 
Not all the reports of conflicting cell surface antigen can be explained by the 
classification system proposed by Anversa and the ultimate cardiac stem cell remains 
elusive. In summary, proposed cardiac stem cells are assigned this status by expression 
of a variety of surface antigens and embryonic genes but generally these cells are 
undifferentiated, lineage negative, demonstrate proliferation and differentiation 
potential in vitro and in vivo as well as self-renewal and clonogenicity. They may prove 
to be a valuable source of cells for investigation into methods of stimulating the 
regenerative cardiac capacity or for comparison to propose cell types for cardiac 
transplantation and they continue to provide a better understanding of the regenerative 
role of the heart. 
1.4 A source of stem cells for cardiomyocyte differentiation 
The cardiomyocytic differentiation potential of a number of cell sources have been 
investigated in an attempt to better understand the gene expression profile and antigenic 
changes associated with the cardiac stem cell population giving rise to the differentiated 
cardiomyocyte. Unrelated cell types have been assessed for their potential as a 
therapeutic cell for the MI heart; to mimic cardiogenesis and improve cardiac function. 
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Investigated cells include skeletal muscle satellite cells, embryonic stem cells, 
hematopoietic stem cells, mesenchymal stem cells and crude bone-marrow cell 
suspensions. These will be discussed. 
1.4.1 Satellite Cells 
The skeletal muscle is able to regenerate itself after injury; a property attributed to the 
satellite cells also termed myoblasts, which are the reservoir of regenerative precursor 
cells for skeletal muscle tissue. These cells normally lie in a quiescent state under the 
basal membrane of skeletal muscle fibres, they have the ability for self-renewal and 
fuse with the surrounding muscle fibre and differentiate into functional skeletal muscle 
following skeletal muscular injury (Collins 2006). For clinical studies, the skeletal 
myoblasts, besides their non-cardiac origin, have ideal properties of a cardiac donor 
cell. They can be easily isolated from a muscle biopsy, rapidly amplified in an 
undifferentiated state in vitro, only able to differentiate into multinucleated myotubes 
eliminating the risk of tumour formation and have a high resistance to ischemia induced 
apoptosis (Hagege et al., 2003). 
Skeletal myoblasts have been used in a large number of experimental studies, using 
both small and large animal models (Dowell et al., 2003) where most studies concluded 
that the grafted cells differentiated into multinuclear skeletal myotubes (Reinecke et 
al., 2000, Reinecke et al., 2002) incorporating into the host myocardium. These cells 
did not demonstrate electrophysiological coupling with the host myocardium 
characterised by short action potential durations, as demonstrated by their lack of 
expression of intercalated disk proteins N-cadherin and connexin-43 (Reinecke et al., 
2000). Despite this, several studies in animal models demonstrated beneficial effects 
including an improvement to both regional and global left ventricular function 
(Menasche et al., 2004); improvement of the left ventricular ejection fraction along with 
increased wall thickness, significant reduction in fibrosis and apoptosis, and a 
significant increase in cell proliferation has also been reported (Hata et al., 2006). 
Skeletal myoblasts were the first cells to be tested in clinical trials for myocardial 
replacement cell therapy (reviewed by Menasche et al., 2005). Several phase I safety 
and feasibility pilot studies have reported the use of autologous skeletal myoblast 
transplantation for the treatment of heart disease (Herreros et al., 2003; Pagani et al., 
2003; Siminiak et al., 2004; Smits et al., 2003; Siminiak et al., 2005; Menasche et al., 
2003). These studies suggested that myoblast transplantation was "technically feasible, 
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could be implemented with a low incidence of procedural complications and resulted in 
differentiation into myotubes whose engraftment seems to be sustained over time" 
(reviewed by Menasche et al., 2005). A growing body of experimental data and initial 
clinical studies has shown not only engraftment of donor cells but also improvement in 
global cardiac pump function (Ghostine et al., 2002; Murry et al., 1996; Hagege et al., 
2003; Taylor et al., 1998). 
However, some clinical studies with myoblasts were associated with a number of 
patients demonstrating ventricular arrhythmias and sudden cardiac deaths, an 
observation that might be explained by the heterogeneity of electrical membrane 
properties between donor and recipient cells (Leobon et al., 2003; Abraham et al., 
2005). This finding guided changes in future protocols involving skeletal myoblasts, 
which now require prophylactic defibrillator implantation and/or amiodarone therapy to 
prevent ventricular tachycardia. This protocol change resulted in less frequent clinically 
evident arrhythmias. Phase II studies of skeletal myoblast therapy are presently 
underway. 
There seems to be an agreement in these studies concerning the functional recovery of 
the transplanted hearts, as indicated by an improved ejection fraction and improved 
regional contractility of the myoblast implanted segments. The mechanisms by which 
skeletal myoblasts elicit the improvement in heart function remain unclear. One 
possibility is that they are able to satisfactorily arrest infarct expansion and limit post-
infarction remodelling. A second hypothesis is that the enhancement of contractile 
function could be mediated by paracrine factors secreted by the grafted cells (Murtuza 
et al., 2004), as was also suggested by observations using bone-marrow derived cells. In 
addition, fusion between engrafted myoblasts and host cardiac cells has been reported 
(Reinecke et al., 2004). 
Satellite cells are committed solely to the myogenic lineage. Therefore, regardless of 
environmental influences, even if implanted into a scar made up mainly of fibroblasts, 
myoblasts differentiate into functional muscle cells. Although initial studies with 
injected skeletal myoblasts showed promise, this approach may not be suitable for long-
term therapy owing to the failure of the injected cells to become electrically coupled to 
the rest of the heart and to the intrinsic differences in contractile properties between 
cardiac and skeletal muscle cells (Reinecke et al., 2002). 
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1.4.2 Embryonic Stem Cells 
Embryonic Stem (ES) cells are from the inner cell mass of the blastocyst-stage embryo. 
They are considered to be pluripotent, able to give rise to many different cell lineages, 
self-renewing and clonogenic (reviewed by Prelle et al., 2002). E S cells can 
differentiate into any cell present in the adult organism and have the potential to 
completely regenerate the myocardium; however two of the obstacles that stand in the 
way of the therapeutic use of ES cells are immunological rejection and the propensity of 
E S cells to form teratomas when injected in vivo (Nussbaum et al., 2007). However this 
may be overcome by genetic selection of differentiated E S cells or differentiation of E S 
cells in vitro into cardiomyocytes or endothelial cells before injection. 
Cardiogenesis is easily induced in E S cells by culture in embryoid bodies (EB) which 
are cell aggregates cultured in suspension. When the E B is developing, areas of 
spontaneous contraction are suggestive of the presence of cardiomyocytes; normally 
within 1-4 days after plating and with continued differentiation the number of 
contracting cells increases; the rate of contraction within a beating area increases with 
differentiation which is then followed by a decrease in average beating rate with 
maturation (Boheler et al., 2002). Within the E B , during the early stages of 
development, the early-stage cardiomyocytes are round and small, situated in 
accumulations. Within some, the myofibrils are irregularly organised and sparse or not 
present at all and in others the myofibrils are arranged in parallel bundles with evidence 
of A and I bands. As the E S cell-derived cardiomyocytes develop they become 
elongated and show well-developed sarcomeres and myofibrils (Baharvand et al., 
2006). The ES-cell derived cardiomyocytes express cardiac gene products in a 
developmentally controlled manner; as in early myocardial development, G A T A 4 and 
Nkx2.5 mRNA is present in the E B before that of atrial natriuretic factor (ANF), 
myosin light chain-2v, a- and P-myosin heavy chain. The sarcomeric proteins also 
develop in the expected manner in the following order: titin (Z-disc), a-actinin, titin (M 
band), M H C , a-actin, cardiac troponin T, and M protein (Boheler et al., 2002). Human 
E S cells have also been shown to differentiate into spontaneously beating cells with a 
cardiomyocyte phenotype. The morphology and ultra-structure of these cells are 
organized with sarcomeric structures, formation of intercalated disks, desmosomes, and 
gap junctions, characteristic of cardiomyocytes. They also demonstrate action potential 
propagation (Baharvand et al., 2006). However, to date, no human clinical studies have 
been initiated because of both the ethical issues surrounding access to embryos and the 
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possibility of teratoma formation, suggested by a study injecting E S cells in skeletal 
muscle. When transplanted into infarcted myocardium of mice and rats, E S cell derived 
cardiomyocytes have been shown to engraft (Kolossov et al., 2006), differentiate into 
cardiomyocytes, smooth muscle cells, and endothelial cells (Singla et al., 2006), and 
improve cardiac function (Min et al., 2002). The engrafted E S cells have demonstrated 
expression of proteins characteristic of cardiac phenotypes such as a- and P-MHC, a-
actinin and cardiac actin, however in one study, despite the presence of N-cadherin 
which is important in formation of intercalated discs and gap junctions, expression of 
connexin-43 was not detected (Laflamme et al., 2005). Recently, using cardiomyocytes 
derived from human E S cells injected into rats, after 4 weeks, engrafted E S cells 
exhibited sarcomeric structure and expressed cardiac muscle markers and connexin 43, 
suggesting the presence of nascent gap junctions between donor and host cells (Dai et 
al., 2007). 
There is, therefore, a growing body of knowledge from animal models regarding the 
steps of isolation, differentiation, and clinical application of E S cells after MI; as 
knowledge of pathways for E S cell differentiation and for heart embryonic development 
increases, E S cell differentiation might become more controllable. 
1.4.3 Haematopoietic Stem Cells 
Haematopoietic stem cells (HSC) are bone marrow derived cells that give rise to 
myeloid and lymphoid lineage. These cells are normally identified broadly by their 
expression of a combination of a number of cell surface antigens including CD34-
ve/low, sca-l+ve, c-kit+ and lineage negative (mouse). H S C are also assigned this stem 
cell status by their demonstration of differentiation and proliferation using colony-
forming units (Ogawa et al., 2006). 
There is some evidence of HSC differentiation into cardiac lineage cells; however this 
is almost entirely in vivo based work. On the occasions, HSC have been reported to 
differentiate in vitro to cardiomyocytes, they are isolated from the bone marrow but not 
separated from the mesenchymal stem cells (MSC) or other bone marrow derived cells. 
The reason for this is mostly because HSCs in culture are indistinguishable by 
morphology from their nuclear differentiated cell types; identifying the true stem cells 
is difficult which is compounded by the reluctance of H S C to proliferate in culture. 
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However there have been a number of investigations into the H S C in vivo; in 2001 
Orlic et al., reported that lineage-ve, c-kit+ve bone marrow HSC, after injection into the 
border zone of infarcted mice, differentiated into cardiomyocytes, vascular endothelial 
and smooth muscle cells. This led to rapid regeneration of more than 60% of the 
infarcted ventricle and improved cardiac function (Orlic et al., 2001). Jackson et al., 
isolated side population cells from bone marrow; these cells extruded Hoechst dye and 
were CD34-ve/low, c-kit+ve and sca-l+ve. When transplanted into lethally irradiated 
mice, rendered ischemic by coronary artery occlusion/perfusion, the engrafted cells 
migrated into ischemic myocardium and differentiated into cardiomyocytes and 
endothelial cells, and contributed to the formation of functional tissue (Jackson et al., 
2001). Kajstura et al., in 2005 showed that lineage-ve, c-kit+ve HSCs efficiently 
differentiated into myocytes and coronary vessels with no detectable differentiation into 
haematopoietic lineages and independent of cell fusion (Kajstura et al., 2005). 
However, a number of recent investigations have questioned whether trans-
differentiation of HSCs actually occurs in damaged hearts; they suggest the transplanted 
HSCs did not readily acquire a cardiac phenotype in the injured heart, but adopted only 
traditional haematopoietic fates and that cell fusion may explain the earlier observed 
results (Murry et al., 2004; Balsam et al., 2004; Nygren et al., 2004). With fusion 
currently being investigated within a large number of research groups it may shed light 
on the H S C potentiality as an independent cell population. 
1.4.4 Mesenchymal Stem Cells 
Mesenchymal stem cells (MSC) are found in bone marrow, muscle, skin, and adipose 
tissue and are characterised by their potential to differentiate into any tissue of 
mesenchymal origin, including muscle, fibroblasts, bone, tendon, ligament, and adipose 
tissue. M S C from adult bone marrow can be separated by density gradient 
centrifugation and adhering-cell culture in defined serum-containing medium (Boyle et 
al., 2006). The cells isolated after adherence in culture are CD34-ve and CD45-ve, 
unlike H S C from bone marrow. They have been investigated by a number of groups 
and are proposed as the most promising cells in the bone marrow for cardiomyocyte 
differentiation. A large number of studies demonstrate M S C treated with 5-azacytidine, 
a global DNA methylating agent, induces MSC to differentiate to contracting 
cardiomyocyte-like cells which, when injected into injured myocardium, express 
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cardiac markers and appear to adopt a differentiated cardiomyocyte phenotype (Hattan 
et al., 2005). However, the grafting of these cells has been reported to be at low 
frequency. The use of 5-azacytidine, although widespread in M S C cardiomyocyte 
differentiation studies, alters the DNA of the cells treated with such potency it is 
arguably not true differentiation but re-programming; such an agent will not likely 
make clinical trial. Although 5-azacytidine may not be suitable for clinical use in this 
manner, differentiation of the M S C prior to implantation appears to remain relevant. 
A number of studies have indicated the potential for these cells to differentiate into 
other MSC lineages in the myocardium; one study demonstrated unselected bone 
marrow cells transplanted into acutely infarcted myocardium caused significant intra-
myocardial calcification; a lineage attributed to M S C (Yoon et al., 2004). However 
there are a number of reports of MSC trans-differentiation into cardiomyocytes and 
vascular-like structures in vitro (for example Toma et al., 2002) in both normal and 
non-MI hearts. These cells have been characterised by immunohistochemistry and stain 
positively for cardiac and endothelial specific markers, as well as gap junction proteins 
(for example Gojo et al., 2003). These results suggest that MSCs act by regenerating 
functionally effective, integrated cardiomyocytes and possibly new blood vessels. 
Allogeneic M S C have also been injected directly into the pig heart, by catheter, 
resulting in regeneration of myocardium, reduced infarct size, and improved regional 
and global cardiac contractile function and, most importantly, with no evidence of 
rejection (Amado et al., 2005). 
Rat MSC, in co-culture with adult rat cardiomyocytes, stained positively for a-actin, 
desmin and cardiac troponin (Wang et al., 2006). In another case rat M S C , co-cultured 
with neonatal rat ventricular myocytes with separation by a semi-permeable membrane, 
demonstrated contractions and cardiac troponin T expression with additional limited 
expression of a-actinin, desmin and cardiac troponin I (Li et al., 2007B). 
MSCs also have been studied clinically; Chen et al., randomized 69 patients after MI to 
receive intracoronary autologous MSC or placebo. They demonstrated a significant 
improvement in global and regional left ventricular function and a significant reduction 
in the size of the perfusion defect, suggesting that M S C therapy can regenerate infarcted 
myocardium or protect against left ventricular remodelling. (Chen et al., 2004). 
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1.4.5 Clinical Trials 
Although the experimental studies, as discussed above, demonstrate contradictory 
conclusions in places regarding cardiac trans-differentiation and cardiac repair of bone 
marrow-derived stem cells, injecting bone-marrow stem cells into an injured heart 
potentially represents a new therapy prompting several clinical trials. 
In most clinical trials, bone marrow-derived cells or peripheral blood-derived 
endothelial progenitor cells were transplanted via intracoronary cell infusion in patients 
after myocardium infarction (reviewed by Wollert et al., 2006). In several other trials, 
bone marrow cells were delivered to the chronic heart failure patients by direct intra-
myocardial injection (for example Stamm et al., 2003) or catheter-based intracoronary 
infusion (Fuchs et al., 2003). Although these clinical trials assure safety and feasibility, 
the initial results are ambiguous. Five separate double-blind, placebo controlled studies 
are described below: 
• R E P A I R - A M I (Reinfusion of Enriched Progenitor Cells and Infarct 
Remodelling in Acute Myocardial Infarction) and the T O P C A R E - C H D 
(Transplantation Of Progenitor Cells And Recovery of left ventricular function 
in patients with Chronic ischemic Heart Disease) Trials 
A modest 3-5% significant improvement in ejection fraction versus controls (Assmus et 
al., 2006; Lunde et al., 2006; Schachinger et al., 2006). Those patients with more 
severe reduction of ventricular function experienced the greatest benefit (Schachinger et 
al., 2006). 
• The B O O S T II (BOne marrOw transfer to enhance ST-elevation infarct 
regeneration) Trial 
Significant improved ejection fraction after 4 months, but no significant difference 
between control and treated individuals at 18 months (Meyer et al., 2006). 
• The S T E M I (ST-Elevation acute Myocardial Infarction) and the A S T A M I 
(Autologous Stem Cell Transplantation in Acute Myocardial Infarction) Trials 
No improvement in global cardiac function (Lunde et al., 2005; Janssens et al., 2006; 
Lunde et al., 2006) 
There are also a number of clinical studies ongoing. Clinical trials, as listed by the 
government of the U.S. of trials associated with their hospitals list in excess of 50 
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current trials, mostly into determination of functional improvement as a result of bone 
marrow stem cell transplantation as well as investigations into their safe administration 
and effect on neogenesis, including: 
• Phase I/II clinical trial at the Rigs hospital in Denmark 
To evaluate safety and clinical effects of autologous M S C transplantation in 46 patients 
with severe chronic myocardial ischemia. This trial will end in November 2009. 
Patients will be treated with direct intra-myocardial injections of ex-vivo expanded 
MSC. Clinical and objective evaluations will be performed at baseline and at 1-year 
follow-up. 
• Myocardial Stem Cell Administration After Acute Myocardial Infarction 
( M Y S T A R ) study 
A randomized, single-blind clinical trial started in 2005 and due to end this year which 
was designed to compare the early and late intracoronary or combined (percutaneous 
intramyocardial and intracoronary) administration of bone marrow-derived stem cells to 
patients after acute MI. The study consists of 360 patients randomly assigned into one 
of four groups, Group A: early treatment (21-42 days after MI) with intracoronary 
injection; Group B: early treatment (21-42 days after MI) with combined 
(intramyocardial and intracoronary) application; Group C: late treatment (3 months 
after MI) with intracoronary delivery; and Group D: late treatment (3 months after MI) 
with combined (intramyocardial and intracoronary) administration of BM-SCs. The 
study was designed to determine the feasibility of the bone marrow-derived stem cell 
delivery modes, determined by the rates of complications, outcomes to be assessed by 
changes in global left ventricular ejection fraction. 
• Amorcyte myocardial repair study (AMRS)- A Phase I Trial of Intra-Coronary 
Infusion of Bone Marrow Derived Autologous CD34+ Selected cells in Patients 
With Acute MI 
This is a 40 patient clinical trial started in 2005 which is still recruiting patients. It is a 
randomized trial to evaluate the safety and efficacy of a CD34+ve stem cell population, 
administered through the infarct related coronary artery 6 to 9 days after successful 
infarct related artery stent placement, and assessment of the effect on cardiac function 
and infarct region perfusion. 
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At this time unequivocal proof of concept is still lacking, in either the clinical or 
experimental arena, for using bone marrow stem cells for cardiac repair through trans-
differentiation into myocardial tissue. Thus, stem cell-based improvement of cardiac 
function may be achieved by mechanisms other than from differentiation of those cells 
into cardiomyocytes. The beneficial effects of cell therapy, as described above, on 
cardiac function following MI might be explained by a number of known variables, 
including host cardiomyocyte survival/death pathways, neo-angiogenesis, matrix 
reorganization, etc. 
There are a number of problems associated with each of the proposed cells types for 
investigation of cardiomyocyte differentiation. E S cell isolation has ethical issues, is 
associated with teratoma formation and the availability of human material is limited. 
HSC are difficult to investigate in vitro as well as difficult to identify in vivo with 
debatable cardiomyocyte differentiation. M S C are capable of differentiation to a wide 
range of cell lineages; the risk of their differentiation into a lineage other than 
cardiomyocyte in the myocardium has been shown to be possible and may be too much 
of a risk for in vivo application, however it remains a promising cell source. Whole 
bone marrow transplantation is possibly the cell type with potential, as is reflected in its 
use in phase II clinical trials however it may also be associated with differentiation of 
cells to a lineage other than cardiomyocyte. Skeletal satellite cells have been associated 
with ventricular arrhythmias and in some cases sudden cardiac deaths. In addition to the 
cell types that have demonstrated differentiation to cardiomyocytes, native cardiac stem 
cells are not sufficiently mobilised after an MI. There is limited consideration as to 
fusion events in a lot of these studies where engraftment is reported and this may 
account for the problems associated with some of the clinical trials where the cells do 
not appear to provide a functional improvement in the heart. Due to the life span of 
rodents, the long term effects of stem cell transplantation and introducing new cells into 
the heart has not been investigated. Long-term studies in the mouse and rat rarely 
extend beyond 6 months. Inevitably, with human clinical trials comes the first long term 
results to date. Therefore the search continues for a suitable cell type for cardiac 
transplantation. In addition to this; the pathways involved in the cardiac stem cell role 
in homeostasis as well as its inability to cope with MI, are not entirely understood; an 
ideal cell type may only be identified when the cardiac stem cell presence and role is 
fully understood. 
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It is interesting that in the work of Beltrami (Beltrami et al., 2003) where 10,000 cells 
were injected into the myocardium of MI hearts; there was comparable functional 
improvement as to that reported by Messina after injection of nearer 60 cardiospheres 
i.e. the number of cells being injected was not relative to the amount of repair or 
functional improvement. This apparent conflict in the number of cells injected and the 
functional improvement has been observed in a number of cases, most significantly 
with injection of bone marrow-derived cells. The differentiation potential of bone 
marrow-derived cells has been discussed in this chapter; however the uncoupling of the 
number of cells injected to the functional improvement, is noteworthy here. Bone 
marrow derived stem cells delivered to the heart were shown to transdifferentiate to 
cardiomyocyte-like cells and rescue cardiac function (Orlic et al., 2001) in a similar 
manner to the cardiospheres and cells described by Beltrami, Matsuura and Messina 
among the others described above. These results were challenged when various groups 
failed to demonstrate permanent engraftment and no evidence of bone marrow cell 
transdifferentiation (Balsam et al., 2004; Murry et al., 2004; Nygren et al., 2004), 
however there did remain significant improvement of left ventricular function. One 
theory was that sub-sets of the transplanted cells secreted growth factors in a paracrine 
fashion that may be involved in the beneficial effects or that cells may induce an 
inflammatory response that induces cell recruitment that in turn increases, for example, 
angiogenesis. When considering the value of the identification of cardiac stem cells and 
their therapeutic role this is an important consideration. It may indicate that the MI 
model may be an unsuitable method of investigation of cardiomyocyte differentiation 
potential, and that in vitro investigation will be a more accurate representation of cell 
source potential until a more suitable cardiac injury model is discovered or the cardiac 
stem cell is better understood. 
It is proposed that components of the skin may be suitable for investigation of 
cardiomyocyte differentiation; specifically the dermal papilla (DP) and dermal sheath 
(DS) cells of the hair follicle. The DP and DS have both demonstrated stem cell-like 
properties both in vivo and in vitro; they are easily accessible and have previously 
demonstrated differentiation towards adipocytic and osteocytic lineages with some 
early spontaneous indications of myocyte differentiation. These properties are described 
below. It is proposed that the cells of the DP and DS may overcome problems 
associated with previously described stem cells as discussed above. 
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1.5 The skin and its appendages 
The skin is derived from the ectoderm and the mesoderm during embryonic 
development, which gives rise to the epidermis and dermis, respectively. Within these 
layers are specialised appendages, also derived from the ectoderm and/or mesoderm 
including sweat glands, sensory nerves and hair follicles. The skin layers rest upon the 
subcutaneous tissue which is largely a mesh of collagen fibre, fat cells and muscle 
(reviewed by Prost-Squarcioni 2006). The skin has a number of functions including 
support where the skin acts as a flexible support for underlying tissues, and protection 
as the epidermis acts as a barrier to potentially dangerous absorptive materials. The 
sensory receptors on the skin recognise pressure, pain and temperature and the 
extensive blood supply and sweat glands control the body temperature. The skin 
excretes waste materials, e.g. excess salt and water, and melanin expression protects the 
lower dermal layers from U V radiation. The outer most keratinized skin layer of the 
epidermis, the stratum corneum, provides passive defence against entry of opportunistic 
organisms and the spinous layer contains epidermal Langerhan's cells for 
immunological surveillance (Romani et al., 2006). The total number of hair follicles for 
an adult human is estimated at 5 million; 1 million are on the head with 100,000 on the 
scalp, the palms and soles of the feet are the only areas of the body that do not contain 
hair follicles. The basic hair follicle structure remains the same from one mammalian 
species to the next, with modifications for specialised functions. The hair follicle is 
recognised as a separate entity within the skin formed and maintained from interactions 
between dermal and epidermal skin components. These cells are abundant and easily 
accessible; a small scalp skin biopsy would yield a large number of follicular cells. 
At the heart of the hair follicle is the dermal papilla (DP) which is encased in the end 
bulb. The DP is onion shaped in the normal hair follicle; however in disease states its 
shape changes e.g. in alopecia areata the DP becomes smaller and densely packed. The 
DP is derived from the dermal mesenchyme and consists of a highly active group of 
cells that are capable of inducing follicle development from the epidermis and 
production of hair fibre as shown in figure 1.3. The cells that lie around the DP, and are 
the source of hair follicle formation, are called the cortical or germinal matrix cells; 
they differentiate and become keratinized to form the hair cortex, which is densely 
packed keratinized cells, and surrounding hair cuticle of the hair shaft in a process 
known as induction. At the centre of the hair shaft is the medulla where the cells aren't 
so densely packed; cells surrounding the hair shaft comprise the inner root sheath which 
34 
is divided into the cuticle, Huxley layer and Henle layer based on structure and pattern 
of keratinisation (Hardy 1992). The hair follicle and hair structure is shown in figure 
1.3. 
At the level of the sebaceous gland the inner root sheath breaks down to leave only the 
hair cortex and the surrounding cuticle which protrude above the epidermis. The outer 
root sheath is distinct from the other epidermal components described, in that it is 
continuous with the epidermis, the upper part is normally keratinized although the 
lower part generally isn't; in the outer root sheath at the bulge region, which will be 
described later, is the arrector pili muscle which allows the hair to stand erect. Between 
the outer root sheath and DS is a basement membrane which has a protective function 
to divide the cells descended from embryonic ectoderm (epidermis) and embryonic 
mesoderm (dermis). The dermal sheath (DS) encloses the epidermal component and 
consists of a layer of mesenchymal cells which extends from the stratum papillaris to 
the DP; it runs the entire length of the hair follicle on the outside of the outer root 
sheath (Hardy 1992). As briefly described cells of the DP and DS are proposed as a cell 
types for differentiation investigation; it is apparent here that the DP and DS cells are 
distinct and defined populations of cells in the hair follicle; they can be isolated from 
the remainder of the hair follicle easily. 
In embryogenesis the establishment of the DP is essential to the development of the hair 
follicle and associated structures. The DP is an aggregation of dermal fibroblast cells 
just below the epidermis which is initially established in the human embryo at 60 days 
old; at this stage the DP cells are loosely connected and present as long and spindle 
shaped; their presence indicates the site for future development of a hair follicle. Above 
the DP develops an epidermal plug which is a collection of cells that proliferates into 
the dermis, known as the hair peg, which links with the DP. There is further 
proliferation of the epidermal matrix cells and differentiation into the sheath and hair 
fibre. The DP develops into its more identifiable round structure. It is the DP that 
directs and dictates the embryonic generation of a hair follicle and it retains this ability 
throughout the life of the hair follicle. If the DP is removed, hair growth is prevented; 
however the lower third of the DS is capable of compensating by supplying new cells 
for regeneration of a new DP. If more than a third of the lower hair follicle is removed 
the DP cannot easily be reformed and the hair follicle is deemed destroyed (Messenger 
etal., 1986). 
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Early development and differentiation of the hair follicle and primitive hair shaft. 
i. The epidermal epithelium, above the dermal mesenchyme, initiates proliferation of 
epidermal basal keratinocytes. Proliferation of these cells results in the formation of the 
hair germ, which signals the dermal mesenchymal cells to aggregate beneath it to form 
the DP. ii. The DP signals the continued proliferation of the hair germ producing the 
hair peg (primitive hair shaft). The DP cells proliferate and tightly aggregate and the 
primitive hair shaft engulfs it to form the inner hair root, directly above the DP. The 
inner root sheath elongates, about halfway up the hair follicle, and the sebaceous cells 
and bulge are formed. Melanin granules enter into the cortex to give the pigmentation. 
Hi. The follicle growth extends at an angle to the epidermis. The sebaceous glands 
mature and become localized on the lateral wall of the follicle. The hair canal is formed; 
the hair shaft differentiates and extends into the hair canal. The hair shaft extends 
beyond the skin. 
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It has been shown that the human dermal components can induce hair growth when 
implanted into athymic mouse vibrissae follicles; the implanted cells interact with the 
follicle epithelium creating new follicle end bulbs; it was found that contact with the 
underlying epithelium was necessary to follicle formation (Home and Jahoda 1992). DP 
and DS can also induce new hair follicles when implanted s.c. into the ears and 
footpads i.e. areas of skin that are normally non-hairy (McElwee et al., 2003). 
1.5.1 Hair cycling 
The average rate of hair growth is 0.35mm a day although the rate does vary upon the 
site of the hair follicle and the age and sex of the individual. Sinus hairs are very large 
cells that are modified to act as mechanical sensors e.g. whiskers or vibrissae on rats, 
which are structurally identical to normal hairs except for size. Hair growth is a cyclic 
event consisting of three main events (Paus 1998): 
1. Anagen 
This is the active growth phase of the hair cycle and is the stage at which the hair fibre 
is produced. It is further split into the following phases: 
Proanagen- This marks the initiation of growth; DNA synthesis occurs in the 
follicle 
Mesanagen - intermediate stage 
Metanagen - at this stage the follicle is at its maximum length and girth 
This is the longest growth phase; up to 90% of follicles in the normal scalp are in this 
active hair growth state at any time. The length of the anagen growth phase for scalp 
hair is usually 6-10 years. In most young mammals, the anagen growth phase occurs in 
waves across the skin surface but in humans the cycles of growth can occur completely 
independent of surrounding follicles. Melanin is made in the hair bulb throughout this 
phase. The hair bulb is located in the subcutaneous fat. 
2. Catagen 
This marks a period of controlled regression of the hair follicle; it normally lasts 14-21 
days. It is a state of quiescence and cessation of new hair growth known as the 
intermediate phase. The hair in catagen may detach itself from the underlying matrix 
which produced it and be held in place by friction, the base of the follicle moves 
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upwards towards the surface of the skin with the hair bulb located in the dermis; this is 
known as the club hair. 
3. Telogen 
This is a transition stage whereby the hair follicle renews itself and makes the change 
over back to the anagen stage again, it is known as the shedding phase. Approximately 
10% of follicles of the normal human scalp are in this phase of hair cycling at any given 
time which normally lasts 30-90 days. In this stage, the hair bulb is located in the mid-
to-upper dermis. 
The fact that the DP needs to be in contact with the underlying epithelium in order to 
produce new hair follicles indicates that the epithelium and DP communicate via direct 
contact. This shows the DP responds to some sort of inductive signal in order to 
produce the specific cell types required which indicates that, under different inductive 
molecules, the DP may be able to produce a different cell type. It has been discussed 
that the DS can produce a new DP in its absence which indicates the DS has stem cell 
properties and again under specific inductive signalling can produce a cell type different 
to itself; it may be that under different inductive signalling the DS can be induced to 
producing a different cell type to that which it produces in the follicle 
microenvironment. 
1.5.2 Stem cells of the skin 
The skin contains stem cell populations that have different roles in normal homeostasis 
as well as in response to injury. The stem cells discussed here are those of the 
epidermis, briefly, and those of the dermis; namely the bulge region as well as the 
proposed second population in the hair follicle; cells of the DP and DS. 
1.5.2.1 Epidermal stem cells 
Mature epidermis is a stratified squamous epithelium whose outermost layer is the skin 
surface. The basal layer, which is mitotically active, secretes and assembles an 
extracellular matrix which constitutes much of the underlying basement membrane that 
separates the epidermis from the dermis. As cells leave the basal layer and move 
outward toward the skin surface, they withdraw from the cell cycle, switch off integrin 
38 
and laminin expression, and become terminally differentiated. The interfollicular 
epidermis contains its own progenitor cells to ensure tissue renewal in the absence of 
injury; the hair follicles contain multipotent stem cells that are activated at the start of a 
new hair cycle and upon wounding to provide cells for hair follicle regeneration and 
repair of the epidermis (reviewed by Blanpain and Fuchs 2006). The interfollicular 
epidermis, which generates the lipid barrier of adult skin, constantly renews its surface 
and undergoes re-epithelialisation after wound injuries. These renewing and repairing 
activities of the skin epidermis imply the existence of stem cells. 
Histological analysis has shown that mouse epidermis is organized in stacks of cells 
with a hexagonal surface area lying on a bed of ten basal cells where the basal cells 
divide asymmetrically relative to the basement membrane to maintain a proliferative 
daughter and give rise to a differentiating daughter cell overlying it; this structure was 
hypothesized to function as an epidermal proliferative unit (EPU) with one putative 
stem cell per unit. Cultured human interfollicular epidermal keratinocytes expressing 
the highest level of (31-integrin have been shown to have the higher proliferative 
potential in vitro; these cells are located in the basal layer of the epidermis and the base 
of the deepest epidermal ridges of palmoplantar skin consistent with the location of 
slow-cycling stem cells (Jensen et al., 1999). These cells, in the basal layer of the 
epidermis, were also found to reside in clusters; possibly indicative of an epidermal 
stem cell niche (Fernandes et al., 2004; Jensen et al., 1999). It is noted, however, that 
these cells have also been identified outside these zones indicating that (31-integral 
levels may not necessarily define the stem cell population. Current research focuses on 
additional markers which are needed to enrich the purification and analysis of these 
potentially highly proliferative cells. 
During injury; the hair follicle cells contribute to the healing of the interfollicular 
epidermis; however the functional role of these cells has not entirely been resolved. A 
recent investigation used the Edaradd mutant mouse, which lacks all appendageal 
structures in the tail skin including hair follicles, was undertaken to investigate the 
epidermal response to wound healing in the absence of the intervention of the hair 
follicle derived cells (Langton et al., 2008). They observed that the wound on the 
hairless skin did not close as quickly, initially, as on normal hairy skin; however after a 
lag period of 4 days, wound reepithelialised in a similar manner to control skin. This 
would indicate that the hair follicle does contribute to wound closure, possibly to 
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accelerate the onset of wound healing, but is not necessarily essential. This in turn may 
help answer the questions as to why hair-bearing areas of skin tend to heal more quickly 
than areas lacking follicles. 
The bulge region of the hair follicle has been most implicated in the hair follicle role of 
epidermal wound healing (Ito et al., 2005). Using cre-recombinase under the promoter 
for keratin 15 (K-15) bulge cells were demonstrated to migrate to the epidermis 
following wounding; short term analysis (8 days) indicated approximately 26% of the 
cells in a reepithelialised wound originated in the bulge which dropped to 4% after 20 
days (Ito et al., 2005) indicating they may behave as transit amplifying cells. 
1.5.2.2 Bulge region stem cells 
The bulge region is located in the hair follicle at the level of the insertion of the arrector 
pilli muscle, for pelage follicles, and located well below the sebaceous glands, not at all 
related to the arrector pilli muscle, in vibrissal follicles. It forms a small protuberance of 
the outer root sheath located in the upper portion of the hair follicle; the basal layer of 
the bulge region rests on a thick basement membrane that separates it from the dermal 
sheath and, nearer the hair, is separated by a layer of stratified cells. The bulge region is 
widely believed to contain epithelial stem cells (Cotsarelis et al., 1990) and these cells 
have been shown to be to be multipotent (Taylor et al., 2000; Oshima et al., 2001). The 
cells located in the bulge region cycle infrequently but have a highly proliferative 
capacity; BrdU label persists in quiescent bulge cells for more than six months 
(Cotsarelis et al., 1990; Morris and Potten 1999). Moreover the bulge region contains 
95% of the clonogenic keratinocytes, as indicated by K-15, K-19 and CD34 expression 
and absence of CD71 expression normally associated with actively cycling cells, where 
the end bulb contains only 5% (Kobayashi et al., 1993). 
Initiation of a new anagen cycle depends upon activation of a small number of 
quiescent stem cells that reside in the bulge, which is considered to be a source of stem 
cells for the hair follicle as well as the epidermis. These activated stem cells proliferate 
and differentiate into progenitor cells (matrix cells) that give rise to the differentiated 
lineages that comprise the hair shaft and root sheaths (Sarin et al., 2005). 
There is a growing body of evidence that bulge region contains pluripotent neural crest 
stem cells, termed epidermal neural crest cells (eNCSC). eNCSC are promising 
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candidates for diverse cell therapy paradigms because of their high degree of inherent 
plasticity (Sieber-Blum et al., 2004). These bulge cells have been shown to be capable 
of directed differentiation towards neurons, glia, keratinocytes, smooth muscle cells, 
and melanocytes in vitro (Amoh et al., 2005). 
Further investigation into the specific markers of the bulge region cells, their potential 
to contribute to hair follicles, skin and other tissues, as well as the cellular and 
molecular microenvironment that maintains these cells, will elucidate the potential of 
the bulge cells. At the moment, although the anatomical location of these cells is 
known, their identification in the excised hair follicle or dermis is difficult and normally 
requires labelling of a number of bulge cell-associated genes to confidently identify it. 
Although it is an exciting population of cells with multipotency, the difficulties in its 
isolation and therefore poor analysis in vitro compared to other stem cell types, make its 
use in differentiation experiments limited at the moment. 
1.5.2.3 Dermal follicular cells - a source of donor cells 
The DP and DS follicular cells do have all the attributes that are important in a donor 
cells. The DP and DS are easy to isolate by micro-dissection; the different cell 
populations are easy to identify and isolate without significant contamination of 
surrounding tissue. Also a considerable amount of cells can be harvested from, for 
example, rat vibrissae for research and human scalp hairs for clinical application. The 
cells have been shown in culture to be proliferative and retain their cell viability 
throughout a number of cell passages. The cells are also immunologically tolerated on 
transplantation (Reynolds et al., 1999) and have inductive and differentiation properties 
(Jahoda et al., 2001B; Jahoda et al., 2003A) The DP and DS are considered by many 
groups to therefore be stem cell-like in their properties and their potential applications 
are increasing. 
A number of adult cell populations have broader stem cell capabilities than previously 
thought; this was examined with the dermal follicular cells and their haematopoietic 
stem cell activity with a view to develop the follicle as a stem cell model system. Cells 
within the DP and DS generated haematopoietic colonies in vitro; rodent hair follicle 
end bulbs as well as micro-dissected DP and DS cells actively produced cells of 
erythroid and myeloid lineages where follicle epithelial cells did not (Lako et al., 2005). 
Cultured DP and DS cells from transgenic donor mice were transplanted into lethally 
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irradiated recipient mice and multilineage haematopoietic reconstitution was observed, 
over 70% of clonogenic precursors were derived from donor hair follicle cells, when 
assayed at intervals of up to one year indicating their potential primitive stem cell 
nature. Harvested bone marrow from primary mice then re-populated secondary, 
myeloablated recipients with multi-lineage haematopoietic engraftment (Lako et al., 
2003). These properties were not associated with blood cell contamination with DP and 
DS isolation as aorta and peripheral blood both failed to demonstrate haematopoietic 
activity in vitro. These observations suggest the DP and DS harbour multi-potent cells, 
the capacity of which is harnessed under specific environmental conditions. 
Components of the hair follicles have also demonstrated inductive properties. 
Amputated hair follicles, where end bulb, DP or entire lower one-third is removed, have 
been shown to regenerate new DP and renew production of hair fibre. However, when 
the amount of amputated tissue exceeded this amount the vibrissae failed to reform a 
new DP as well as hair fibre (Jahoda et al., 1992). Moreover, DP can be implanted to 
adult skin and wil l induce the formation of new hair follicles from undifferentiated 
epidermis; these induced hair follicles retain morphologic and hair cycle characteristics 
of the donor hair follicle (Reynolds and Jahoda 1991). In a similar manner, human hair 
follicle DP also demonstrated induction of hair growth when implanted into mouse 
follicle epithelium where new fibre-producing end bulbs were created (Jahoda et al., 
2001B). 
DS cells are capable of regenerating the DP, however in a wound environment they 
have also demonstrated the ability to become wound healing fibroblasts and perform an 
important function in the repair of skin dermis after injury (Jahoda and Reynolds 2001). 
The dermal follicular cells have demonstrated capacity to be incorporated into skin 
wounds where they are capable of forming hair follicles; these cells can also create hair 
follicle-derived skin equivalents (Gharzi et al., 2003). In a wound environment new hair 
follicles were formed only with the inclusion of intact DP, however DS cells combined 
with outer root sheath cells were capable of producing skin equivalents in organotypic 
chambers with characteristic dermal and epidermal architecture and a normal basement 
membrane (Gharzi et al., 2003). Such inductive properties have been associated with 
stem cell types and provide further evidence as to the stem cell properties of the DP and 
DS. 
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Spontaneous appearance of muscle, lipid and bone-type cells in discretely isolated DP 
and DS cell primary cultures from rat vibrissa follicles were reported by Jahoda et al., 
as well as reports that DP and DS cell lines were capable of being directed to lipid and 
bone differentiation. This group produced clonal cell lines, a property of stem cell 
populations which demonstrated extended proliferative capabilities (Jahoda et al., 
2003A). Clonal cell lines with differing capacity to exclude rhodaminel23, an 
identifying feature of stem cells, were cultured in supplemented medium known to 
induce adipocytic and osteocytic differentiation; DP and DS derived clones both 
showed the capacity to make lipid and to produce calcified material. However the 
clones had varied behaviour that was uncoupled with dye exclusion. Interestingly, 
Jahoda et al., also reported beating cells reminiscent of cardiomyocytes in primary 
follicular cell cultures and muscle cells in cultures of mixed DP and DS and in DS 
cultures (Jahoda et al., 2003A). In addition, more recently, the myogenic differentiation 
potential of the bovine DP has been investigated. Bovine DP cells were reported to be 
capable of adopting a myogenic fate when co-cultured with murine C2Q2 cells; the DP 
cells incorporated into myotubes and expressed muscle commitment and differentiation 
markers, MyoD and myogenin, in DP derived myotubules. Clonal cell lines also 
produced similar myogenic activity to the primary populations (Rufaut et al., 2006). 
Clonally derived lines of cells isolated from the entire dermis, termed skin-derived 
precursors (SKP), are capable of differentiating into neurons, glial cells, adipocytes, and 
smooth muscle cells (Toma et al., 2001; Joannides et al., 2004). SKPs can be derived 
from isolated DP and continue to express DP markers in vitro, suggesting they also 
represent a multipotent population of follicular dermis cells (Fernandes et al., 2004; 
Richardson et al., 2005); these cells may be responsible for the differentiation potential 
observed here. 
1.6 Thesis objectives 
The initial evidence for DP and DS differentiation towards a cardiomyocyte lineage is 
limited but encouraging and, supported by evidence of on their differentiation towards 
adipocytic and osteocytic lineages, suggests these cells could be manipulated to 
differentiate towards lineages other than their designated fate in the hair follicle. This 
thesis proposes the DP and DS as cell populations for somatic cell differentiation 
towards a cardiomyocyte lineage. In addition, in understanding the importance of 
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further investigation of the cardiomyocyte, it also provides analysis of the mTert-GFP 
mouse as a potential better indicator of cells in the dermis with differentiation potential 
as well as a marker for exploring the infarcted heart. 
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2 Methods and Materials 
2.1 Materials 
A list of materials and buffers is provided in Appendix 2-3. Al l procedures were carried out 
at room temperature unless otherwise specified. The grade of water used throughout was 
Molecular Biological (Sigma) unless otherwise specified. 
2.1.1 Animals 
Rats (Wistar, WST/Nhg) (denoted WT) and CD1 mice (denoted WT) were supplied by 
Charles River Laboratories and maintained by the Departmental Animal Facility. The 
mTert-GFP mouse was produced by Dr. D. Breault, Boston Childrens' Hospital and 
Harvard University in collaboration with Dr. N . Hole, University of Durham. The 
breeding colony of mice was maintained as heterozygotes on a strain 129Sl/SvImJ 
background (denoted WT). Work was approved by local ethical review panels of Durham 
and Harvard University; carried out under the authority of Home Office 
personal and project licences. 
2.2 Microscopy and centrifugation 
Primary cultures were monitored using a light microscope (Olympus, ckx41); photographs 
of phase contrast images were taken using a Nikon digital camera attachment. Dissections 
were visualised using a dissection microscope (Nikon) and photographs taken with a Nikon 
digital camera attachment. Al l fluorescence was visualised on a Zeiss Axio imager.Ml 
microscope with a Hamamatsu digital camera attachment. Al l centrifugation was carried 
out at room temperature (Sigma and Philip Harris Scientific centrifuge) unless otherwise 
stated.where centrifugation was carried out at 4°C (Biofuge, Heraeus). 
2.3 Isolation of primary tissues 
2.3.1 Isolation of vibrissae DP and DS from mouse/rat mystacial pad 
The DP and DS were located in the end bulb component of the hair follicle (Reynolds and 
Jahoda 1991), as shown in figure 2.1. The end bulb was typically contained within the 
lower third of the hair follicle (figure 2.1/), which contains the DP on a stalk protruding 
from the surrounding DS (figure 2.1/7). It was distinguished from the rest of the hair follicle 
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by a slight indentation below the hair root and above where the DP resides. The DS coats 
the entire inner surface of the collagenous capsule of the end bulb and extends up the early 
part of the growing hair root where it associates with the outer root sheath. 
The DP and DS were dissected from adult rat or mouse follicles of the vibrissa using 
previously described methods (Jahoda and Oliver 1981; Reynolds 1989). Briefly, the 
method is as follows: 
The mouse/rat was sacrificed and the mystacial pad cut open, the nerve tracts indicated the 
correct depth of incision (see figure 2.2/). The skin was inverted to reveal the under 
surface of the mystacial pad and the protruding end bulb component of the hair follicles 
(figure 2.2/7.). The tissue surrounding the protruding hair follicle was dissected away and 
the hair follicle removed from the inside of the mystacial pad and pulled back through the 
skin (figure 2.2m.) so to avoid hair follicle damage and minimise contact with the skin 
surface. The follicles of the vibrissa were placed into a 10cm petri dish (Fisher) in 10ml of 
10% MEM (Minimal Essential Media; see Appendix 5). The end bulb was excised from 
the hair follicle using a scalpel blade (Fine Scientific Tools, Scalpel#3); the incision was 
made at the indentation on the hair follicle at the end bulb (see figure 2.1). The end bulb of 
the hair follicle was removed into PBS (phosphate buffered saline; see Appendix 3) for DP 
and DS isolation or for immediate processing for RNA. 
The end bulb collagen capsule was inverted using forceps (Fine Science Tools, Dumont 
forceps, type#5); the epithelial matrix component removed to expose the DP which was 
easily pinched off and isolated using forceps. 
The DS was removed ensuring the collagen capsule and epithelial matrix remains. Isolated 
DP and DS were then processed for RNA or transferred to a 16mm tissue culture dish for 
culture. Typically, four DP or DS were placed into each 16mm dish. 
In some experiments, the DP and DS were cultured together without separating the DP 
from the DS; this type of mixed culture was used when investigating spontaneous 
cardiomyocyte-like differentiation. Typically, four mixed population primary explants were 
placed into each 16mm dish. 
46 










Phase contrast images of the hair follicle of the mouse vibrissae at x5 magnification (/'.) and 
x40 magnification (#,) showing the location of the DP and DS. The end bulb is the lower 
one third of the hair follicle and contained the DP and most of the DS. It is excised from 
the hair follicle using a scalpel blade at the indentation shown (/.) 
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Images showing mystacial pad excision and vibrissa retrieval. The initial nerve tracts 
indicated the correct depth of incision (/.). The skin of the mystacial pad was inverted to 
show the underside of the hair follicles (//.). The vibrissae was pulled back through the skin 
(Hi.) and removed to minimal essential media (iv.) in preparation for removing the follicle. 
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2.3.2 Isolation of neonatal skin dermal cells 
The mouse was sacrificed at 3-5 days post partum, when the hair was just visible. The skin 
from the torso of the neonate was removed in its entirety. Fat was carefully removed from 
the underside of the dermis using a scalpel, avoiding abrasion of the underlying dermal cell 
layers and the skin cut into 1cm2 pieces for freezing for cryo-sectioning or for immediate 
processing to obtain a single dermal cell suspension for flow cytometry. 
In the case of the latter, the 1cm pieces from each neonate were transferred to a 15ml 
Falcon (Sigma) of 15ml Hank's Balanced Salt Solution (HBSS; see Appendix 3) 
containing 4mg/ml dispase (Sigma) (see Appendix 2) and incubated for 3 hrs at 37°C with 
gentle shaking (lOOrpm) in a heated incubator (Labnet). The sample was removed from the 
dispase and placed on a fresh petri dish, epidermis down; the dermis was stripped using 
forceps, leaving the epidermis adhered to the petri dish. The dermis was sliced into 
approximately 1mm2 pieces and transferred to 5ml of HBSS containing lmg/ml type 1A 
collagenase (Worthington) and incubated for 2.5hrs at 37°C with shaking (250rpm). 
approximately 10ml of MEM was added to the cell suspensions and then filtered through 
40micron sterile filters (Sigma) twice and the cell filtrate pelleted by centrifugation (5 min, 
2475g), followed by re-suspension in PBS for flow cytometry (section 2.14). 
2.3.3 Removal of mouse/rat embryos 
Embryos were removed from the mouse/rat uterus by tearing the mesometrium away with 
forceps and isolating the embryo away from the muscular walls of the uterus, Reichert's 
membrane and visceral yolk sac. Embryos were placed into PBS for further processing for 
cardiomyocyte isolation or for cryo-sectioning. For tissue typing purposes, for mTert-GFP 
embryos, the placentas were transferred into PBS. 
2.3.4 Isolation of cardiomyocytes from embryonic hearts 
Embryonic hearts were routinely isolated from El2.5 mouse embryos or El5.5 rat 
embryos; ages which were developmentally matched. (Kaufman 1992). The myocyte 
isolation method used was adapted from The Worthington Neonatal Isolation System (as 
described in Toraason et al., 1988). In brief: 
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Embryos were removed from the uterus as described (section 2.3.3). The hearts were 
removed from the embryo, with forceps and fine scissors; following the severing of the 
aorta and pulmonary blood vessels, the heart was lifted from the thoracic cavity. For each 
experiment 30-90 embryo hearts were isolated and they were placed into ice cold HBSS for 
immediate processing for RNA or culture. 
In the case of the latter, the hearts were finely minced in 5ml HBSS on ice and trypsin 
added to a final concentration of 50ug/ml trypsin for incubation for 16hrs at 4°C. Trypsin 
inhibitor (Sigma) was then added to a final concentration of 180ug/ml and the solution 
warmed to 37°C. 1500 units of collagenase (Worthington Neonatal kit) was added to 
further dissociate the tissue and the cell suspension incubated for 45 min at 37°C. The 
suspension was triturated and filtered using 40micron filters. Following centrifugation to 
pellet cardiomyocytes away from red blood cells (RBC) (5 min, 2178g) the pellet was re-
suspended and the cells were seeded onto 35mm diameter tissue culture dishes (Nunc); 
1.2xl06cells/dish (equivalent to 1.25xl05 cells/cm2). The cells were then cultured in 10% 
Leibovitz culture media (L-15) (Sigma) (see Appendix 5). 
2.4 Tissue culture 
All plastics were sterile unless otherwise stated. All cultures were incubated at 37°C in a 
humidified environment under atmospheric oxygen (see Appendix 8 for incubator details) 
unless otherwise specified. Al l medium was warmed to 37°C prior to use to maintain tissue 
viability, unless otherwise stated. Fetal bovine serum (FBS) used was from Sigma and lot 
number 085k3396. In selected experiments the DP and DS explants were also incubated 
under hypoxic conditions. In the latter case, the cells were maintained within the incubator 
in a gas-tight culture container (see Appendix 8) which had been exhaustively flushed with 
5% (v/v) oxygen (5% (v/v) C02, 90% (v/v) N 2 ) . 
2.4.1 Primary culture of isolated DS and DP 
In order for the follicular cells to adhere and begin attached growth in culture, cells were 
undisturbed for the first three days of culture. Typically, 80% of DP and 50% of DS 
explants showed adherent cell proliferation after this period. 
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When the tissue culture dish was approximately 80% confluent (which took approximately 
2 weeks) the adherent cells were transferred to a 35mm diameter tissue culture dish. The 
cells were removed from the dish by trypsinisation as follows: cells received a 3 min 
application of 1ml trypsin (0.25% (w/v) in PBS; Sigma). After the incubation period 5ml 
10% MEM was added to the cells and the cell suspension was pelleted in a 15ml Falcon 
tubes (5 min, 2475g), the supernatant discarded. Following trypsinisation the cell pellets 
were re-suspended in 3ml 10% MEM and transferred into a 35mm tissue culture dish. 
When the cells reached near-confluency, approximately 7 days later, they were transferred 
to a 25cm culture flask (Nunc) by trypsinisation as described above; the cells were re-
suspended in 5ml of 10% MEM for transfer into the culture flask. The cells were 
incubated in flasks until 80-100% confluent, a process which normally took a week, and 
then the cells trypsinised and re-suspended in 1ml 10% MEM and counted using a 
haemocytometer (Sigma) (see Appendix 8). Typically 1.5xl05cells were harvested from 
each flask. Cells were then seeded at 5xl04cells per new flask. The cell culture medium 
was normally changed from the flasks every three days. DP and DS primary culture cells 
were typically used at passage 3 when there are sufficient cells for experimentation. 
2.4.2 Primary culture of isolated embryonic cardiomyocytes 
The culture media (10% L-15) was changed every other day and the cultures maintained 
without passaging for up to 24 days. Confluency and spontaneous contractions were 
monitored by microscope. The cells were seen to maintain contractions for the entire 
period of culture. 
2.4.3 Culture of ES cells 
The mouse ES cell line CGR8 (see Appendix 5), originally established from the inner cell 
mass of a 3.5 day male pre-implantation mouse embryo of strain 129, was used for 
experimentation. The cell line was maintained in 10% Glasgow's Minimal Essential Media 
(GMEM; Appendix 5) (Sigma). The cells were grown in 25cm flasks pre-coated with 
0.1% (v/v) gelatin (Sigma) (see Appendix 2) in PBS. The cells were maintained in an 
undifferentiated state by the addition of 5ul/flask of leukaemia inhibitory factor (LIF) 
(Sigma) resulting in a final LIF concentration of O.Olug/ml (see Appendix 2). 
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The cells were routinely passaged at 3 days; the cells were removed from the dish by a 3 
min application of 1ml of Trypsin, Versene, Phosphate (TVP; see Appendix 3). After the 
TVP treatment period, 5ml of 10% GMEM was added and the cells scraped using a cell 
scraper (Sigma) to remove them from the flask. The cell suspension was pelleted in a 15ml 
Falcon tube (5 min, 2475g), the supernatant discarded and the pellet re-suspended in 
approximately 1ml of 10% GMEM. The cells were counted and the concentration adjusted 
to 2xl05cells/ml; 5ml was added to each new flask equating to seeding at lxl0 6cells per 
new 25cm2 flask and 5ul LIF added to each flask. 
2.4.4 Hanging drop culture of ES cells 
ES cells are capable of differentiation towards a cardiomyocyte lineage (Maltsev et al., 
1994); the ES cells were cultured as hanging drops which encourages the cells to form 
aggregates; when this is carried out in the absence of LIF these aggregates can differentiate 
into embryoid bodies (EB). The adapted method of Maltsev et al., (1994) was used. In 
brief: 
ES cells were harvested as above and concentration adjusted to 30cells/ul of 1% GMEM in 
the absence of LIF.lOul drops were created on the underside of the lid of a square dish 
(100cm2, Sigma), 100 drops per lid. 5ml water was placed in the dish, the lid was inverted 
and the hanging drops cultured for 3 days. EB's were then collected and transferred into 
petri dishes in final volume of 10ml of 10% GMEM; each dish containing approximately 
100 EB's. The cell aggregates were further cultured for 5 days. 
2.4.5 Co-culture of DP and DS with ES cells in aggregates 
Rat dermal cells and mouse CGR8 ES cells were harvested as above and adjusted to a final 
concentration of 30cells/ul in 10% GMEM in the following ES/dermal ratios; 1:1, 1:3, 
1:10, ES cells alone or dermal cells alone. Aggregates were produced by hanging drop and 
further cultured as described for ES cells in section 2.4.4. 
This co-culture procedure is summarised in the figure 2.3. 
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Figure 2.3: Illustration of co-culture of DP and DS wi th ES cells i n aggregates 
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2.4.6 Co-culture of rat DP and DS with mouse embryonic 
cardiomyocytes 
The co-culture was based upon a protocol for B M MSC (Yoon et ah, 2005). Briefly, 
mouse embryonic cardiomyocytes were isolated as described and plated into a 35mm 
diameter tissue culture dish at a density o f 4 x l 0 5 cells/dish; the cells were left to reach 
approximately 50% confluency, which normally took 6 days, at which point the cells have 
typically synchronized contractions. The rat DP and DS cells were removed from their 
tissue culture dishes by trypsinisation as described; the cell pellet re-suspended in 3ml 10% 
L-15 and plated onto the cardiomyocyte cultures at a density o f 1x10 s DP or DS 
cells/dish. The co-culture was incubated for 5 days. For RNA processing the cells were 
trypsinised as described above and pelleted (5 min, 2475g). A summary of this procedure is 
shown in figure 2.4. 
2.4.7 Co-culture of DP and DS with matching species 
cardiomyocytes 
Two co-culture experiments were set up in parallel. Both rat and mouse embryonic 
cardiomyocytes were isolated, plated and cultured to 50% confluency as described in 
section 2.3.4 and 2.4.2. As the dermal cells to be added to cardiomyocytes o f the same 
species they needed to be pre-labelled using Carboxyfluorescein diacetate succinimidyl 
ester (CFSE) according to the manufacturer's instructions (see Appendix 4). CFSE can also 
be used to monitor cell division (Lyons et al., 2000). Briefly the method was as follows: 
CFSE (provided with CFSE kit) was adjusted to a concentration of 5mM with PBS, to each 
preparation o f 5mM CFSE 18|il of DMSO was added (supplied with kit) and this 
suspension added to the cell suspensions to a final concentration o f I O J I M . The cell 
suspensions were incubated at 37°C for 10 min in a dry bath (Labnet). CFSE uptake was 
stopped by addition o f 5 volumes o f ice-cold M E M to the cells and incubated on ice for 5 
min. Cells were pelleted by centrifugation (5 min, 2475g at 4°C), washed twice by re-
suspending in ice-cold M E M and pelleted again. The cells were then re-suspended in 
warmed M E M . The CFSE labelled dermal cells were immediately analysed by flow 
cytometry, cultured for 7 days and then analysed or immediately used for co-culture with 
embryonic cardiomyocytes o f the same species. This can be seen in figure 2.5. 
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Figure 2.4: Il lustration of co-culture of rat DP and DS wi th mouse cardiomyocytes 
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2.4.8 Flow cytometry of CFSE labelled cells 
In order to analyse cells o f dermal origin from the mixed population tissue culture dishes, 
or from CFSE labelled cells after 7 days culture, the cells were trypsinised from the flasks 
as described and the cells re-suspended in 1ml PBS. The single cell suspension was 
subjected to f low cytometric analysis on a FACS Aria fluorescence activated cell sorter 
(FACS) (Becton Dickinson) by The Centre for Life f low cytometry unit (University o f 
Newcastle). In selected experiments the flourescein positive cells were FACS sorted into 
l m l M E M . This is summarised in figure 2.5. 
2.5 RNA isolation 
2.5.1 Harvesting cells for RNA 
Cells in culture were trypsinised and pelleted as above (section 2.4.1), FACS isolated cells 
were pelleted (section 0) or cells were taken directly from flasks. In the latter case flasks 
were washed by adding 10ml PBS into culture flasks and aspirating; all liquid was removed 
before continuing. 500ul o f denaturing solution was added directly onto cells either in 
1.5ml microcentrifuge tubes or flasks and incubated for 3 minutes with agitation. The cell 
lysate was removed into a 1.5ml microcentrifuge tube and either used immediately or snap-
frozen in liquid nitrogen (see Appendix 2) and stored at -80°C for use at a later date. 
2.5.2 Harvesting tissues for RNA 
RNA was isolated from tissue and cells using the Totally RNA Ki t (Ambion) (see 
Appendix 4). Tissue was excised as described and transferred into a nitrogen filled 
porcelain pestle and mortar (Sigma). Tissue was ground under liquid nitrogen until it was a 
fine powder; this was transferred to a 1.5ml microcentrifuge tube (chilled under liquid 
nitrogen) after the nitrogen boiled off; tissue remained frozen. Once thawed and warmed to 
room temperature, 500ul of denaturing solution was added to the ground tissue and 
incubated for 1 minute. The lysate was snap-frozen in liquid nitrogen and stored at -80°C. 
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Figure 2.5: Illustration of species matched co-culture of DP and DS wi th cardiomyocytes 
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2.5.3 RNA extraction 
Phenol Chloroform extraction was first carried out. 500ul o f phenol chloroform (see 
Appendix 4) was added to the thawed cell or tissue lysate, mixed by inversion for 1 min, 
incubated on ice for 5 min and centrifuged for 5 min (12350g at 4°C). The top, aqueous, 
phase was collected and transferred into a 1.5ml microcentrifuge tube containing 50ul of 
3M sodium acetate (see Appendix 4). Phenol chloroform extraction was repeated; the final 
aqueous phase was transferred into 500ul o f isopropanol (Sigma) and chilled to -80°C for a 
minimum 2hrs to precipitate RNA. 
The precipitated RNA was pelleted by centrifugation (5 min, 12350g at 4°C) and the 
supernatant discarded; the pellet was re-suspended in 300(4.1 of 70% (v/v) ethanol, the RNA 
again pelleted by centrifugation (10 min, 12350g at 4°C) and the supernatant discarded. 
The pellet was air dried and dissolved in 20ul of Diethyl Pyrocarbonate (DEPC) treated 
water (see Appendix 2) and stored at -80°C. 
The sample was then treated to eliminate genomic DNA using the "DNA-free k i t " 
(Ambion) (see Appendix 4). 12ul of the thawed RNA sample was incubated at 37°C on a 
dry block with 1.5uJ of lOx DNase-1 buffer and 1.5ul DNase-1 (see Appendix 4) for 30 
minutes in 1.5ml microcentrifuge tube. 5uJ o f Inactivation Reagent was then added and 
incubated for 2 minutes, followed by centrifugation (30s, 12350g at 4°C). The supernatant 
containing the RNA was transferred to a new 1.5ml microcentrifuge tube and was either 
used immediately or stored at -80°C. 
2.5.4 Agarose gel electrophoresis 
1% agarose gel was prepared as follows: 0.7g agarose powder (Sigma) was added to 70ml 
l x T A E buffer (Appendix 3) and heated in a microwave (Matsui 850W) at fu l l power for 2 
min. The melted agarose was left to cool to approximately 50°C before adding 7ul of 
lOmg/ml ethidium bromide (Sigma) (see Appendix 2). The gel was poured into the gel tank 
cradle (CBS Scientific) (see Appendix 8) with a 13 well comb (12ul capacity/well) and left 
to cool, l u l o f RNA sample was added to 5ul o f Agarose Gel Load buffer (see Appendix 
4) and run along side a lkb ladder to determine product sizes (Fermentas) (ladder provided 
in Appendix 4). Gel Electrophoresis was carried out in l x T A E buffer at 120 volts for 20 
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minutes (Consort) (see Appendix 8). The gel was visualised using a Uvidoc transluminator 
(Uvitec) and the image captured. 
2.5.5 RNA quantification 
The RNA was quantified using a spectrophotometer (GenQuest) (see Appendix 8). 5ul o f 
the purified RNA sample is diluted 1 in 100 with DEPC water and loaded into a U V quartz 
cuvette (Sigma). RNA quantitation was carried out and the concentration automatically 
determined. 
2.6 cDNA synthesis 
cDNA was synthesised from RNA for RT-PCR using the "Superscript I I RNase H -
Reverse Transcriptase K i t " (Invitrogen) (see Appendix 4) according to the manufacturer's 
instructions. For Q-PCR the "High Capacity cDNA Reverse Transcription K i t " (Applied 
Biosystems) was used. 
2.6.1 cDNA synthesis for reverse transcriptase PCR (RT-PCR) 
For each synthesis reaction, l ug of RNA was added to l u l oligo(dT) primer (see Appendix 
4) and made up to 12ul with DEPC water. The samples were incubated at 70°C on a dry 
block for 10 minutes. 4ul o f 5xFirst strand buffer, 2ul 0.1M 1,4-Dithiothreitol (DTT) (see 
Appendix 4) and 2ul 2.5mM deoxyribonucleotide triphosphates (dNTP) (Invitrogen) (see 
Appendix 2) are added to each sample 1 ul o f reverse transcriptase (RT) (see Appendix 4) 
was added and incubated at 42°C on a dry block for 1 hour. The samples were either used 
immediately or stored at -20°C for storage. For control reactions the reverse transcriptase 
was substituted with l u l DEPC water. 
2.6.2 cDNA synthesis for real time quantitative PCR (Q-PCR) 
For each synthesis reaction, lug o f RNA in lOul in DEPC water was added to lOul o f 
2xRT mix (components provided with the Capacity cDNA Reverse Transcription kit) 
which is made up with 2ul lOxRT buffer, 0.8ul 25xdNTP Mix, 2ul lOxRT random primers, 
l u l MultiScribe reverse transcriptase, l u l RNase inhibitor, 3.2ul nuclease free water. The 
samples were sequentially heated to 25°C for 10 min then 37°C for 2hrs, and finally 85°C 
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for 5 seconds before being put on ice. For control reactions the reverse transcriptase was 
substituted with l u l DEPC water. 
2.7 Primer Design 
2.7.1 Primers designed for RT-PCR 
Primers were designed according to following rules: 
• Nucleotides o f gene of interest were located for species required (mouse/rat) by 
searching for the gene using NC B I software; BLAST (Altschul et al., 1997) and 
GenBank (Benson et al., 2000) available online (see Appendix 6) 
• The open reading frame was identified within NCBI 
• Forward and reverse primer sequences were designed with the following parameters: 
• Sequence length 17-25 bases long, with no more than three contiguous 
nucleotides with the same base or repeats o f sequences o f three or more bases, 
GC content was 50-60%, predicted product ideally be larger than 200bp, no 
hairpin loops or secondary structures predicted within primers as determined 
using the online software "Oligonucleotide Calculator" 
• Predicted melting temperatures o f both primers were no more than 4°C apart 
and ideally be around 50-60°C 
• The primer product should span an intron so that genomic contamination can be 
identified by an aberrant size product 
• Primer specific for target gene and species under study 
A l l products were o f the size predicted. The image of this product was isolated for 
presentation. Primer details including predicted band sizes are provided in the Appendix 
6.1. 
2.7.2 Primers for Q-PCR 
TaqMan gene expression assays were inventoried sets from Applied Biosystems. Each 
assay contained 2 unlabeled PCR primers (final concentration o f 900nM each) and 1 
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F A M (reporter) dye-labelled TaqMan MGB (minor groove binder) probe (final 
concentration o f 250nM). A list o f the assays used is provided in Appendix 6.2. 
2.8 Polymerase Chain Reaction 
2.8.1 RT-PCR 
RT-PCR was run using the "Taq DNA polymerase, recombinant k i t " (Invitrogen) (see 
Appendix 4) according to the manufacturer's instructions. In brief, each sample for PCR 
was prepared in 0.5ml PCR tubes (Sigma) and the following added to each sample in the 
order provided: 38.8ul RNAse free water (Sigma), 5ul 10X Taq buffer, 1.5ul 50mM 
MgCb, 1.5ul of 2,5mM dNTP's, l u l each of lOuM forward and lOuM reverse primer 
specific to gene of interest, l u l template (cDNA, water or positive control), 0.2ul Taq 
polymerase. 
PCR was carried out in a thermocycler (Biometra, T personal) for 35 cycles. Each cycle 
consisted o f 94°C for 5 min (1 cycle) followed by 35 cycles o f 95°C for 30s, annealing 
temperature for 1 minute followed by 72°C for 1 minute. After the 35 cycles there was an 
extension step at 72°C for 7 min (1 cycle) and the samples were held at 4°C for use. The 
annealing temperatures were specific to primer sequences as detailed in Appendix 
6.1. Following PCR, lOjxl o f loading buffer is added to each sample and lOjxl run on an 
agarose gel described as in section 2.5.4 except it was 2% gel (1.4g agarose in 70ml 
lxTAE) , and run at 120v for 30 minutes. 
2.8.2 Q-PCR 
Q-PCR was run using the "TaqMan Fast Universal PCR Master Mix (2x)" (Applied 
Biosystems) (see Appendix 4) according to the manufacturer's instructions. In brief, Q-
PCR was run in a 96 well plate; each sample was run in triplicate. To prepare the reaction 
10-100ng cDNA was required (routinely lOOng was used) to which was added to l u l 
TaqMan gene expression assay mix (20x) (Applied Biosystems), specific to the gene o f 
interest, lOul PCR master mix (2x) (see Appendix 4) and made up to 20ul with DEPC 
water. The plate was centrifuged (30s, lOg) and subjected to Q-PCR and analysed in an 
7500 Fast Real-time PCR machine (Applied Biosystems). 
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2.9 Induced myocardial cryo-injury 
In order to investigate the effects o f myocardial injury on stem cell mobilisation the method 
of Leferovich et al., (2001) was used. In brief, as follows: 
Mice were weighed using an electronic small animal weighting balance (Shimadzu) and 
anaesthetised using 1.25% (v/v) Avertin in sterile saline (0.9% (w/v) NaCl) by sub-
cutaneous (s.c.) injection o f 25ul/g body weight. Once anaesthesia was achieved, the 
ventral abdomen wall was shaved, using clippers, immediately caudal to the costal 
margin. The mouse was placed on a polystyrene tray, on its back, head facing away. 
A vertical incision was made, using a scalpel, o f approximately 6mm length, just left o f 
midline. The cryo-probe (2mm rounded probe) was cooled in liquid nitrogen. The right 
superior epigastric artery, running caudally in the abdominal wall was visualised; the 
muscle was divided vertically between this vessel and midline for 5mm with "tenting" of 
the muscle to avoid damage to the viscera. The thorax was elevated by approximately 
5mm by raising the animals back so the thoracic cavity is higher than the abdomen, by 
which process the medial lobe o f the liver is moved out of the way. Forceps were used to 
hold the incision open to expose the abdominal cavity; the liver was gently manipulated 
away from the diaphragm. The heart was seen as a dark purple area against the 
diaphragm. 
The cooled probe was carefully passed through the incision and applied to diaphragm 
adjacent to the heart surface with f i rm pressure for 20s. PBS pre-warmed to 37°C was 
dropped onto and along the probe using a disposable Pasteur pipette, to allow non-
traumatic detachment of the probe from the diaphragm. Excess PBS was absorbed with 
cotton wool buds. 
The muscle o f the abdominal wall was closed with interrupted sutures using vicryl coated 
4-0 suture (Ethicon) and surgical skin glue (dermabond). Analgesia was provided by s.c. 
injection of Buprenorphine (supplied by Dr. David Breault) at 3.3ul/g body weight and the 
mouse allowed to recover in a warmed box with constant monitoring until conscious. On 
occasion, additional analgesia was administered as necessary. 
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2.10 Immunohistology 
2.10.1 Preparing tissue 
Organs for study were washed in PBS and transferred into 4% (w/v) paraformaldehyde 
(Sigma) (see Appendix 2) in PBS and held on ice for a minimum of 2hrs. The tissues were 
then put into ice cold 40% (w/v) sucrose (Sigma) in PBS overnight at 4°C. The tissue 
samples were then embedded in TissueTek solution (Electron Microscopy Sciences) and 
snap-frozen in liquid nitrogen before storing at -80°C or using immediately. 
2.10.2 Slide preparation 
Tissue embedded in TissueTek solution, were cryo-sectioned using a cryostat (Leica) (see 
Appendix 8). lOurn sections were collected onto positively charged glass slides (Fisher). 
The sections were allowed to air dry for an hour after which they were stored at -20°C or 
used immediately. The tissue was delineated using a phthalamidoperoxycaproic acid (PAP) 
pen (Abeam) which formed a hydrophobic barrier around each section to aid antibody 
labelling. The slides were then incubated in cold 4% (w/v) paraformaldehyde in PBS for 20 
minutes at 4°C with rocking on a mini-gyro-rocker (Stuart) (in refrigerated room) and used 
immediately for antibody labelling. 
For blood smear slides, fresh blood in microcentrifuge tubes on ice was spotted onto glass 
slides within 2 minutes o f collection and smeared using a second glass slide. A l l blood 
slides were fixed with cold methanol (Sigma) for 5 minutes rocking at 4°C and used 
immediately for antibody labelling. 
2.11 Immunohistochemistry antibody labelling 
The primary GFP antibody used was a polyclonal Rabbit anti-GFP (Abeam, ab6556). The 
secondary antibody was a polyclonal Goat anti-rabbit biotin (Abeam ab6720). The 
secondary antibody was detected using VIP (Vector) diluted in PBS according to the 
manufacturers instructions. The tissue was blocked with goat serum (Vector). 
This method is used for sections of testes, adult mystacial pad, embryos and adult heart 
(section 2.10.1) using the GFP antibody. Details o f the antibodies and detection chemicals 
are provided in Appendix 7. The method was as follows: 
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Day 1 
1. Wash slides twice in PBS-TritonX-100 buffer (PBS-T100; see Appendix 3), 
rocking (Sigma rocker at room temperature) for 5 min each 
2. Wash slides twice in PBS, rocking for 5 min 
3. Apply 0.3% (v/v) hydrogen peroxide (Sigma) in methanol (Sigma) for 30 minutes, 
rocking 
4. Wash slides twice in PBS, rocking for 5 min 
5. Block with streptavidin (Vector) (see Appendix 4) for lhour , rocking 
6. Wash slides twice in PBS, rocking for 5 min 
7. Block with biotin (Vector) (see Appendix 4) for l h r , rocking 
8. Wash slides twice in PBS, rocking for 5 min 
9. Block with blocking buffer ( 1 % (v/v) serum specific to serum suitable for antibody 
combination as described above - in this case rabbit anti-GFP) for l h r , rocking 
10. Shake o f f excess blocking buffer and apply primary antibody (specific to antibody 
as indicted above - in this case goat serum) diluted in 1% (v/v) serum blocking 
buffer (as above) at 4°C overnight 
Day 2 
1. Wash slides in PBS-T100, rocking for 5 min 
2. Wash slides in PBS, rocking for 5 min 
3. Apply biotinylated secondary antibody (specific to antibody as indicted above) 
diluted in 1 % (v/v) serum blocking buffer as above - in this case goat) rocking for 
30 min 
4. Prepare A B C solution (Vector) required for step 7 30 min prior to use (see 
Appendix 4) 
5. Wash slides twice in PBS, rocking for 5 min 
6. To inactivate endogenous peroxidise activity, application of 1.6% (v/v) H2O2 (see 
Appendix 2) in PBS for 10 min rocking 
7. Wash slides twice in PBS, rocking for 5 min 
8. Incubate in ABC solution rocking for lh r 
9. Wash slides twice in PBS, rocking for 5 min 
10. Make VIP stain (Vector) (see Appendix 4) 
11. Apply VIP stain for 1 minute monitoring under the microscope constantly 
12. Stop reaction by placing slides in running tap water for 5 min 
13. The nucleus was counterstained with methyl green staining solution (Vector) on a 
60°C slide warmer (Fisher) for 5 min 
14. Wash slides in water for 1 minute then dip 10 times in acetone (Sigma) containing 
0.05% (v/v) acetic acid (Sigma) 
15. Dehydrate slides for 2 min in each sequential step: 
70% (v/v) ethanol 
90% (v/v) ethanol 
100% (v/v) ethanol 
Xylene 
16. Mount in permount (Fisher) and coverslip (Fisher) and leave to dry 
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2.12 Immunofluorescence antibody labelling 
The primary GFP antibody used was a polyclonal Rabbit anti-GFP (Abeam, ab6556). The 
secondary antibody was a polyclonal goat anti-rabbit FITC (Abeam, 7086). For this 
combination the tissue was blocked with goat serum (Vectastain). 
The primary anti-CD45 and anti-CD34 antibodies used were a monoclonal Rat anti-mouse 
CD45 (Abeam, ab25386) and a monoclonal Rat anti-mouse CD34 (Abeam, ab8158). The 
secondary antibody used for both was a biotinylated monoclonal Chicken anti-rat (Abeam, 
ab6835). The secondary antibody was detected using streptavidm-7-amino-4-
methylcoumarin-3-acetic acid (streptavidin-AMCA) (Vector, SA-5008). For this 
combination the tissue was blocked with chicken serum (Abeam ab7477). 
Details of the antibodies and detection chemicals are provided in Appendix 7. 
2.12.1 Single labelling methods 
A single labelling method was used for GFP antibody labelling o f neonatal skin. The 
method was as follows: 
Day 1 
1. Wash slides twice in PBS, rocking for 5 min 
2. Block with 1% (v/v) serum blocking buffer (specific to serum suitable for antibody 
combination as described above - in this case goat) for 20 min , rocking 
3. Remove block and apply primary antibody (specific to antibody - in this case 
ANTI-GFP) diluted in 1% (v/v) serum blocking buffer (as above) at 4°C overnight 
Day 2 
1. Wash slides twice in PBS, rocking for 5 min 
2. Apply secondary antibody (specific to antibody as indicted above - in this case goat 
anti-rabbit FITC) diluted in 1% (v/v) serum blocking buffer (as above) rocking for 
lhr 
3. Wash slides twice in PBS, rocking for 5 min 
4. Shake o f f excess PBS 
5. The nuclei are labelled wi th 4',6-diamidino-2-phenylindole (DAPI) (Vector) and the 
slide mounted with a glass cover slip 
A single labelling method was used for anti-CD45 and anti-CD34 antibody labelling of 
neonatal skin. The method was as follows: 
Day 1 
1. Wash slides twice in PBS-T100 rocking for 5 min 
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2. Wash slides twice in PBS, rocking for 5 min 
3. Apply 0.3% (v/v) H2O2 in methanol for 30 minutes, rocking 
4. Wash slides twice in PBS, rocking for 5 min 
5. Block with streptavidin for 1 hour , rocking 
6. Wash slides twice in PBS, rocking for 5 min 
7. Block with biotin for l h r , rocking 
8. Wash slides twice in PBS, rocking for 5 min 
9. Block with 1 % (v/v) serum blocking buffer (specific to serum suitable for antibody 
combination as described above - in this case either goat or chicken) for lhr , 
rocking 
10. Remove block and apply primary antibody (specific to antibody as indicted above -
in this case either anti-CD45 or anti-CD34) diluted in 1% (v/v) serum blocking 
buffer (as above) at 4°C overnight 
Day 2 
1. Wash slides in PBS-T100, rocking for 5 min 
2. Wash slides in PBS, rocking for 5 min 
3. Apply biotinylated secondary antibody (specific to antibody as indicted above) 
diluted in 1% (v/v) serum blocking buffer as above - in this case goat anti-rabbit) 
rocking for 30 min 
4. Wash slides twice in PBS, rocking for 5 min 
5. To inactivate endogenous peroxidise activity, application of 1.6% (v/v) H2O2 in 
PBS for 10 min rocking 
6. Wash slides twice in PBS, rocking for 5 min 
7. Incubate in streptavidin-AMCA for 30 min 
8. Wash slides twice in PBS, rocking for 5 min 
9. Shake o f f excess PBS 
10. The nuclei are labelled with Propidium Iodide (PI) (blood smears for all antibodies) 
at 1 in 5000 dilution; 20ul per section and the slide mounted with a glass cover slip. 
2.12.2 Dual labelling method 
A dual labelling method was used for GFP antibody labelling in combination with anti-
CD45 and anti-CD34 for neonatal skin and adult heart. The method was as follows: 
Day 1 - anti-GFP antibody labelling 
1. Wash slides twice in PBS, rocking for 5 min 
2. Block with 1% (v/v) serum blocking buffer (specific to serum suitable for antibody 
combination as described above - in this case goat) for 20 min , rocking 
3. Remove block and apply primary antibody (specific to antibody - in this case GFP) 
diluted in 1% (v/v) serum blocking buffer (as above) at 4°C overnight 
Day 2 
1. Wash slides twice in PBS, rocking for 5 min 
2. Apply secondary antibody (specific to antibody as indicted above - in this case goat 
anti-rabbit FITC) diluted in 1% (v/v) serum blocking buffer (as above) rocking for 
lh r 
3. Wash slides twice in PBS, rocking for 5 min 
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Day 2 - anri-CD45 or anti-CD34 antibody labelling 
4. Wash slides twice in PBS-T100, rocking for 5 min 
5. Wash slides twice in PBS, rocking for 5 min 
6. Apply 0.3% (v/v) H2O2 in methanol for 30 minutes, rocking 
7. Wash slides twice in PBS, rocking for 5 min 
8. Block with streptavidin for lhour , rocking 
9. Wash slides twice in PBS, rocking for 5 min 
10. Block with biotin for l h r , rocking 
11. Wash slides twice in PBS, rocking for 5 min 
12. Block with 1% (v/v) serum blocking buffer (specific to serum suitable for antibody 
combination as described above - in this case chicken) for l h r , rocking 
13. Remove block and apply primary antibody (specific to antibody as indicted above -
in this case either anti-CD45 or anti-CD34) diluted in 1% (v/v) serum blocking 
buffer (as above) at 4°C overnight 
Day 3 
1. Wash slides in PBS-T100, rocking for 5 min 
2. Wash slides in PBS, rocking for 5 min 
3. Apply biotinylated secondary antibody (specific to antibody as indicted above) 
diluted in 1% (v/v) serum blocking buffer as above) rocking for 30 min 
4. Wash slides twice in PBS, rocking for 5 min 
5. To inactivate endogenous peroxidise activity application o f 1.6% (v/v) H2O2 in 
PBS for 10 min rocking 
6. Wash slides twice in PBS, rocking for 5 min 
7. Incubate in streptavidin-AMCA (as described above) for 30 min 
8. Wash slides twice in PBS, rocking for 5 min 
9. Shake o f f excess PBS 
10. The nuclei are labelled with PI (blood smears for all antibodies) (1 in 5000 dilution 
20ul per section) and the slide mounted with a glass cover slip. 
2.13 Cell preparation for flow cytometry immunofluorescence 
analysis 
2.13.1 Adult heart 
The adult heart was isolated and dissociated to single cells as described with the embryonic 
hearts (section 2.3.4). The final cell pellet was re-suspended in PBS and concentration 
adjusted to approximately lxl0 6 cel ls /ml for f low cytometry antibody labelling 
2.13.2 Neonatal skin 
The neonatal skin was dissociated to single cells as described (section 2.3.2). The final cell 
pellet was re-suspended in PBS and concentration adjusted to approximately lxl0 6 cel ls /ml 
for flow cytometry antibody labelling. 
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2.14 Flow cytometry 
Native GFP expression is able to be detected by flow cytometry without the need for 
antibody labelling. The cells are labelled with the following: 
The mouse lineage antibody cocktail (BD Pharmingen) is APC conjugated (see Appendix 
7.2); it labels CD3e chain, C D l l b , CD45R/B220, Erythroid Cells (Ly-76/TER-119), Ly-
6G and Ly-6C. Cells expressing these genes were considered to be associated with cells 
that may be present in the blood or o f haematopoietic lineage such as T lymphocytes, B 
lymphocytes, monocytes/macrophages, N K cells, erythrocytes, and granulocytes. Cells 
positive for APC were therefore excluded when sorting for cells that are GFP+ve. 10(0.1 of 
the lineage cocktail solution was added to a maximum of lx l0 6 cel ls in 1ml PBS and 
incubated on ice for 30 min then pelleted by centrifugation (5 min, 1235g at 4°C). The cells 
were re-suspended in 5ml PBS to wash and pelleted before being re-suspended in 1ml PBS 
for FACS. 
7-AAD (BD Pharmingen) is a viability dye. 7AAD only enters membrane-compromised 
cells and binds to DNA. Cells positive for 7AAD were therefore excluded when sorting for 
cells that are GFP+ve. The 7-AAD fluorescence is detected in the far red range of the 
spectrum at 650 nm using a long-pass filter. 1 Ojo.1 of 7-AAD solution was added to a 
maximum o f lxl0 6 cel ls in 1ml PBS 5 min prior to FACS. 
2.15 Statistical analysis 
Any statistical analysis was using a students t-test; statistical significance is assigned when 
p<0.01 unless otherwise stated; where significance is still attributed but at a higher p value. 
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3 Characterisation of dermal follicular cells 
The use o f primary cultures o f stem cell populations as a tool for investigating their 
developmental and differentiation potential has a number o f advantages; the lack o f tissue 
culture adaptation reduces the risk o f aneuploidy (Baker et al., 2007); they are more useful 
in the development o f tissue engineering strategies and they are more likely to be 
representative of the in vivo condition (Polak et al., 2006). However, such cultures 
normally have a limiting lifespan in tissue culture (Rubin et al., 1997) and this affects their 
utility for extended biological studies. One approach to extend their in vitro culture lifespan 
has been to immortalise primary cultures however this has been associated with cellular 
transformation; such examples include over expression o f telomerase (Cerni 2000), human 
papilloma virus (Takeuchi et al., 2007) or T antigen activation by simian virus 40 (Sv40) 
(Potter and Potter 1975). Such transformation limits interpretation of cellular physiology 
and normally precludes their use in tissue engineering. The alternative approach has been 
to develop conditions for the reproducible isolation and culture o f primary tissues. 
This chapter describes the isolation and culture o f dermal papilla (DP) and dermal sheath 
(DS) cell populations and demonstrates that these primary cultures show reproducible 
patterns o f cell morphology, gene expression and population doublings, indicating that 
these cell populations are suitable for further study o f their developmental potential. 
3.1 Morphological characteristics of the dermal follicular cells in 
adherent culture 
The DP and DS were isolated from the hair follicle by manual dissection (section 2.3.1) 
and cultured as described (section 2.4.1). The adherent DP and DS monolayers were seeded 
to a 25cm 2 culture flask for expansion after a period of proliferation in a 16mm then 35mm 
dish to expand the isolated DP and DS primary explants. Cells were routinely passaged at 
80% confluency, a cell density of approximately 6 x l 0 3 cells/cm2, and seeded into 
subsequent flasks at a density o f 2x10 3 cells/cm2; cells were maintained in 25cm 2 flasks 
until use. In total in excess o f 20 primary cultures were set up and monitored for up to 10 
passages. 
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Figure 3.1 Morphology of DP and DS in vitro culture 
it DS 
9b 
Gross morphology of DP (/) and DS (//') cultures in vitro at passage 3. DP and DS cultures 
were similar in cellular appearance; broadly fibroblastic in appearance and had a high 
cytoplasm to nucleus ratio. Morphology was maintained over 10 passages as assessed by 
phase microscopy at x40 magnification 
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The images in figure 3.1 show representative images o f DP and DS primary culture cells in 
vitro; the morphology of these both cell types in culture was consistent with previous 
suggested descriptions: 
- The first outgrowth of cells from the primary explant were closely packed together, 
irregularly shaped and often granular in appearance at the perinuclear area which 
grew in a monolayer, this was maintained to sub-confluency (Jahoda and Oliver 
1981) 
- The cells on the periphery of the primary outgrowth from the DP and DS explants 
were fibroblastic, flattened, polygonal shaped cells with a single speckled nucleus 
and a number o f cellular processes; this morphology defined the DP and DS after 
the first passage (Jahoda and Oliver 1981) and was maintained throughout the 
period of culture which was up to 10 passages; a total o f approximately 4 weeks 
Both the DP and DS had phase-dark microfilament bundles (Jahoda and Oliver 
1981) 
At confluency multilayered aggregates were often observed (Messenger et al., 
1986; Jahoda and Oliver 1984) 
Although the cells demonstrated limited morphological changes throughout investigation, 
there may have been gene expression changes in the cells associated with culturing which 
would be undetectable by microscopy. In order to address this and confirm their DP and 
DS identity, the gene expression profile o f dermal follicular associated genes was 
examined. 
3.2 Expression of dermal follicular genes in DP and DS primary 
cultures 
Dermal follicular cell populations have a characteristic gene expression profile which 
includes nexin, versican and LEF-1. In vivo, nexin is expressed in the DP and lower DS 
(Sonoda et al., 1999; Y u et al., 1995), versican is expressed in the DP, DS, bulb matrix and 
epithelial column (Harris and Jahoda 2001; Fernandes et al., 2004) and LEF-1 is expressed 
in the DP, DS and matrix cells o f the lower hair follicle (DasGupta and Fuchs 1999; Merril l 
et al., 2001). Nexin is the most useful of these genes as its expression is not detectable in 
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dermal fibroblasts, mast cells, adipocytes, endothelial cells or keratinocytes in vivo (Xiang 
and Yang 1998). Therefore when nexin is expressed in conjunction with LEF-1 and 
versican in cells isolated from the hair follicle in vitro, it allows the very specific 
identification o f the DP and DS; an important tool when these cell populations are isolated 
by manual dissection from surrounding tissue, this method o f identification has proved 
useful in identifying the DP and DS primary culture cells in vitro and investigating their 
differentiation into adipocytic and osteocytic lineages (Jahoda et ai, 2003). 
Expression o f these genes were assessed in the DP and DS primary cultures to confirm 
their identity and investigate culture associated changes as shown in figure 3.2. Cells were 
sampled at passage 1; considered early passage, and passage 3; the stage at which there was 
sufficient cells for experimentation (see Methods section 2.4.1). DP and DS primary 
cultures were investigated along with three independent DP and DS clonal cell lines (gift o f 
Prof. Colin Jahoda). 
The end bulb was also analysed; as described the end bulb is the lower one third o f the hair 
follicle and contains the DP and DS in an un-manipulated state. However, the dermal 
populations have not been excised from other structures, such as the epithelial matrix o f the 
hair follicle or capillaries containing haematopoietic or endothelial progenitor cells, and are 
less useful in defining DP and DS properties. An alternative approach is to examine 
primary cultures from surgically excised dermal populations. Representative samples are 
shown in figure 3.2. 
Expression of the genes characteristic o f the dermal follicular cells was reproducibly 
detected across all the samples investigated. This expression pattern is consistent with the 
maintenance of the dermal follicular cell type in the DP and DS primary culture cells and 
the clonal cell lines. 
The gene expression o f the entire DP and DS primary cultures were sampled and there was 
detectable expression o f all three genes. These primary cultures are considered to be a 
mixed population o f biochemically distinct cells (Jahoda et ai, 2003) therefore not all of 
the cells may express nexin, LEF-1 and versican at the same time. 
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Figure 3.2: Gene expression profile of DP and DS pr imary cultures and clones 
End 
Bulb DP DS DPI DP2 
Clones 
DP3 DSl DS2 DS3 




RT-PCR of genes characteristic o f the follicular dermal cells. Nexin, LEF-1 and versican 
were consistently expressed in isolated whole end bulb, cultured populations o f DP and DS 
and dermal clonal cell lines. Representative bands are shown from passage 1, 2 and 3 
primary culture DP and DS cells and passage 6 clonal cell lines GAPDH was used as a 
loading control. 
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The clonal cell lines, derived from single DP and DS primary culture cells, did express all 
three genes indicating those individual founder cells had a similar gene expression profile. 
This can be extrapolated back to the DP and DS primary cultures, suggesting there are cells 
isolated that must be capable of expressing all three genes simultaneously, as is observed in 
vivo. In summary, this indicates there are cells present in the DP and DS primary cultures 
that are representative of the cells in vivo by dermal follicular cell gene expression 
profiling. 
Although the expression of genes characteristic o f in vivo dermal follicular cells were 
consistently observed in the DP and DS primary cultures, this does not exclude the 
possibility o f these cells having undergone tissue culture adaptation in vitro which may not 
be apparent by gene expression or morphology. Indeed, clones of single cells from DS and 
DP cultures can show a similar gene profile to the in vivo cells (figure 3.2) despite having 
undergone such cellular transformation. Transformation of other mesenchymal stem cell 
types demonstrates a characteristic shift in population doubling times (Zhou et al., 2006). 
In order to monitor whether such changes occurred during the duration o f primary culture 
of DS and DP, the population doubling times were assessed. 
DS and DP established cell lines, cultured from primary explants, were typically used at 
passage 3. The effects o f extended culture by changes in cell doubling time from passage 3 
to passage 5 were therefore studied for comparison to passage 3. Any changes would 
potentially indicate tissue culture adaptation or transformation, as has been used to indicate 
i f a bone marrow derived mesenchymal stem cell (MSC) population has become senescent 
(Kern etal, 2006). 
3.3 Dermal follicular cell population doubling time as determined 
by cell counts 
The population doubling time of untransformed primary DS and DP cultures has been 
reported to range from 1.1 days (Hoogduijn et al., 2006) to 3.8 days (Bassukas et al., 
1993). Clonal cell line doubling times also vary in a similar manner from 1 day to 3.8 days 
(Jahodaetal., 2003). 
The population doubling times across the three passages, as calculated by cell counts, were 
comparable with published data for both DP and DS primary cultured cells (2.5 to 2.8 
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days) as shown in figure 3.3. The effect o f cellular transformation would be to shorten this 
significantly as the cells rapidly proliferate. Mouse bone marrow derived MSC have 
demonstrated spontaneous transformation, starting at passage 3, as indicated by rapid 
proliferation which correlated with karyotype changes and loss o f contact inhibition (Zhou 
et al., 2006). As can be seen from figure 3.3, the time taken for the population to double in 
these three independent cultures actually increased modestly from 2.5 days to 2.8 days over 
the period o f study. These results were consistent with an absence of frequent cellular 
transformation in the cell populations; however it would be possible that heterogeneity in 
cell division rates in this large cell population could mask the effects o f a rapidly dividing 
minority. In order to address this, the cell division profile o f the whole population was 
examined. 
3.4 Pulse chase proliferation assay to examine cell division 
CFSE can be used in a pulse-chase experiment to monitor cell division (Lyons 2000). The 
principle o f this assay is shown in figure 3.4. Cells incubated with CFSE take up and retain 
this fluorescent dye independent of cell type; subsequent cell divisions can then be 
monitored throughout a period o f culture. Cell division results in daughter cells retaining 
half o f the fluorescence o f the parental cell type, which is halved again when these cells in 
turn divide. Preliminary experiments demonstrated that labelling by CFSE of dermal cells 
at passage 3 was very efficient (less than 6% (DP) or 10% (DS) unlabelled cells (data not 
shown) making CFSE suitable for labelling o f these cell types; the fluorescence o f the cells 
labelled with CFSE was detectable and distinguishable from non-labelled cells as shown in 
figure 3.5. 
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Average population doubling times and cell yields for DP and DS primary cultures across 
three passages with standard deviation error bars. Primary DP and DS cultures showed 
similar cell population doubling times over three passages; passage 3, 4 and 5 from three 
independent experiments. 
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l is \ b 1. Incubati  > with cell 7 2. CFS diffuses into c 
3. Cellular esterases 
cleave acetate groups; 
CFSE is rendered 
fluorescent and now cell 
impermeable 
4. CFSE dilut 
Illustration to show the mode o f action of CFSE. Non-fluorescent CFSE enters the cells 
where it is cleaved and becomes fluorescent and cell impermeable which then prevents it 
from leaving the cell. On cell divisions, the CFSE fluorescence signal is diluted as the 
CFSE is passed to daughter cells. 
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Figure 3.5: Pulse chase CFSE labelling of DP and DS in culture: control CFSE 







1 • I I 1 I 
10° 10 1 10 2 10 3 10° 10 1 1 0 2 1 0 3 
FL1-H FL1-H 
B Unlabelled DS d=0 100% labelled DS d=0 
FACS analysis of control samples for CFSE proliferation assay. Unlabelled DP and DS 
primary cultures had a low level o f autofluorescence. CFSE labelled cells had a peak 
fluorescence of 103. When the DP and DS cells were labelled with CFSE their initial peak 
fluorescence was as above; reductions in fluorescence were correlated to generation 
number as shown in figure 3.6. 
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The majority o f the DP and DS primary culture cells have an average doubling time 
between 1.4 days and 3.5 days; average o f 1.8 days for DP and 1.6 days for DS as shown in 
figure 3.6. This is within the published range of 1.1 days to 3.8 days (Hoogduijn et al., 
2006; Bassukas et al., 1993), although the average doubling time calculated by pulse chase 
is lower than the cell count-calculated doubling time. One explanation for this is that the 
cells show different population dynamics in bulk culture (figure 3.3) compared to low 
density analysis necessitated by the CFSE approach; however, the fact that population 
doubling times both fell within published range gave confidence that these cultures were 
suitable for study. 
A spread of cell division history was observed, varying f rom cells that had not undergone 
division (DP 6.2%, DS 3.8%) to cells that had 7 divisions over 7 days with an average 
doubling time of 1 day (DP 0.4%, DS 1.0%). This distribution of cell division rates was 
consistent with other mesenchymal stem cell types, for example human bone marrow MSC 
have demonstrated a range of doubling times from 1.6-6.7 days with an mean of 4 days 
(Suva et al., 2004). 
Having established that the isolated DP and DS populations may contain populations o f 
cells wi th stem cell properties, one approach to facilitate stem cell culture in vitro is to use 
low oxygen tension. 
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Figure 3.6: Pulse chase C F S E labelling of DP and DS in culture: C F S E proliferation 
assay of DP and DS primary culture cells 
DP 100% labeUed with C F S E d=7 
Average DP doubling time 1.8 days 
DS 100% labelled with C F S E d=7 
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% of original 
cell population 
GO (no divisions) - 24 6.2% 13 3.8% 
G l (1 division) 7 59 7.6% 73 10.8% 
G2 (2 divisions) 3.5 295 19.1% 224 16.6% 
G3 (3 divisions) 2.3 729 23.5% 434 16.1% 
G4 (4 divisions) 1.75 1710 27.7% 1512 27.9% 
G5 (5 divisions) 1.4 1483 11.9% 1879 17.4% 
G6 (6 divisions) 1.2 781 3.1% 1397 6.4% 
G7 (7 divisions) 1 183 0.4% 430 1.0% 
A proliferation assay using CFSE to examine the cell division profile o f the DP (;'.) and DS 
(//.). The cells were CFSE labelled and cultured for 7 days then FACS analysed; this 
sensitive technique allowed each cell to be evaluated and assigned a generation number 
based on fluorescence. The percentage o f cells dividing (HI.) and the original percentage o f 
cells which gave rise to the final generation cell counts (HI.) were broadly similar. The 
graphs are generated by the flow cytometry Flow Jo software (Tree star, Ashland, Oregon). 
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3.5 Investigation of hypoxic culture on population doubling time 
The quantity o f cells that can be harvested from tissues is limited; one constraint with using 
primary tissue is that cell numbers need to be increased prior to experimentation. However, 
extensive passaging, as well as storage, can cause cellular damage such as karyotypic 
changes, cell culture adaptation and inability for cell cycle exit (Mather and Roberts 1998). 
The number o f primary DP and DS cells that can be isolated from the hair follicle is 
limited, therefore the ability to expand these cells in vitro, in the absence of accumulated 
damage, is necessary. It may be possible to alter the dermal follicular cell culture 
conditions to necessitate this. The in vitro growth o f cells is subject to many culture-related 
factors one o f which is oxygen tension. Standard culture oxygen levels (20-21%) have been 
described as being "hyper-physiologic" for many cell types (Moussavi-Harami et al., 
2004), including cells such as MSC which are adapted to relatively low oxygen levels in 
vivo; higher oxygen levels can cause sufficient oxidative stress to induce premature 
senescence. In order to investigate whether low oxygen tension had an effect on dermal 
follicular cells in culture, DS and DP populations were isolated from the hair follicle and 
cultured in normoxic (20-21% O2) or hypoxic (5% O2) conditions. 
3.5.1 Outgrowth from primary explant: day 1-14 
The DP and DS primary explants were placed into culture as described in the Method 
section 2.4.1. 
The cells were observed to grow in a monolayer, in a roughly spherical area o f outgrowth 
from the primary explant in DP (n=4) and DS (n=4) cultures in both normal (figure 3.7/.) 
and low (figure 3.7/i.) oxygen culture. The cell morphology between the two oxygen 
concentrations was similar. The area o f confluency was observed to spread further from the 
primary explant material for low oxygen culture; the diameter o f the outgrowth in hypoxic 
culture was significantly larger than that o f the cells in normoxic culture (p<0.01) (DP n=4 
and DS n=4); this result was independent o f primary material diameter. At day 14 (passage 
1) the cells were seeded into fresh dishes and grown as monolayers. 
3.5.2 DP and DS primary culture: day 14-30 
From day 14 the DP and DS cells were allowed to proliferate to sub-confluency. 
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The DP and DS primary culture cells both appeared more densely packed in the low 
oxygen (figure 3.7/v.) compared to normal oxygen (figure 3 J Hi.) (DP n=4 and DS n=4). 
The cell morphology was similar between the two oxygen conditions. The final cell count 
is higher in hypoxic culture compared to normoxic culture; the doubling time was 
significantly lower for the low oxygen compared to the normal oxygen (p<0.01) (figure 
3.8) (DP n=4 and DS n=4). 
This first monolayer culture was then passaged at day 30 (passage 2) and further cultured. 
3.5.3 DP and DS primary culture: day 30-46 
The cells were grown in dishes from day 30 to day 46, the time point at which they would 
normally be used for expanding at flasks. 
The DP and DS primary culture cells both appeared more densely packed in the normal 
oxygen compared to low oxygen (DP n=4 and DS n=4). The cell morphology was similar 
between normal oxygen (figure 3.7v.) and low oxygen (figure 3.7vi.) culture conditions. 
The final cell count was higher in normoxic culture compared to the hypoxic culture; the 
doubling time was significantly lower in the normoxic culture (p<0.01) (figure 3.8) 
contrary to previous sampling times (figure 3.8J.-/V.). The doubling time for the normoxic 
DP and DS primary culture cells is consistent with published cell doubling times o f 2.5 
days for the dermal cells 
For in vitro experiments, DP and DS primary cultures were routinely used at passage 3; 
culturing the cells under hypoxic conditions resulted in a significantly increased cell 
doubling time at this passage, however the numerical value lies within previously 
published ranges for dermal follicular cells. Cell morphology was identical between the 
different oxygen concentrations, and no overt differences in sub-populations were 
observed. However, at passage 3 the hypoxic culture doubling time was significantly 
longer indicative o f cell death or cellular senescence. Given this, and that cell numbers 
were limiting for further experiments, the normoxic conditions were selected for further 
work as they delivered the significantly greater yield o f cells at passages where hypoxia 
was having a detrimental effect upon the cell population. 
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Figure 3.7: Morphology of DP and DS pr imary cells in normoxic and hypoxic in vitro 
culture 
ii. H y 
to 
[ ,;>. iY 
Hi. Normoxic iv. Hypoxic 
m 
. Hypoxic v. Normoxic VI 
x40 
I 
Primary explant cell outgrown, confluency and gross morphology of DP and DS primary 
cells in normoxic and hypoxic in vitro culture. The outgrowth of DP and DS cells from 
primary explants spread further for cells under hypoxic culture (/'/'); by passage 2 the DP 
and DS primary cells were more confluent under hypoxic culture [iv). Morphology of the 
DP and DS primary cells were broadly similar (v.vz) throughout; by passage 3 the cells 
were more confluent under normoxic culture (v). Cell images are representative of the DP 
and DS cultures analysed. 
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Figure 3.8: DP and DS pr imary culture population doubling time changes f r o m 
passage 2 to passage 3 i n normoxic and hypoxic in vitro culture 
Sample Passage 2 Passage 3 
DP normal oxygen 3.9 2.5 
DS normal oxygen 3.5 2.6 
DP low oxygen 3.0 5.9 
DS low oxygen 2.7 5.1 
DP normal oxygen 
DS normal oxygen 
DP low oxygen 





P3 P2 Passage Number 
Population doubling times for DP and DS primary culture at passage 2 and passage 3 for 
normoxic and hypoxic culture with standard deviation error bars. At passage 3 the DP and 
DS primary cells in normoxic culture had a significantly lower doubling time compared to 
hypoxic culture (p<0.01). The change in doubling time for DP and DS primary cells, in 
both normoxic and hypoxic culture , from passage 2 to passage 3 was also significant 
(p<0.01). This indicates DP and DS cells under normoxic culture at passage 3 were most 
suitable for experimental purposes. Average doubling times shown for DP and DS passage 
2 (day 30) and passage 3 (day 46) (n=8) 
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Should low oxygen culture have been conductive for a stem cell population, in the absence 
of significant cell death or senescence, there would be a decrease in average population 
doubling time as the stem cells proliferate and the overall cell number in culture increase. 
This in turn would make the final cell count, taken at passage, greater or the flasks would 
reach confluency earlier, either of which would result in a lower average population 
doubling time. The cell counts indicated a significant increase in population doubling time, 
as shown in figure 3.8; suggesting hypoxia had a detrimental effect upon the population. 
Should low oxygen have in fact been conductive for a small number of potential stem cells 
present, it was masked by the detrimental effect of hypoxia upon the population. Therefore, 
there was no evidence that hypoxic culture promoted stem cell proliferation within the DP 
and DS culture populations. 
3.6 Spontaneous appearance in DP and DS culture 
cardio myocyte-1 ike cells 
In analysing the potential for the dermal cells to differentiate to a cardiomyocyte-like 
population, the first step in their investigation was the spontaneous in vitro differentiation 
of the DP and DS primary cultures to this lineage. Cells in DP and DS primary cultures 
have been reported to spontaneously differentiate to cell lineages such as adipocytic and 
osteocytic (Jahoda et al., 2003). Contractions consistent with cardiomyocytic 
differentiation were observed. However, this latter differentiation was less well defined. 
Gross morphology and contracting areas of dermal cells in primary culture have been 
reported (Jahoda et al., 2003) as well as myotubules like cells (Rufaut et al., 2006) but 
systemic analysis has not been published. Further, the expression of genes characteristic of 
cardiomyocyte commitment has not been studied with the exception of general myocyte 
markers: MyoD and myogenin (Rufaut et al., 2006). This was therefore investigated 
further. 
The DP and DS were cultured together producing a mixed DP and DS primary culture by 
removing the dermal follicular cells from the end bulb and, instead of separating the two 
populations, putting them into culture while they are still attached to one another. The cells 
grew out from the explant in a monolayer as seen in individual DP and DS primary culture 
making it impossible to determine which cells were DP or DS derived. However, with this 
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type of culture, on occasion, spontaneous appearance of cells with cardiomyocyte and 
myotube morphology have been observed as well as cells with synchronised contractions, a 
hallmark of cardiomyocytes, were also observed. 
3.6.1 Spontaneous appearance of myocyte-like cells 
As a comparator for expected morphology of cardiomyocytes in vitro, cell cultures of 
embryonic cardiomyocytes were set up. As seen in figure 3.9///, these have rod shaped 
morphology, a single nucleus and a small number of cytoplasmic processes overlapped 
with neighbouring cells, a result consistent with published studies (Maltzev etal., 1993). 
Cells with morphology similar to adipocytes spontaneously developed in several cultures 
under sub-confluent conditions, a result consistent with that reported by Jahoda at al. 
(2003). However, in at least 5 of the 40 cultures examined, cells indicative of individual 
myocytes were observed (figure 3.9). These latter cells did not spontaneously contract but 
had morphology to similar to embryonic cardiomyocytes from an early in vitro culture time 
point as described above (figure 3.9///). Over time (typically seven days) the numbers of 
these cardiomyocyte-like cells increased in some cultures, whereupon they developed into 
more organised structures (figure 3.9ii.) in a manner reminiscent of myotube formation. 
3.6.2 Spontaneous appearance of myotube-like cells 
In at least two of the 40 cultures examined, larger cellular structures were observed in 
mixed DP and DS primary cultures that appeared morphologically similar to conventional 
myotubes formed in vitro. These are characterised by having a narrow spindle shape, a 
dense cytoplasm and with a conspicuous bulge in the portion of the cell occupied by the 
nucleus; individual myoblasts fusing to form larger, multinuclear cells (Capers 1960). As 
can be seen in figure 3.10, such structures appeared in some of the DP and DS mixed 
cultures, extending across many undifferentiated DP and DS cells. They were not observed 
to produce spontaneous contraction over the period of observation. These cells were 
typically observed after 14 days of culture. 
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Figure 3.9: Morphology of cells similar to cardiomyocytes spontaneously appearing in 
mixed DP and DS primary cultures in vitro 
i. 
Morphology of cardiomyocyte-like cell in mixed DP and DS culture in vitro. In primary 
cultures of mixed DP and DS, cells similar to cardiomyocytes (A) and adipocytes (B) 
appeared disorganised (/.) or highly organised (//.). The morphology of these cells appeared 
very similar to El2.5 embryonic cardiomyocytes (C) after 6 days in primary culture (Hi.). 
Representative image shown; cardiomyocyte-like cells were observed after 7 days in mixed 
DP and DS primary culture. Images at x20 magnification. 
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Figure 3.10: Morphology of cells indicative of myotubules, spontaneously appearing 




Morphology of myotubules-like cells in mixed DP and DS primary culture in vitro. There 
spontaneously appeared cells indicative of myotubules (A) These long tubular cells were 
multi-nucleated (B) with the nucleus to the centre of the cells; a quality consistent with 
myotubules. Representative image shown; myotubules-like cells were observed after 14 
days mixed DP and DS primary culture. 
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3.6.3 Synchronised contractions 
Large areas of contractile cells were also observed in more than 5 mixed DP and DS 
cultures (figure 3.11), although not in those areas of culture where the myotube-like cells 
described above were present. In these instances the contracting cells were co-located with 
non-contracting cells and appeared to orientate their axes parallel to one another but were 
otherwise indistinguishable from surrounding non-contracting cells. The contracting cells 
appeared to radiate from the primary explant across the entire culture dish and contraction 
was synchronised across all the cells. 
The spontaneous appearance of contractions and myotube-like cells in the dermal cultures 
does not distinguish between a skeletal myocytes which spontaneously contract (Florini et 
al., 1991) and cardiomyocyte lineages. Makino et al., showed that bone marrow stromal 
cells, treated with 5-azacytidine, which formed myotube-like structures, began 
spontaneously beating after two weeks, and beat synchronously after three weeks. These 
cells, although appearing more like skeletal cells in vitro, displayed a cardiomyocyte-like 
ultrastructure by electron microscopy analysis including typical sarcomeres, a centrally 
positioned nucleus. In addition, the cells expressed the contractile protein genes, myosin 
heavy chain, myosin light chain, and a-actin, in a phenotype indicated that similar to that of 
foetal ventricular cardiomyocytes (Makino et al., 1999). 
Skeletal myoblasts do not normally synchronise their contractions in culture (Itabashi et al., 
2005); the appearance of cells with synchronised contractions in the dermal cultures 
indicates that cells capable of cardiomyocyte differentiation were present within these 
cultures. 
The genes controlling conventional cardiomyocytic differentiation have been described, as 
discussed in Chapter 1. In order to examine whether cells with this profile were present 
within the primary cultures, DP and DS cultures were subjected to RT-PCR analysis. 
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Figure 3.11: Morphology of spontaneous appearance of contractile cells in mixed DP 




Large areas of spontaneous contractile cells (A) in mixed DP and DS primary culture. The 
areas of contracting cells were arranged in a linear manner radiating from the primary 
explant material; the DP (B) and DS (C); in this instance there was induction of hair shaft 
growth (D). Representative image shown; contracting cells were observed after 14 days 
mixed DP and DS primary culture. 
* This is a composite image consisting of 6 separate photographs (/.) 
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3.7 Directed cardiomyocytic differentiation potential of DP and 
DS cultures by gene expression analysis 
The gene expression of the transcription factors associated with early cardiomyocyte 
induction and commitment; Nkx2.5, GATA4, Mef2c and tbx5, a number of genes 
associated with the functional cardiomyocyte; cardiac specific sarcomere structural genes: 
alpha myosin heavy chain (a-MHC), myosin light chains specific to the atria (MLC1A) and 
ventricle (MLC1V), tropomyosin and cardiac actin as well as genes associated with 
contracting cardiomyocytes: troponin I and titin were investigated as an indicator of 
cardiomyocyte differentiation potential. These genes are discussed in Chapter 1. In 
addition, sca-1, which is implicated in the identification of native cardiac stem cells 
(Tateishi et al., 2007) and Tert, associated with stem cells and important in increased 
proliferative capacity (Serakinci et al., 2008) were also investigated. Tropoelastin, an 
extracellular matrix protein associated with vessels (McKee et al., 2003) was also 
investigated. 
The expression of these three groups of genes were investigated in the in vitro DP and DS 
primary culture cells at passage 1 and passage 3. The end bulb represents the intact DP and 
DS structures before isolation and culture. These primary cultures could contain a small 
number of contaminating cell types. In order to further characterise the gene expression 
profiles of DP and DS cells, independent clonal cell lines isolated from individual dermal 
follicular cells were also analysed. 
The adult heart produced a positive signal for all of the PCR targets, confirming their 
suitability. Interestingly, the adult heart consistently produced PCR products specific for 
mTert and sca-1, genes characteristic of stem cells. 
Of the cardiac transcription factors investigated, the DP and DS primary culture samples 
expressed only Mef2c (figure 3.12). Of the functional genes, tropomyosin and troponin I 
were detected, albeit at very low levels in the latter case (figure 3.13). Tropoelastin was 
detected as well as Tert at very low levels, but transcripts for sca-1 were not present at 
levels sufficient to produce a PCR product (figure 3.14). That such detectable gene 
expression was a product of the dermal cells and not any contaminating cell type is 
supported by the expression of these genes in a number of the clonal cell lines. 
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The end bulb sample expressed a number of cardiomyocyte transcription factors (Nkx2.5 
and Me£2c), functional genes (cardiac actin, tropomyosin, titin, MLC1A and possibly 
MLC1V) and low level expression of tropoelastin and Tert. By definition of isolation, the 
end bulb may contain contaminating cells that could attribute the gene expression observed 
here however the level of expression is in some instances relatively high and may represent 
the gene expression of the DP and DS in vivo or when the DP and DS are combined, 
however the end bulb sample does express a number of genes not detected in the DP and 
DS primary cultures or in the clones namely Nkx2.5, cardiac actin and titin. In addition, 
elastin is expected to be abundant in the skin and has previously been identified in the DP, 
its stalk and the peribulbar mesenchyme (Young et al, 1980). 
The clonal cell lines were also investigated; these cell lines were established from single 
DP and DS primary culture cells. These cell lines have previously been investigated for 
their differentiation potential to adipocytic and osteocytic lineages (Jahoda et al., 2003) 
where their doubling times were monitored and were within published ranges, indicating 
the cells had not undergone transforming events. The expression of troponin I and 
tropoelastin varied between clonal cell lines, suggesting that this may not be a property 
common to all follicular dermal cells. In addition, all clonal cell lines examined expressed 
a-MHC, MLC1A and Tert, despite an absence of strongly detectable expression in the 
primary cultures. This may indicate the clones are representative of a small population of 
cells within the DP and DS primary culture which are then undetectable when in primary 
culture. 
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Figure 3.12: Cardiac transcription factor-associated gene expression profile of DP 
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RT-PCR analysis of genes associated with early induction and commitment of 
cardiomyocytes. The dermal follicular cells did not consistently express genes associated 
with cardiomyocyte induction. RT-PCR analysis indicated the expression of Mef2c in the 
DP and DS primary cultures, confirmed by clonal cell lines, with expression of Nkx2.5 
detected in the end bulb alone. Representative samples are shown; the results were 
confirmed by three independent DP and DS primary cultures at passage 1 and 3 and three 
independent clonal cell lines. 
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Figure 3.13: Cardiac function-associated gene expression profile of DP and DS 
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RT-PCR of genes associated with cardiomyocyte function. The dermal follicular cells did 
not express the entire profile of genes associated with cardiomyocyte function. The DP and 
DS primary cultures expressed tropomyosin and troponin I , at low levels, which were 
confirmed by clonal cell lines. At this level of analysis the end bulb expressed all the 
cardiac genes investigated with the exception of a-MHC and troponin I . In addition, a 
number of the clones expressed a-MHC, atrial MLC (MLC1A) and titin at varying 
levels. Representative samples are shown; the results were confirmed by three independent 
DP and DS primary cultures at passage 1 and 3 and three independent clonal cell lines. 
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Figure 3.14: Gene expression profile of DP and DS primary cultures and clones for 
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RT-PCR of stem cells associated genes and tropoelastin. The DP and DS primary cultures 
expressed tropoelastin and Tert at low levels alone which was confirmed by expression in a 
number of the clonal cell lines. Tert was expressed in all of the clones and sca-1 was 
undetectable. The end bulb expressed tropoelastin and Tert at very low levels. 
Representative samples are shown; the results were confirmed by three independent DP 
and DS primary cultures at passage 1 and 3 and three independent clonal cell lines. 
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3.8 Chapter 3 Discussion 
The DP and DS primary culture cells were investigated to determine if they had 
reproducible culture characteristics as determined by monitoring morphology, population 
doubling times and gene expression. The DP and DS cell populations were easily isolated 
and readily available from the vibrissae. The cells isolated had morphology consistent with 
previously described DP and DS culture populations; population doubling times were 
within range of published results and indicated the cells proliferation rate was clinically 
relevant; DP and DS isolates were reproducibly produced. The population dynamics and 
gene expression profile did not substantially change over the period of in vitro culture. 
These data indicate that the DP and DS cultures were suitable for further study. 
Furthermore, these features were evaluated to determine if the cells were suitable as a 
model system investigating for somatic cell differentiation specifically of commitment 
towards a cardiomyocyte lineage. 
Given the similarity of the behaviour of the two cell populations in vitro, the question 
arises as to which to study further. Evidence suggests that the DP and DS have different 
roles in the hair follicle and surrounding dermis. The DP has hair and dermal follicular 
inductive properties (Jahoda et al., 2001) and these cells have also demonstrated the ability 
to form new hair follicles even in undifferentiated epidermal tissue (Reynolds and Jahoda 
1991) and is a necessary component for follicle formation in wounded skin (Ghazi et al., 
2003). The DS has been suggested to play a role in wound healing in the dermis where it 
has demonstrated fibroblastic properties (Jahoda and Reynolds 2001). The DS is also 
capable of inducing new follicles as well as skin substitutes with outer root sheath (Ghazi 
et al., 2003). The overlapping but distinctive in vivo capabilities of the DP and DS may 
have an effect upon their potential to differentiate to cells of a cardiomyocyte lineage in 
vitro. The DP has demonstrated properties that are more involved in normal skin 
homeostasis e.g. induction, whereas the DS appears to be more significant in a wound 
healing environment in an adaptive response. The infarcted heart is considered to be a 
hostile, hypoxic, in vivo wound healing environment therefore the DS, as demonstrated by 
its role in the skin, may be more adaptive in this environment. However, the method of in 
vitro differentiation of cells may be more suited to the properties of the DP where the cells 
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are being induced to differentiate to a new cells type. In addition to this, the DP and DS 
have different alkaline phosphatise activities in vivo; the DP having high alkaline 
phosphatise activity with the lower DS, as used here, having low alkaline phosphatise 
activity; expression of which is associated with stem cells and may suggest the DP is more 
stem-cell like where the DS is more proliferative, this may play an important role in 
induction and differentiation potential, respectively (McElwee et ai, 2003). The proposed 
differences between the two cell types suggest investigating the DP and DS as separate cell 
populations. 
Cells of the DP and DS can show properties of mesenchymal stem cell types, but have 
some discrepancies with other MSC. Those MSC originating from bone marrow, umbilical 
cord blood and adipose tissue do show comparable morphology in culture; the cells are 
adherent, mononuclear and grow to a monolayer although they do have more elongated 
spindle-shaped cell morphology than the DP and DS primary cells in culture (Kern et ai, 
2006). During in vitro culture, MSC have an average doubling time of 3 days (Bertani et 
ai, 2005) which is comparable to the DP and DS primary culture cells (2.5-2.8 days). MSC 
possess a limited life span and finally undergo replicative senescence, as indicated by loss 
of proliferation and altered morphology. For bone marrow MSC, this is at passage 7, for 
adipose tissue MSC at passage 8 and umbilical cord blood MSC at passage 9 (Kern et ai, 
2006). Other reports suggest that relicative arrest for these stem cell types can occur 
slightly later, between passage 10 and 12 (Bertani et ai, 2005). Interestingly, both DP and 
DS demonstrated changes in morphology and incidence of cell death at passage 8. These 
data suggest that both these cell types may show a similar limit to cell expansion in vitro. 
This similarly extended to the rate of cell division. The population doubling times were 
first investigated by whole population cell counts. These data demonstrated a predicted 
population doubling time that was within range of previously published reports. However, 
whole-population studies cannot discriminate between a fast-dividing sub-population and a 
slow-dividing bulk population; the net effect is the same. 
A CFSE-based proliferation assay allowed the generation status of each cell to be 
determined where the grouping of cells based on doubling times can be appreciated; CFSE 
has been shown to be a reliable method for studying the proliferative activity of MSC sub-
populations (Urbani et al., 2006) however a CFSE profile of the dermal follicular cells has 
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not been published. Pulse chase analysis resulted in a lower average doubling time for the 
DP (1.8 days) and DS (1.6 days) primary cells in culture than had been calculated by cell 
counts (2.5-2.8 days); interestingly a doubling time closer to that of the dermal clones, as 
described in figure 3.2 (Jahoda et al., 2003). Consistent with the DP and DS clones in 
comparison to the primary populations; MSC clonal cell lines have demonstrated an 
average doubling time of 1.5 days (Suva et al., 2004) as indicated by CFSE labelling. 
Adherent cells from bone marrow have demonstrated a doubling population time of 1.6-6.7 
days with a mean of 4 days (Suva et al., 2004), however when the MSC are specifically 
isolated by FACS and analysed by CFSE 65% of the population were mature MSC and 
35% were a re-cycling population of MSC; these re-cycling cells had a higher proliferative 
potential as as suggested by CFSE proliferation analysis (Urbani et al., 2006). This 
complex CFSE profile is comparable with the DP and DS profiles. When the MSC profile 
was split into two separate profiles representing the recycling and more mature MSC as 
identified by FACS, it was demonstrated that the majority of the mature MSC (99.6%) and 
recycling MSC (70%) had a population doubling time of 1.5 days however 30% of the 
recycling cells had a population doubling time of 0.6-1 days (Urbani et al., 2006). 
Therefore MSC doubling times based on bulk cell counts do suggest a higher proliferation 
that that calculated with CFSE labelling as was demonstrated with the DP and DS cells 
however CFSE-calculated doubling times do not indicate this is due to a small, transformed 
population of cells which suggests experiments with different primary isolated would have 
little variation. 
This adds further evidence to the theory of the DP and DS cultures being a mixed 
population of cells. It poses the question: in order to use a population of DP and DS 
primary cells for differentiation investigation, indeed any type of primary cell, will a sub-
population of cells with stem cell capabilities need to be identified and isolated within the 
culture system first? One possible approach to investigate a potential sub-population is to 
first identify it by way of stem cell markers. This was investigated with the expression of 
Tert which may allow identification of a cell population with a higher proliferative capacity 
as described in Chapter 5. In the first instance the bulk population was investigated. 
Several studies have suggested that low oxygen tension can be conducive for proliferation 
of a number of cell populations. For example, osteoblasts show increased cellular 
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proliferation rate with decreased differentiation under hypoxic in vitro culture (Tuncay et 
ah, 1994). In a similar manner, Warren showed hypoxia affected rat primary osteoblast 
controlled osseous healing by increasing expression of cytokines and bone-specific 
extracellular matrix molecules and their regulators (Warren et ai, 2001). However, bone 
marrow MSC showed induction of differentiation under hypoxic conditions, resulting in 
accelerated differentiation, proliferation and morphological changes (Ren et ai, 2006), a 
result consistent with that of published work on osteoblastic established cell lines cultured 
under low oxygen; hypoxia appears regulate gene expression, cellular proliferation and 
cellular differentiation (Steinbrech et ai, 1999, Park et ai, 2002). 
DP and DS appeared not to show these properties. DP and DS cells demonstrated 
unchanged morphology in culture suggesting an absence of gross differentiation. In 
addition, by passage 3 there was increased population doubling time inconsistent with 
accelerated proliferation. The culture stage of the cells in question, as well as the length of 
hypoxic exposure, may play an important role in the effect of the hypoxia; Potier showed 
that human MSC exposed to prolonged hypoxia resulted in cell death however temporary 
hypoxia had no detectable effect on MSC survival (Potier et al, 2007). The pulse chase 
experiments suggested the DP and DS primary culture cells to be a mixed population of 
cells, of which one group may be stem cell-like in their properties and differentiation 
ability. One suggestion was that culturing the cells under hypoxic conditions could have 
been conductive for differentiation as well as proliferation of a stem cell population as 
indicated by the MSC work described. However, the morphology of the DP and DS 
primary cells remained unchanged; suggesting an absence of gross differentiation, and 
population doubling time was significantly increased. Cell counts from the hypoxic 
cultures were significantly higher within the first two passages as compared to normoxic 
culture conditions; this initial burst of cellular activity could be the result of hypoxia-
induced increased motility. MSC have demonstrated increased migration in tumour 
angiogenesis environment as induced by hypoxia (Annabi et ah, 2003). One explanation is 
that the cells are responding to the hypoxia in a similar manner to a wound healing 
environment as has been shown with dermal fibroblasts. Li showed that hypoxia promoted 
dermal fibroblast motility by inducing their secretion of heat shock protein 90alpha (HSP-
90a) via hypoxia-inducible factor 1 alpha (HIF-la); this secreted HSP-90a in turn executes 
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the pro-motility signal of hypoxia (Li et al., 2007B). The dermal follicular cells may act in 
a similar manner as they have been attributed wound healing capabilities (Jahoda and 
Reynolds 2001). However, the extended period of hypoxic culture resulted in a reduced 
cellular doubling time as would be seen with the outcome of hypoxic cell death (Zhu et al., 
2006). Low oxygen, for these reasons was deemed an unsuitable for further investigation, 
including for promoting differentiation. 
Cells similar in morphology and behaviour to myocytes, myotubes and cardiomyocytes 
developed spontaneously in a small number of mixed DP and DP primary cultures. Due to 
the nature of the isolation of the primary material for these cultures there is a greater 
possibility of contaminating cell types. The DP and DS were isolated from the hair follicle 
with precision to ensure surrounding cells were not transferred into culture, however in any 
in vitro system where more than one cell is studied; there remains a small, but finite, risk of 
contamination with other cell types. This is a problem for studies of stem cell fate of a 
specific cell type. With this type of culture there is also the risk of blood being transferred 
into culture with the isolated DP and DS; components of the blood, such as HSC, have 
been reported to contribute to cardiomyocyte lineage in vivo (Orlic et al., 2001). The 
frequency of these events is very low (possibly zero), and indeed the physiology of such 
cardiomyocyte commitment from HSC that may occur remains unclear. However, the 
possibility formally remains. Other circulating stem cell types have been suggested to 
commit to cardiomyocytes such as MSC (Toma et al., 2002), endothelial progenitor cells 
(Anversa et al., 2006B) and potentially, circulating adult cardiac stem cell types as may 
exist (Weissman et al., 2001). 
Myocyte differentiation has been previously suggested by the spontaneous appearance of 
contracting cells in dermal cultures (Jahoda et al., 2003) however this was not investigated 
further. Contracting cells, as well as cells of myocyte morphology, spontaneously 
appearing in culture has not been identified in MSC cultures to date except in response to 
5-azacytidine, which is a potent de-methylation agent (for example Hattan et al., 2005). 
Specific culture media supplemented with growth factors has been demonstrated to induce 
myocytic differentiation of ear MSC (Gawronska-Kozak et al., 2007) with the appearance 
of spontaneous contractions however contractions were not synchronised and gene 
expression analysis was limited to general myocyte genes. Therefore Gawronska-Kozak et 
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al., could only conclude that the cells identified did not display a definitive cardiomyocyte 
or skeletal myocyte phenotype but a heterogeneous mixture of cells with a partially 
differentiated myogenic phenotype. 
Mixed cultures of DP and DS did show spontaneous appearance of cells with myotube-like 
morphology similar to cells differentiated from bone marrow stromal cells (Makino et al., 
1999), suggesting cardiomyocyte commitment. This morphology is not unique to 
cardiomyocytes, as skeletal muscle cells can show similar forms (Capers 1960). However, 
the spontaneous, synchronised contraction of the myotubes in the dermal cultures indicates 
the presence of differentiated cardiomyocytes. One approach is to study primary cells on a 
single cell basis (Short et al., 2003). However, given the slow population doubling time of 
primary DP and DS, and the potential limit before replicative senescence (see above), this 
approach would prove very challenging for in vitro differentiation studies. However, using 
dermal clones would be a potential route of investigation. These cell lines are derived from 
single DP or DS cells therefore they would overcome the possibility of contaminating cell 
types and any differentiation would be attributed to the dermal follicular cells. 
RT-PCR analysis demonstrated that the clones investigated had a gene profile consistent 
with that of follicular dermal cells (section 3.7). Gene expression analysis showed 
expression of Mef2c; a gene associated with cardiomyocyte commitment. This could 
suggests that these cell types have propensity for cardiac commitment, in a fashion similar 
to, for example, undifferentiated ES cells which express genes associated with mesodermal 
lineages and spontaneously differentiate towards mesoderm lineage (Heo et al., 2005). 
However, this may not be the case. Of the transcription factors, only Mef2c had detectable 
expression in the primary culture DP and DS and clonal cell line. Mef2c is normally 
expressed in developing striated muscle playing an important role in efficient 
differentiation of heart precursor cardiomyoblasts into cardiomyocytes (Karamboulas et al., 
2006) by being upstream of a subset of cardiac genes essential for contraction. Mef2c is 
regulated by Nkx2.5 and GATA4 however the dermal cells did not express these 
transcription factors at baseline. Mef2c, Nkx2.5 and GATA4 are upstream of tropomyosin 
(Reddy et al., 2000) and elastin; which both the DP and DS express, as well as a-MHC 
(Molkentin et al., 1993) and troponin I (Di Lisi et al., 1998). Mef2c, associated with 
muscle regulation and cardiovascular development, has also been reported to control bone 
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development by activating chondrocyte hypertrophy and was detected in developing 
chondrocytes (Arnold et al., 2007), and the expression of this gene may be associated with 
osteogeneic potential in dermal cells. Previous work has confirmed that at least some cells 
in the follicular dermis can demonstrate bone formation in vitro (Jahoda et al., 2003). 
Genes characteristic of functional cardiomyocytes appeared to be expressed by primary cell 
types; these included tropomyosin in the DP and DS, and cardiac actin in end bulb. In 
respect of the latter, recent work suggests that the primer pairs used may cross-react with 
specific actin isoforms found in fibroblasts (Yasuda et al., 2006), suggesting that inclusion 
of these cell types in the whole end bulb may be responsible for the production of the PCR 
product. The absence of detectable expression in follicular dermal cells explanted from the 
end bulb supports this. In respect of tropomyosin, in a similar manner to Mef2c, the 
products of this are expressed in osteoclasts and up-regulated during osteoclastogenesis 
where it has been suggested to play a role in determining the dynamic properties of the 
actin cytoskeleton and thus osteoclast activity (McMichael et al., 2006). Therefore this 
expression may be associated with the osteogeneic potential of the dermal cells (Jahoda et 
al., 2003). 
A number of the genes investigated were expressed in the dermal clones but not in the end 
bulb or DP and DS primary cultures; these were a-MHC, troponin I and MLC1A. The 
clones are considered to be representative of the primary cells as has previously been 
suggested with bovine DP clonal cell lines (Rufaut et al., 2006). This pattern of expression 
may indicate that these genes are expressed in a limited number of the cells present in the 
DP and DS, the expression of which may be diluted in the entire end bulb sample and in 
the primary cultures; it may be that these genes were expressed in the cells used for clonal 
cell line establishment and therefore they are expressed in the clones but not primary 
material. The primary cells may be more representative of the tissue or origin, as non-
representative sub-populations may be selected during the cloning process. If this were the 
case, this would explain the a-MHC, troponin I and MLC1A expression detected in the 
clonal cell lines but not in the primary cell lines. 
Tert, which adds telomeric repeats to the ends of chromosomes, is associated with the 
maintenance of stem cell populations and extended culture in vitro (reviewed by Hiyama 
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and Hiyama 2007). Tert expression in the clonal cell lines may be associated with the 
proliferate potential of these cells. The clonal cell lines have high proliferative potential; 
they have been shown to be maintained for up to 26 passages, (Jahoda et al., 2003). 
Expression of Tert is unsurprising as it correlates with the lack of cellular senescence. 
Interestingly there was low level in the end bulb suggesting that at least some cells within 
these cultures may have equally high proliferative potential. This possibility is investigated 
later, in Chapter 5, where the Tert expression is examined in the DP and DS with the used 
of the mTert-GFP mouse model. Sca-1, a potential marker of cardiac stem cells and was 
detected in the end bulb, but not in DP or DS or any of the clones. However sca-1 is not 
exclusively expressed by potential cardiac stem cells, but by other cells types as has been 
demonstrated with the bone marrow, endothelial progenitor cells and HSC. 
The appearance of three distinct cell types in culture: myocytes, myotubules and cells with 
synchronised cardiomyocyte-like contractions, are indicative of there being cells present 
within the DP and DS primary cultures which are capable of differentiation towards a 
myocyte lineage and under specific conditions, cardiomyocytic lineage. On no occasion did 
these three cell types appear when DP and DS were cultured alone nor in the same culture 
dishes to one another. This was observed by Jahoda et al., (2003) when investigating the 
adipocytic and osteogenic differentiation potential of the DP and DS primary cultures. It 
appears the microenvironment determines the differentiation response of the dermal 
follicular cells into adipocytes and osteocytes, as suggested by activation or inhibition of 
the MAP kinase ERK (Jaiswal et al., 2000), regardless of their multipotency (Jahoda et al., 
2003). This would indicate that in order to direct the differentiation of the DP and DS 
primary cells towards a cardiomyocytic lineage, an inductive microenvironment is 
necessary as has been suggested with their differentiation towards adipocytic and 
osteocytic lineage. The gene expression profile of the dermal follicular cells suggests an 
inductive environment that would switch on the expression of early cardiomyocyte-
associated genes. Although isolated populations contain cells with the potential to produce 
cardiomyocytes, they only express that potential spontaneously in mixed cultures and the 
end bulb is not a suitable model for study. The consistent isolation of the end bulb would 
be complicated; variation in follicle sizes would make the end bulb section more difficult to 
reproducibly identify. It would be expected that there would be variations from one 
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primary culture to the next for example in the morphology of the mixed population of cells, 
the proliferative rates of sub-populations, spontaneous contraction rates and spontaneous 
differentiation rates in vitro as well as the possibility of contaminating cell types. In 
addition to this, there is no evidence of spontaneous differentiation in vivo in the end bulb. 
In order to examine whether DP and DS have the potential for cardiomyocytic 
differentiation and expression of cardiomyocyte-associated genes, an inductive approach is 
necessary. Co-culture provides an inductive micro-environment; intimate cell contact 
allows gap junction communication which may lead to efficient transduction of autocrine 
and paracrine factors secreted by an inductive cell type which would induce 
cardiomyocytic differentiation (reviewed in Christoforou and Gearhart et ai, 2007). This 
type of method has been shown to be successful in differentiation of MSC to 
cardiomyocytes (for example Li et ai, 2007) as well as differentiation of bovine DP cells 
to myotubules-like structures (Rufaut et ai, 2006). Differentiation of cells to 
cardiomyocytes has been shown to be dependent on communication with an inductive cell 
(Xu et ai, 2004), co-culture is therefore the most suitable next step in the investigation of 
the DP and DS and their potential towards cells of cardiomyocyte lineage. 
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4 In vitro cardiomyogenic differentiation potential of the 
dermal follicular cells 
Work described in Chapter 3 indicated that cells of the follicular dermis expressed genes 
characteristic of functioning cardiomyocytes, and could spontaneously demonstrate 
differentiation consistent with the formation of these cell types. However, the level of gene 
expression and spontaneous differentiation was comparatively modest. In order to examine 
whether this potential could be enhanced, an inductive approach was adopted. There is 
evidence from other mesenchymal cell types that such an approach can help demonstrate 
cardiomyocytic potential in vitro. 
The bone marrow (BM) contains several populations of stem cells including HSC, which 
are responsible for forming blood, as well as MSC or stromal cells. These cells are capable 
of differentiating to osteocytes, chondrocytes, adipocytes and skeletal myoblasts; there is 
also a large body of evidence that they can commit to a cardiomyocyte lineage. For 
example, Wang showed that rat MSC in cell contact with rat adult cardiomyocytes 
differentiated to cells of cardiomyocyte phenotype as indicated by expression of a-actin, 
desmin and troponin T (Wang et al., 2006). Human MSC are also capable of differentiating 
in vivo in murine heart where they have demonstrated a similar gene expression profile of 
oc-actinin, desmin, cardiac troponin T and P-MHC (Toma et al., 2002). This differentiation 
has also been shown to have function attributes, Beeres showed human MSC restored 
experimental conduction blocks in rat cardiomyocytes (Beeres et al., 2005). 
In attempting to differentiate the dermal follicular cells a similar method of induction was 
implemented as described for MSC. At least two sources of inductive cell could be used. 
Embryonic cardiomyocytes, as has been successfully used with MSC (Yoon et al., 2005), 
and ES cells. 
4.1 Inducing the dermal follicular cells to differentiate to 
cardiomyocytes by hanging drop co-culture with E S cells 
When cultured in suspension, under conditions favourable for differentiation, ES cells 
spontaneously form cells aggregates termed embryoid bodies (EB) which is required for in 
vitro differentiation of the cells towards cardiomyocytes (Wei et al., 2005). During this 
differentiation, cells similar to those of the three primary germ lines are identified namely 
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the endoderm, ectoderm and mesoderm; the cardiomyocytes that form in the EB are located 
between the outer epithelial layer and the basal mesenchymal cells (Boheler et al., 2002). 
The cells of the EB expressed a number of cardiogenic lineage markers (Boheler et al., 
2002) and have been seen to contract with a similar action potential to that of the early 
chamber myocardium (Fijnvandraat et al., 2003). 
The EB inductive microenvironment is therefore crucial to the commitment of the ES cells 
to cardiomyocytes. The ability of EB formation, from ES cells, to facilitate the 
cardiomyocyte differentiation of the dermal follicular cells was examined. In order to 
confirm reproducible cardiomyocyte differentiation of ES cells, the method of Fijnvandraat 
was followed (Fijnvandraat et al., 2003). In brief, the mouse ES cell line CGR8 was used; 
hanging drop culture was set up with 30cells/nl in lOul drops as described in the methods 
section 2.4.4. EB were produced by differentiation for 8 days consisting of 3 days in 
hanging drop culture and 5 days in suspension culture and routinely demonstrated 
spontaneous contractions, a result consistent with Fijnvandraat (data not shown). Gene 
expression profiles of these differentiating ES cells confirmed cardiomyocytic potential (as 
integrated into figure 4.2). Having demonstrated that cardiomyocytic differentiation of ES 
cells was consistently observed, their effects upon dermal follicular cells were investigated. 
4.1.1 Morphological comparison of ES cell embryoid bodies with DP 
and DS co-culture cell aggregates 
ES cells and dermal follicular cells were added together in different ratios and co-cultured 
in hanging drop and suspension culture as described above for ES cells. In order to 
discriminate the differentiation attributed to the two different cell types, rat dermal 
follicular cells were cultured with mouse ES cells. This type of co-culture relies upon the 
cross-species communication between the mouse ES cells and the rat dermal follicular 
cells. Previous experiments have indicated these two species are capable of communicating 
with one another in co-culture and inducing differentiation towards a myocyte lineage. 
Fukuhara et al., showed rat cardiomyocytes in cell-to-cell in vitro co-culture with mouse 
BM stromal cells produced myotubules formation with cardiomyocyte associated gene 
expression in cells of mouse origin that had synchronised contractions with surrounding rat 
cardiomyocytes (Fukuhara et al., 2003). Macdonald et al., showed this communication was 
also possible in vivo by injecting mouse BM MSC into the peri-infarct zone of rat hearts 
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after induced myocardial infarction (MI). They observed mouse cells with cardiomyocyte 
associated gene expression and improved cardiac function (Macdonald et al., 2005). In 
these two cases rat cells induced mouse cells to differentiate towards cardiomyocytes, the 
opposite has also been reported; mouse neonatal cardiomyocytes in vivo co-culture with a 
rat liver stem cell line has shown to induce contractile cardiomyocytes, expressing 
cardiogenic proteins, of rat origin; differentiation that was not attributed to cell fusion 
(Muller-Borer et al., 2004). 
Previous work therefore indicates the two species are capable of communicating as well as 
inducing cross-species cardiomyogenic differentiation when cultured together. Cell ratios 
were set up as described in the methods at the following ratios of ES: dermal ratios; 1:1, 
1:3, 1:10, ES cells alone or dermal follicular cells alone. The mouse ES cells and rat dermal 
follicular cells were distinguished from one another post-culture with species-specific 
primers. 
100 hanging drops were set up for each culture ratio; randomly selected samples of 
approximately 20 were monitored by phase microscopy throughout suspension culture. All 
cell ratios produced cell aggregates after 3 days in hanging drop culture. The cell 
aggregates were roughly spherical with the cells appearing to be tightly attached to one 
another; aggregates did not break apart upon transferring from hanging drop to suspension 
culture consistent with EB observations. Figure 4.1 shows a representative photograph of 
an EB and a cell aggregate in suspension culture after 3 days in hanging drop culture. 
Contractions were observed in aggregates that contained ES cells however there were no 
contractions observed in any of the cell aggregates made entirely of DP cells or DS cells 
alone. The centre of the co-culture aggregates appears darker than the outer layer of cells 
which may indicate there is a cell dense core or a degree of cell death; this was comparable 
with the EB (Wei et al., 2005). 
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Figure 4.1: Morphology of ES cell embryoid bodies and ES: dermal cell aggregates 
Gross morphology of (/) mouse ES cell embryoid bodies (EB) and (ii) aggregates of mouse 
ES cells and rat dermal follicular cells. The aggregates/embryoid bodies were cultured for 8 
days; 3 day in hanging drop culture and 5 days suspension culture. Areas of contractions 
were observed in both EB and mixed cell aggregates. Bright field image, x5 magnification. 
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The morphology of an early EB, i.e. after 2 days into hanging drop culture, is a spherical 
aggregate of cells with a defined cell surface where individual cells cannot clearly be 
distinguished from one another. An EB after approximately 10 days in culture remains 
roughly spherical, however the aggregates have a less well defined edge as individual 
clumps of cells appear raised from its surface (Wei et al., 2005). The morphology of the ES 
cell EB after 8 days in hanging drop and suspension culture, figure 4.1, was consistent with 
this morphology. However, the appearance of the aggregates of mixtures of ES and dermal 
follicular cells after 8 days co-culture appeared more morphologically similar to that of an 
early EB (Wei et al., 2005) as seen in figure 4.1, as was the case for the cell aggregates of 
dermal follicular cells alone (data not shown). 
Although the mixed population aggregates (ES and dermal follicular cell) were seen to 
contract, the cellular origin of the contractile cells was not known. In order to address this, 
species-specific PCR for cardiomyocyte-characteristic markers was used. 
4.1.2 Expression of cardiomyocyte associated genes in DP and DS 
primary cells after ES cell co-culture 
The hanging drop method of culturing cells promotes tight gap junctions to be formed 
between cells (Oyamada et al., 1996). On washing the cell aggregates after co-culture, the 
cells do not dissociate from one another; it would therefore be difficult to isolate single 
cells for analysis without causing damage. Species-specific PCR allows the gene 
expression of cells of ES and dermal origin to be investigated following co-culture without 
the need to separate them post-culture. 
The species-specificity of the PCR primers was first confirmed. As can be seen in figure 
4.2, mouse-specific primers generated a PCR product from mouse cDNA but never from 
rat cDNA; similarly the rat specific-primers generated a PCR product from rat cDNA but 
never from mouse cDNA. This provided confidence that this method of detection was 
suitable for investigating single species-specific gene expression changes in a sample of 
mixed populations of cells. 
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Figure 4.2: Expression of genes characteristic of cardiomyocyte lineage during ES 
cell differentiation and dermal cell aggregate culture. 
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Expression of genes characteristic of cardiomyocyte lineage in mouse EB and rat dermal 
aggregates as assessed by species-specific RT-PCR. The species specificity of both sets of 
primers was confirmed by the presence or absence of PCR product from the positive and 
negative control species, respectively. Note that expression of Nkx2.5 was only just 
detectable even in the positive controls. The expression of this panel of genes is consistent 
with cardiomyocyte differentiation of the murine ES cells, but the rat dermal aggregates did 
not express detectable levels of the majority of genes characteristic of cardiomyocytes. 
The GAPDH primer set was common to both rat and mouse and acted as a loading control 
in this and subsequent RT-PCR analyses. 
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When the DP and DS cells were cultured in cell aggregates in the absence of ES cells, the 
only detectable gene expression was Mef2c with very low expression of titin and possibly 
GATA4 as can be seen in figure 4.3. DP and DS primary culture cells expressed Mef2c 
when in conventional culture in flasks; however GATA4 was previously undetectable 
(figure 3.11) as was titin (figure 3.12). This may indicate that culturing the DP and DS 
primary cells in hanging drop culture, and promoting them to have close contact with one 
another in suspension, induces the expression of addition cardiomyocyte-associated genes, 
however the level of expression was consistently very low and very substantially less than 
the positive control heart. 
After co-culture with mouse ES cells, the rat dermal follicular cells maintained detectable 
expression of both Mef2c and tropomyosin as can be seen in figure 4.3; both of which were 
previously identified in conventional DP and DS primary cell cultures (figure 3.11 and 
3.12). There was low level expression of a-MHC which was previously undetected in 
dermal primary cell cultures (figure 3.12). a-MHC is expressed in EB at this stage of 
differentiation but normally precedes Nkx2.5 and GATA4 expression (Boheler et al., 2002) 
of which neither are detectable here. This may indicate the expression of a-MHC is not 
associated with cardiomyocyte lineage commitment. Interestingly, tropomyosin is normally 
expressed in the EB very early in their differentiation; of the genes investigated here it is 
normally the first to be expressed in the EB at day 1 of differentiation (Boheler et al., 
2002); its expression here may indicate the start of the network of genes important to 
development of cardiomyocytes. 
One possible outcome of co-culture of rat dermal follicular cells with ES cells is that it 
could interfere with endogenous ES commitment to, and induction of, the cardiomyocytic 
lineage. The differentiation of ES cells in the EB has previously been shown to be affected 
by the co-culture cell type. For example murine EB cultured in contact with embryonic 
pulmonary mesenchyme showed appearance of structural organisation of epithelial lined 
channels throughout the EB that expressed early developmental markers of pulmonary 
epithelium (Van Vranken et al., 2005). In order to confirm that such commitment was not 
affected or suppressed in the ES cells, the expression of genes characteristic to ES-derived 
cardiomyocytic differentiation was examined. 
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Figure 4.3: Expression of genes characteristic of cardiomyocyte lineage by dermal 
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Rat dermal follicular cells were cultured as aggregates with differentiating mouse ES cells 
in different ratios, and species-specific expression of genes examined by RT-PCR. The 
dermal follicular cells, as detected with rat-specific primers, maintained expression of 
Mef2c when cultured with the differentiating ES cells. These culture conditions also 
produced detectable expression of tropomyosin and low level a-MHC. 
112 
As can be seen in figure 4.4, transcription factors characteristic of early cardiomyocyte 
commitment (Mef2c, GATA4 and tbx5) were consistently detected in differentiating ES 
cells in the presence or absence of rat dermal follicular cells at any ratio. Nkx2.5 was 
difficult to detect in EB cultures, but was just detectable in some ES follicular dermal co-
cultures. Genes characteristic of functional cardiomyocytes were detectable, a result 
consistent with observations that contractility was observed in all aggregates. Although 
there was some dose-dependant variability in gene expression, the consistent detection of 
characteristic genes suggested that the inductive environment of the EB was maintained. 
In summary, the expression profile of the rat dermal follicular cells after co-culture with ES 
cells was almost identical to that of dermal follicular cell primary cultures. Although a 
modest level of a-MHC was detected in one culture condition, the absence of detectable 
expression of any of the other cardiomyocyte-characteristic genes indicates that there was 
no substantial inductive event. This data suggests that although ES cell commitment was 
not compromised, such inductive signals as were present were unable to induce substantial 
cardiomyocyte commitment of the dermal follicular cells. However, an alternative 
approach that has been successfully used with mesenchymal stem cells is co-culture with 
cardiomyocytes (Yoon et al., 2005). 
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Figure 4.4: Expression of genes characteristic of cardiomyocyte lineage by 
differentiating murine ES cells cultured in the presence of rat follicular 
dermal cells 
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Differentiating mouse ES cells were cultured as aggregates with rat follicular dermal cells 
at different ratios, and species-specific expression of murine genes examined by RT-PCR. 
With the exception of tropoelastin in aggregates with rat DS cells, the mouse ES cells 
demonstrated a pattern of gene expression consistent with the cardiomyocytic 
differentiation observed in embryoid bodies. 
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4.2 Inducing the dermal follicular cells to differentiate to 
cardiomyocytes by co-culture with embryonic 
cardiomyocytes 
In order to assess whether co-culture would induce dermal follicular stem cells to a 
cardiomyocyte phenotype, El2.5 mouse embryonic cardiomyocytes were used in co-
culture with rat dermal follicular cells. The in vitro culture of embryonic cardiomyocytes is 
not well described in the literature; therefore a better understanding of the cell's behaviour 
in culture is necessary in order to analyse co-culture results. 
Yoon described co-culture of neonatal and adult cardiomyocytes with BM MSC 
concluding that the age of the cardiomyocytes was important in the success of the 
differentiation of the MSC. The results suggested that the ability of the cardiomyocytes to 
act as inducers of cardiomyocyte differentiation was dependant on their age; that inducing 
agents may be progressively lost through the cardiomyocyte post-natal life (Yoon et al., 
2005). Embryonic cardiomyocytes express all of the genes under investigating here; the 
expression of the early transcription factors may be reduced in post-natal hearts therefore 
the use of embryonic heart may be preferential in this set of experiments. The embryonic 
age of the hearts used El2.5, at a time point when the contracting four chamber heart has 
atrial and ventricular formation (Christoffels et al., 2000) and expression of all the genes 
investigated. 
4.2.1 Establishing embryonic cardiomyocytes in adherent culture for 
co-culture with DP and DS primary cells 
Ten separate groups of mouse embryonic cardiomyocytes were isolated and cultured in 
vitro and a time course of their proliferation, contractile activity and baseline gene 
expression analysed over a period of 24 days at which point the contractions had ceased 
and the cells were considered to no longer by typical of in vivo cardiomyocytes. 
The cardiomyocytes were isolated from the embryonic heart and transferred to adherent 
culture as described in methods section 2.3.4, the cells took 24hrs to settle on the plastic; 
all settled cells monitored were seen to contract within the first 24hrs in culture. The 
cardiomyocytes were small, spherical, refractive, non-contracting cells in suspension which 
settled onto the plastic, where they were multi-nucleated with a fibroblastic morphology 
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and were phase-dark. The adherent cardiomyocytes had many cytoplasmic processes, a 
raised appearance and contracted independently of one another. Within the first three days 
the cells reached 40% confluency; representative images are shown in figure 4.5/. 
By day 10 in culture the cells had increased to approximately 70% confluency; the 
individual cells were distinguishable from one another and arranged in raised clumps of 
cells. Within each group the cells could be seen to contract rhythmically in unison, 
independent to other collections of cells on the culture dish. Representative images are 
shown in figure 4.5//. 
At day 16 the cells were 100% confluent; individual cells were barely distinguishable from 
one another with cells overlapping, as seen in figure 4.5///. Rhythmic contractions were 
synchronised across the entire culture dish. 
After day 16 the cells remained at 100% confluency however nuclei became less 
distinguishable from the overlaying cytoplasmic processes until at approximately day 20 
nuclei were barely visible. This made it impossible to monitor individual cells to determine 
the surface area of each cell or determine if there was any cell death. Contractions 
remained consistent across the entire dish, however individual contracting cells could not 
be identified making the percentage of contracting cells still present impossible to 
determine. For this reason, at day 25 the cells were labelled with cardiac a-actin. 
Contracting cells would express this geneand any cell not expressing cardiac actin was 
considered to no longer be representative of an in vivo cardiomyocyte i.e. have ceased 
contractions. Representative image are shown in figure 4.6. Approximately 30-40% of the 
surface area labelled positive for cardiac actin indicating, by this time point, cells may no 
longer be representative of in vivo cardiomyocytes or those cells in early in vitro culture. 
All contractions ceased by day 26 of culture in all sample cultures. 
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Figure 4.5: Morphology of embryonic cardiomyocytes in adherent primary culture 
in 
Morphology of mouse El 2.5 embryonic cardiomyocytes in adherent culture. At day 3 (/.) 
cultures were approximately 40% confluent with individual cells arranged in small groups 
which contracted independent of one another. By day 10 (it), at 70% confluence, the cells 
were clumped together in larger groups with unified rhythmical contraction. At day 16 (Hi..) 
the cells were 100% confluent. However, the cells could still be distinguished from one 
another. Synchronised contractions rippled across the entire culture dish. Representative 
phase images are shown at xlO magnification. 
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Figure 4.6: Identification of individual embryonic cardiomyocytes at day 25 in 
adherent primary culture by cardiac actin immunofluorescence 
/'. Phase 
a. f i t c /V/*. Merge 
Cardiac actin fluorescent labelling of individual embryonic cardiomyocytes at day 25 of 
adherent culture. At day 25, the individual cardiomyocytes could not be distinguished from 
one another; contractions ceased at day 26. The cells were visualised with fluorescent 
antibody labelling for cardiac actin to establish the presence of typical cardiomyocytes at 
this late culture time point when contractions were about to cease. Representative images 
are shown at x20 magnification. 
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4.2.2 Co-culture of rat dermal follicular cells with mouse embryonic 
cardiomyocytes 
The method described by Yoon for culturing BM MSC with neonatal cardiomyocytes was 
followed (Yoon et ai, 2005) with alterations as described in method section 2.4.6. Cell-to-
cell contact is an important factor for transdifferentiation of adult stem cells into 
cardiomyocytes possibly by gap junction formation and thereby electrical coupling. Taking 
this into consideration, the mouse embryonic cardiomyocytes were allowed to proliferate to 
50% confluency before the addition of rat dermal follicular cells thus allowing plastic for 
the dermal follicular cells to adhere to and sufficient contracting cardiomyocytes for cell-
to-cell contact. In order to detect specific changes in commitment of the DP and DS 
primary cells, as induced by mouse embryonic cardiomyocytes, species-specific PCR 
primers were used. 
The rat dermal follicular cells were added to the El2.5 mouse cardiomyocytes and allowed 
7 days co-culture. Representative images in figure 4.7 show the appearance of the 
cardiomyocytes which were distinguishable from the dermal follicular cells. Although the 
dermal cells were added to cardiomyocytes when they were at 50% confluency the cells 
appeared at close to 100% confluency after the 7 days co-culture which was consistent with 
the time course for the cardiomyocytes as pre-determined (figure 4.5). Interestingly, the 
dermal follicular cells appeared as small, spherical cells quite unlike the morphology of DP 
and DS in conventional adherent culture. The DP and DS were adherent to the surface of 
the cardiomyocytes and, in no instance observed, adherent to the culture ware. This would 
indicate the dermal follicular cells were prevented from adhering to the plastic ware or 
preferentially chose the cardiomyocytes to attach to. Visually, on seeding the dermal cells, 
there was sufficient plastic clear of cardiomyocytes as well as sufficient time for the dermal 
cells to adhere before the cardiomyocytes reached 100% confluency. The uncharacteristic 
culture behaviour of the DP and DS in this case may have to be taken into account when 
analysing gene expression changes 
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Figure 4.7: 2D co-culture of mouse embryonic cardiomyocytes with rat dermal 
follicular cells 
| ^ ^ ^ ^ ^ :A / / 
Morphology of dermal follicular cells (A) and embryonic cardiomyocytes (B) in 2D co-
culture under phase microscopy. At low magnification (xlO) the DP (/.) and the DS (//.) 
were observed to be on the surface of the confluent cardiomyocytes. At higher 
magnification (x40) the DP (;'/'.) and DS (/v.) were distinguishable from the cardiomyocytes 
with a morphology unlike that seen in normal primary dermal follicular cell culture. The 
cells appeared round and refractive with no cellular processes. 
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4.2.3 Expression of cardiomyocyte associated genes in DP and DS 
primary cells after embryonic cardiomyocyte co-culture 
As can be seen in figure 4.8, the embryonic cardiomyocytes in co-culture demonstrated 
detectable expression of all the genes investigated with the exception of GATA4 and titin. 
The dermal follicular cell expression was consistent between all three DP and DS and 
detectable expression of tropomyosin; both of which were previously identified in 
conventional dermal follicular cultures (figure 3.11 and 3.12). However, there was 
detectable expression of a-MHC and cardiac actin both of which were not expressed in DP 
and DS primary culture cells (figure 3.12). In summary, there remains absence of 
expression of a number of the transcription factors and sarcomeric-associated functional 
genes. 
This may indicate that complete differentiation has not occurred. The data suggests that the 
approach of using co-culture for cardiomyocyte commitment was capable of inducing a 
more complete molecular profile consistent with cardiomyocyte differentiation than using 
ES cells; using an inducing cell from a species that does not match that of the dermal stem 
cells may be inadequate to the task of full cardiomyocytic commitment. Therefore 
embryonic cardiomyocytes from the same species were investigated to determine i f they 
would be better able to induce the DP and DS primary cells. 
4.3 Inducing the dermal follicular cells to differentiate to 
cardiomyocytes by co-culture with embryonic 
cardiomyocytes of matching species 
As discussed, the dermal follicular cells do not express the entire cardiomyocyte gene 
profile. Previous experiments have indicated that mouse and rat cells are capable of 
communicating with one another; expecting cells of different types as well as species may 
not be suitable for this experiment. Therefore the co-culture was repeated using mouse 
embryonic cardiomyocytes with mouse DP/DS, and rat embryonic cardiomyocytes with rat 
DP/DS. Species-specific primers were not suitable for this type of co-culture, therefore the 
dermal follicular cells needed to be labelled in order to identify co-culture cells that were of 
dermal origin. 
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Figure 4.8: Expression of cardiomyocyte lineage genes in rat primary dermal 
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Expression of cardiomyocyte lineage genes by rat follicular dermal cells after 5 days co-
culture with murine E12.5 embryonic cardiomyocytes, as assessed by species-specific RT-
PCR. Results from two sets of six independent co-cultures (1-6), DP and DS cultured alone 
and mouse embryonic cardiomyocytes alone are shown. DP and DS were broadly similar in 
their gene expression profile, with detectable levels of Mef2c, a-MHC, low level cardiac 
actin and tropomyosin, as detected using rat-specific primers. The expression of 
cardiomyocyte lineage genes in the co-culture embryonic cardiomyocytes was confirmed 
using mouse specific primers. 
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4.3.1 Identifying cells of dermal origin in same species co-culture 
Carboxyfluorescein Succinimidyl Ester (CFSE) was used to track the cells of dermal 
origin. CFSE is a harmless, flourescein derivative which is cell permeable and non-
flourescent. Upon entering cells, CFSE undergoes esterase cleavage and diffuses 
throughout the cytoplasm making the molecule flourescent and cell impermeable. As cells 
divide, the CFSE is split equally between the daughter cells resulting in diminished CFSE 
signal detection. This division, and resultant signal diminishment occurs with each 
subsequent cell division (Lyons 2000). 
There is no evidence of CFSE being used on dermal follicular cells previously; therefore in 
the first instance it was important to investigate its suitability for co-culture purposes. The 
CFSE fluorescence must be detectable above, and distinguishable from, the 
autofluorescence of the embryonic cardiomyocytes. The method dictates 100% of the 
dermal follicular cells were labelled with the CFSE prior to co-culture, according to this the 
CFSE positive cells collected post-co-culture would represent cells of dermal origin. 
Should the efficiency of the labelling be less than 100% then the isolated cells may not 
represent the entire population of dermal origin which would need to be considered in 
analysing gene expression results. It is imperative that the CFSE cannot pass from one cell 
to another in co-culture, with the exception of cell division, as this may lead to 
contaminating cardiomyocytes in the cells assigned dermal follicular cell origin status. 
CFSE, by its nature, should not do this however it is important to investigate the efficacy 
and efficiency of dermal follicular cell CFSE labelling. The effect of incubation on the 
dermal follicular cells with CFSE, as described in methods section 2.4.7, was first analysed 
to determine i f it affected the cells viability as determined by the side scatter (SSC) and 
forward scatter (FSC) of the cells by flow cytometry. This is shown in figure 4.9 where the 
FSC and SSC for the CFSE labelled cells were consistent for both DP (figure 4.9/.) and DS 
(figure 4.9h) with the unlabelled dermal follicular cells. There was no indication of CFSE-
associated detrimental effect upon the cell size or complexity indicating cell viability after 
labelling. It is noted that the fluorescence of the CFSE labelled cells was distinguishable 
from the unlabelled cells with nominal overlap of cell populations by fluorescein 
fluorescence analysis; a result confirmed in three DP and DS replicates. 
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Flow cytometric analysis of DP (/) and DS (»') cells after CFSE labelling. Results from 
three independent labelling experiments are shown (green, blue and brown). Results from 
unlabelled control dermal cells are shown in red. The left hand histograms indicate the log 
fluorescence (FL1-H), the right hand dot plots show the forward (FSC) and side (SSC) 
scatter patterns. CFSE labelling was highly efficient and produced little discernable change 
in FSC and SSC profiles. 
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CFSE-labelled dermal follicular cells were allowed a period of 7 days culture and analysed 
by flow cytometry for FSC and SSC to estimate i f the CFSE throughout this period of 
culture had a detrimental effect upon the cells and to ensure the fluorescence of the day 7 
cells remained distinguishable from the unlabelled cells. As can be seen in figure 4.10, the 
SSC and FSC were sufficiently consistent to indicate there was no detrimental effect of 7 
days culture on the cells. The fluorescence of the CFSE was reduced, as expected, to a 
level of closer to that of the unlabelled cells however an acceptable proportion of labelled 
cells remained distinguishable from the unlabelled cells indicating the technique suitable 
for co-culture. 
The CFSE labelling did not cause any detectable alteration to the dermal follicular cell's 
FSCvs.SSC scatter and fluorescence after 7 days was sufficiently distinguishable from the 
unlabeled cells. Therefore the efficiency of labelling was investigated; the labelled dermal 
follicular cells were mixed with non-labelled cardiomyocytes to determine there was no 
transfer CFSE between the two populations. 
The dermal follicular cells were labelled with CFSE as described; labelled cells were then 
mixed with unlabelled dermal follicular cells at the following ratios of unlabelled: labelled; 
75%:25% 50%:50% and 75%:25%. The cell mixes were analysed immediately as well as 
after 7 days culture. Figure 4.11 shows the proportions of positive fluorescence cells at 
each percentage mix; the level of fluorescence for each percentage of DP or DS CFSE 
labelled cells were within the same range and distinct from non-labelled cells. The 
graphical representation of cells analysed immediately after labelling shows the percentage 
of positive cells was consistent with the actual labelling for both the DP and DS cells at 
25%, 50% and 75% percentages. Positive fluorescence was assigned to cells at a 
fluorescence level of ^ lO 2 as was indicated with 100% labelling (figure 4.10). The actual 
numbers of cells sorted at both time points, immediate and after 7 days culture, are shown 
in figure 4.12. The cell counts taken immediately after CFSE labelling were very closely 
matched to the actual percentage mixes with the labelling of DP cells appearing to be more 
efficient than the DS cells. After 7 days the number of cells with detectable fluorescence 
was reduced compared to the immediate samples as would be expected due to cell division. 
I f the d=0 samples represent the number of cell taking up the CFSE and the d=7 samples 
represent the number of those initial CFSE cells that are able to be sorted away from the 
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assigned negative cells, then the percentage of cells able to be recovered was 44.1% for the 
DP primary culture cells and 51.2% for the DS primary culture cells. When analysing the 
sorted cells from co-culture this will have to be considered however at this level of analysis 
the percentage of cells able to be recovered is acceptable. The fluorescence of cells after 14 
days was also investigated in a similar manner however the autofluorescence of the cells 
was reduced to the level of the unlabelled cells and was therefore unsuitable for co-culture 
purposes (data not shown). 
CFSE was confirmed suitable for co-culture application and was therefore used to label rat 
and mouse dermal follicular cells prior to co-culture with embryonic cardiomyocytes of 
matching species. 
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Figure 4.10: Flow cytometry analysis of CFSE labelled dermal follicular cells after 7 
days culture 
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Flow cytometric analysis of dermal follicular cells after CFSE labelling before and after 7 
days culture, (i) dot plot of forward scatter (FSC) and side scatter (SSC). There was no 
substantial change in forward/side scatter profile after seven days culture (green) compared 
with unlabelled controls (red), (if) Fluorescence histograms. Data shown from unlabelled 
(red), CFSE-labelled with no culture period (green) and CFSE-labelled cells cultured for 
seven days in vitro (purple) for DP (left) and DS (right) cells. The level of detectable 
fluorescence decreased with 7 days culture, however a substantial number of cells 
continued to be contained within a gate which excluded unlabelled cells (fluorescence 
above 102, shown by the black bar) (»'/.). 
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Flow cytometric analysis of populations of mixed populations of CFSE-labelled and 
unlabelled dermal follicular cells. The histogram plots show 100%, 75%, 50% and 25% 
CFSE labelled cells for DP (/.) and DS (//.) samples. This data demonstrated that flow 
cytometry could detect CFSE-labelled dermal cells in a quantitative fashion against a 
background of unlabelled cell types. 
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Figure 4.12: Percentage recovery of CFSE labelled cells following FACS sorting 
immediately after labelling or after seven days culture. 
CFSE Sample % recovery from 
d=0 (3 sample 
average) 
% recovery from 
d=7 (3 sample 
average) at sorting 
Cells retrieved at 
d=7 as a 
percentage of d=0 
DP 100% 93.8+0.7 40.4±1.2 43.1 
DP 50% 44.4±1.5 19.9+2.4 44.7 
DP 25% 22.9+2.1 10.2+4.1 44.4 
Average DS 44.1 
DS 100% 85.2+0.9 48.9+0.7 57.4 
DS 50% 44.8+1.7 22.7+3.7 50.7 
DS 25% 25.5+0.4 11.6+5.3 45.5 
Average DS 51.2 
Labelled dermal follicular cells were mixed with non-labelled cells at the ratios indicated, 
and the cultures either subjected to FACS sorting for positive cells immediately afterward 
or after seven days culture (d=7) . The percentage of positive cells was determined and 
compared to the original number of cells labelled to determine the yield of cells. After 
seven days of culture, more than 40% of labelled DP and 45% of DS cells were recovered, 
regardless of starting ratios. Peak yields were 44.7% and 57% for labelled DP and DS cells 
respectively. 
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4.3.2 Expression of cardiomyocyte associated genes in DP and DS 
primary cells after same species embryonic cardiomyocyte co-
culture 
The DP and DS CFSE labelled cells were co-cultured on the embryonic cardiomyocyte 
cells (methods figure 2.5). The morphology of the dermal follicular cells on the 
cardiomyocytes was similar to that of the cells on cardiomyocytes of mis-matching species 
namely small, spherical, refractive cells (data not shown). After 7 days co-culture the cells 
were FACS analysed; unlabelled dermal follicular cells and cardiomyocytes were used as a 
negative control; the cardiomyocytes had a higher autofluorescence than the dermal 
follicular cells therefore the fluorescence level for sorting was set higher than in the CFSE 
test experiments at 103 5 to ensure there were no cardiomyocytes in the sorted population. 
CFSE positive cells of fluorescence >10 3 5 were retained representing cells of dermal 
origin; only viable cells were included in the sorting as determined by 7-AAD uptake 
(method 2.15.1). In total, three DP and three DS co-culture samples were sorted of both rat 
and mouse species; representative FACS images are shown in figure 4.13. The example 
shown is rat DP primary co-culture cells with the negative control sample in red. As can be 
seen each co-culture sample (DPratl, DPrat2 and DPrat3) had two fluorescence peaks; the 
first overlapping with the negative cells, this was the cardiomyocytes and potentially a 
number of dermal follicular cells that either did not take up the CFSE in the first instance 
or have undertaken a number of cell divisions thereby diluting their CFSE fluorescence. 
The second peak is within the fluorescence range assigned to CFSE labelled dermal 
follicular cells. As can be seen by the level of sorting, the labelled cells retained were those 
that were the brightest although this did result in loosing up to half of the population of 
CFSE positive cells. 
The difference between peak fluorescence of the unlabelled cells to peak fluorescence of 
CFSE labelled cells, is 100 fold; although the yield of cells collected is reduced by this 
fluorescence sorting level, the purity of the cells was ensured. The gene expression changes 
in the mouse and rat dermal follicular co-culture cells was analysed to determine i f same 
species co-culture induced a better dermal differentiation response towards a 
cardiomyocyte lineage. 
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Figure 4.13: FACS identification of cells of dermal origin in co-culture with 
embryonic cardiomyocytes of matching species 
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FACS analysis of co-culture mixed cell population and isolation of CFSE positive cells of 
dermal origin. After co-culture, the CFSE labelled cells were sufficiently flourescent for 
the cells to be isolated from non-labelled cells; the fluorescence level of sorting was set 
high to ensure there were no negative cells included. A representative sample (rat DP after 
co-culture with rat cardiomyocytes) is shown, where the control (red) represents the 
autofluorescence of unlabelled DP, DS and embryonic cardiomyocytes. The fluorescence 
sorting level is shown at 103 5 ; cell yield was sacrificed at the expense of purity. 
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4.3.3 RT-PCR analysis 
Rat and mouse dermal follicular cells were analysed by RT-PCR as shown in figure 4.4 and 
figure 4.5 respectively. The genes investigated were those used previous; those indicative 
of cardiomyocyte induction and functional ability as well as a number of stem cell genes 
and genes that may prove important in a cardiomyocyte. Within these figures the gene 
expression for DP and DS primary culture cells prior to co-culture is included for 
comparison. 
Both rat and mouse DP and DS demonstrated maintained expression of the transcription 
factor Mefic and the functional associated gene, tropomyosin, as was previously seen in 
primary cultures. However the remaining gene expression profde of the two species was 
quite different with a number of differences. 
The rat DP and DS primary co-culture cells, figure 4.1, showed limited expression of the 
transcription factors, Nkx2.5 and GATA4, with one DS sample expressing both (DS1) 
however tbx5 was not detectable in any of the dermal follicular cells. The mouse DP and 
DS primary co-culture cells had an opposite expression prolife of no detectable Nkx2.5 or 
GATA4 but low level expression of tbx5 in all replicates. 
Of the function associated genes, the rat DP and DS primary co-culture cells had limited 
expression of a-MHC and troponin I , with cardiac actin expression in all replicates. The 
mouse DP and DS primary co-culture cells had limited expression of a-MHC, cardiac 
actin, troponin I and titin, with MLC1A in all replicates. 
The rat DP and DS primary co-culture cells had limited expression of sca-1 and 
tropoelastin. The mouse DP and DS primary co-culture cells had similar expression of 
tropoelastin with expression of sca-1 in all samples. Tert was also investigated in the 
mouse DP and DS where it was expressed in a number of the samples. 
These data indicated that definitive cardiomyocytic commitment of follicular dermal cells 
was not observed. However, there were substantial changes in expression of genes 
associated with a stem cell phenotype. 
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Figure 4.14: R T - P C R Gene expression profile of CFSE+ve rat dermal follicular cells 
after co-culture with rat embryonic cardiomyocytes. 
Pre-co-culture 
Rat Cultured Cultured 
heart D P DS 
Co-culture rat dermal cell expression 












Dermal follicular cell expression o f cardiomyocyte lineage genes after co-culture with 
embryonic cardiomyocytes. The CFSE labelled rat dermal follicular cells were isolated 
from rat embryonic cardiomyocytes by FACS; RT-PCR analysis showed dermal cell 
expression of a number o f cardiomyocyte function and induction genes: Nkx2.5, Mef2c, 
GATA4, a-MHC, cardiac actin, tropomyosin, troponin I and stem cell associated gene sca-
1, as well as tropoelastin. 
133 
Figure 4.15: R T - P C R Gene expression profile of CFSE+ve mouse dermal follicular 
cells after co-culture with mouse embryonic cardiomyocytes. 
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Mouse Cultured Cultured 
heart DP DS 
Co-culture mouse dermal cell expression 
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Dermal follicular cell expression of cardiomyocyte lineage genes after co-culture with 
embryonic cardiomyocytes. The CFSE positive mouse dermal follicular cells were isolated 
from mouse embryonic cardiomyocytes by FACS; RT-PCR analysis showed dermal cell 
expression o f a number o f cardiomyocyte function and induction genes: Mef2c and tbx5, a-
MHC, cardiac actin, tropomyosin, troponin I , titin, MLC1A and the stem cell associated 
genes sca-l and Tert, as well as tropoelastin. 
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Following co-culture, the DP and DS primary cells showed dramatically increased levels of 
both sca-1, a surface antigen marker characteristic of a number of different stem cell types, 
potentially including cardiac stem cells (Matsuura et ai, 2004), as well as Tert, a gene 
product which is a phenotypic marker of proliferative stem cells (Breault et al., 2008). 
These data could suggest that co-culture changed the numbers or properties of stem cells in 
the DP and DS cultures. One approach to investigate this is to examine the expression of 
stem cell-characteristic transcription factors. However, the low level of transcripts for this 
class of gene products is typically that which is amenable to routine detection by RT-PCR. 
However, Q-PCR can detect transcripts at low levels and with high reproducibility 
(reviewed by Ginzinger 2002), and thus this approach was used to investigate expression of 
stem cell associated gene products. 
4.3.4 Q-PCR analysis 
The RT-PCR analysis indicated there may be significant changes in the expression of a 
number of the genes investigated; therefore Q-PCR was completed to attempt to determine 
if the observed differences in genes were significant, as well as to try to better establish 
evidence of differentiation. 
RT-PCR analysis indicated that the most marked gene changes were in the mouse dermal 
follicular cells when they are cultured with mouse embryonic cardiomyocytes. Therefore, 
these samples were prepared for Q-PCR and probed for number of genes associated with 
the cardiomyocyte and stem cell phenotype. The genes investigated in the DP and DS 
primary cells included Sca-1, tropomyosin, mTert, Nanog, Oct4, Sox2, tbx5 and a-MHC 
(figure 4.16) 
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Figure 4.16: Q - P C R Gene expression profile of CFSE+ve mouse dermal follicular 
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s - 1 
Q-PCR gene expression analysis of selected genes in embryonic cardiomyocytes and 
dermal follicular primary cells before and after co-culture. Results are presented as logio o f 
the relative quantitation (RQ) with respect to the control gene GAPDH. Results are 
normalised with respect to expression o f each gene in DP or DS in the absence of co-
culture; logiozero indicates a relative expression o f one, i.e. identical to that found in DS or 
DP. Each sample was run in triplicate. 
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Sca-1 
As mentioned previously, Sca-1 is a surface antigen expressed by a number of cell types, 
including stem cell types, as well as those of the adult heart (Matsuura et al, 2004); if the 
dermal follicular cells were capable of differentiating towards a cardiomyocytes lineage 
they may change their expression of Sca-1 in this process. In contrast to RT-PCR analysis 
(figure 4.15), Sca-1 expression was detectable by Q-PCR in both in the DP and DS primary 
cells. There was a significant increase in expression in both DP and DS following co-
culture, showing a relative increase of approximately 130+20 and 4200+100 respectively 
(fold changes p<0.01 in both cases) 
Tropomyosin 
Tropomyosin, a structural gene which is important in the formation of the sarcomere was 
detectable in the DP and DS primary cells by Q-PCR; it was also detectable by RT-PCR. 
Q-PCR analysis suggested a modest increase in the level of tropomyosin expression in the 
DP and DS after co-culture; however this change was not statistically significant. 
mTert 
mTert, associated with stem cells and proliferative capacity, was detectable in the DP and 
DS primary cells by Q-PCR, confirming the RT-PCR expression. Q-PCR analysis 
indicated the level of mTert in the DP and DS increased after co-culture increased by 3.8 
fold and 10.4 fold respectively; this change was statistically significant (p<0.02). 
Nanog 
Nanog is a gene whose expression is associated with embryonic stem cells; co-expression 
of Nanog with Oct4 and Sox2 has been argued to be definitive for E S cells (Reviewed by 
Pan and Thomson 2007). Nanog was detectable in the DP and DS primary cells by Q-PCR; 
its level of expression in the DP and DS after co-culture increased by 1.4 fold and 2.6 fold 
respectively; this change was only statistically significant for the DS sample at a p<0.03. 
Oct4 
Oct4 was detectable in the DP and DS primary cells by Q-PCR and the reported level of 
expression after co-culture increased by 11.5 fold and 5.4 fold respectively. The very low 
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level of expression was associated with increased variation in replicates, such that these 
apparently large changes were not statistically significant. 
Oct4 expression was detectable in the heart; its level of expression similar to the DS and 
DP primary cells pre-co-culture which was at a lower level that the embryonic 
cardiomyocytes and the dermal follicular cells after co-culture. 
Sox2 
Sox2 was detectable in the DP and DS primary cells by Q-PCR; its level of expression in 
the DP and DS after co-culture increased by 1.9 fold and 6 fold respectively. This relatively 
modest change was statistically significant (DP p<0.04 and DS p<0.01). 
Sox2 expression was detectable in the heart; its level of expression similar to the DS and 
DP primary cells pre-co-culture which was at a lower level that the embryonic 
cardiomyocytes and the dermal follicular cells after co-culture, in a similar manner to Oct4. 
tbx5 and a-MHC 
The expression of these genes were not detectable in the DP and DS primary cells before 
co-culture following Q-PCR for 60 cycles. However, tbx5 expression was detected in DP 
primary cells (but not DS) after co-culture (data not shown). As a minimum, this reflects an 
increase in gene expression of at least lOMo 4 fold, although this is from a very low 
assumed level. 
Tbx5 was expressed by both adult and embryonic heart at very similar levels between the 
two with the level of expression in the DP co-culture samples was less. a-MHC was 
expressed in both the DP and DS primary cells after co-culture. This reflected an increase 
in expression, admittedly from a very low level, of at least 104-105 fold. 
In summary, there was increase in gene expression of all of the genes investigates from 
mouse dermal cells pre-co-culture compared to cells after co-culture with mouse 
cardiomyocytes. The expression of these genes was lower than the expression of the 
cardiomyocytes with the exception of sca-1. However, the gene changes were consistent 
with the RT-PCR findings and whilst dermal cell commitment to cardiomyocyte lineage 
may have been incomplete, there was increase in expression of a number of stem cells 
genes consistent with the development of the stem cell phenotype 
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4.4 Chapter 4 Discussion 
Work described in Chapter 3 demonstrated that DP and DS did not spontaneously produce 
myotubes and spontaneous contraction when cultured independently, but that an inductive 
environment, such as may be found in the end bulb, could express this potential. Cells 
similar to cardiomyocytes, as determined by gene expression, have also been demonstrated 
in dermal follicular cell cultures as a result of 5-azacytidine treatment (Hoogduijn et al., 
2006).However, the use of such a potent de-methylation agent would not allow for 
investigation of any physiological cardiomyocyte differentiation and understanding of the 
pathways involved. In order to examine the molecular changes during commitment, DP and 
DS were co-cultured in an inductive environment; differentiating embryoid bodies. 
E S cells spontaneously differentiate to cardiomyocytes, but only do so with high efficiency 
in hanging drop culture (Maltsev et al., 1994). Dermal follicular cells were mixed with the 
E S cells to determine if this microenvironment promoted their differentiation towards a 
cardiomyocyte lineage as determined by gene expression. RT-PCR analysis indicated that, 
despite possessing an inductive environment suitable for E S cell commitment to a gene 
profile consistent with that of cardiomyocytes, the gene expression profile of both the DP 
and DS primary culture cells in these embryoid bodies remained substantially unchanged. 
Only one or two of the cardiomyocyte-associated genes increase their axpression and some 
actually went down. This data suggested that the inductive environment in embryoid 
bodies was not suitable for this lineage commitment of DP and DS. One explanation for 
this is that recent work suggests that DP and DS may directly influence the embryoid body 
inductive environment; Liu have recently investigated the interactions between the dermal 
follicular cells and E S cells in 2D adherent and embryoid body co-culture. In 2D culture 
the DP and DS cells maintained E S cells in an undifferentiated state; the E S cells settled 
onto the dermal monolayer as they would on a M E F feeder layer and demonstrated 
maintenance for the entire observation period; up to 4 weeks/8 passages with no loss of 
colony formation with passaging (Lui et al., 2008; in publication). The E S cells also 
maintained their pluripotent potential as indicated by differentiating towards neural, 
adipogenic and endoderm lineages following co-culture. The DP and DS cells were 
reported to express cytokines which were involved in the support of the E S cell e.g. L I F . 
The expression of these cytokines in the embryoid body were not sufficient to maintain the 
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ES cells in an undifferentiated state; as was observed here by gene expression consistent 
with E S cell cardiomyocyte differentiation and the apparent contractions in developing cell 
aggregations of mixed cells. This suggests that such inductive signals that are present 
within the embryoid body are insufficient to induce the dermal cells to adopt a 
cardiomyocytic fate. 
An alternative approach was investigated. Co-culture has previously been shown to be 
inductive for cardiomyocyte differentiation; co-culture of dermal follicular cells with E S 
cells and embryonic cardiomyocytes of different species allowed the dermal follicular cells 
to be identified with species-specific primers for PCR without question of contamination, 
as has been previously used with co-culture of bovine DP with murine C2C12 cells (Rufaut 
et al., 2006). This method of cross-species co-culture has been demonstrated to induce 
differentiation. Human MSC, after co-culture with embryonic rat cardiomyocytes, have 
been reported to express cardiac specific P-myosin indicate of differentiation, proposed to 
be as a result of communication between the two cells types cardiomyocytes supported by 
evidence of gap junctions (Plotnikov et al., 2007). Therefore the rat dermal follicular cells 
were co-cultured with mouse embryonic cardiomyocytes and differentiation determined by 
changes in expression of the early transcription factors and function associated genes. 
Following co-culture, there was very little evidence of up-regulation of inductive genes. 
This absence strongly indicates that there was no substantial differentiation to the 
cardiomyocyte lineage. There was evidence of up-regulation of some structural genes in 
the DP and DS. The dermal follicular cells had up-regulated gene expression of a-MHC 
and cardiac actin both of which were undetectable in DP and DS primary cultures, genes 
that are essential to functioning cardiomyocytes (Jones et al., 1996; Buckingham et al., 
2005). One explanation is that a cellular stretch response is responsible for the up-
regulation of these genes. Sadoshima demonstrated that expression of sarcomeric MHC and 
smooth muscle a-actin were both induced to detectable levels in rat neonatal 
cardiomyocytes exposed to stretch (Sadoshima et al., 1992). This was supported by the 
work of Fink which demonstrated a-sarcomeric actin RNA/DNA expression increased by 
98% and protein by 40% in response to chronic mechanical stretch (Fink et al., 2000). This 
may explain the induction of expression of these genes in the DP and DS cells after co-
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culture with contracting embryonic cardiomyocytes; the cells may be expressing these 
genes in response to stretch in the absence of differentiation. 
Therefore, the work described here indicated that cardiomyocytes from one rodent species 
did not induce cardiomyocytic commitment of dermal cells from a different rodent. 
Successful cross-species induction of stem cell differentiation has been reported for rat 
cardiomyocyte induction of mouse MSC differentiation (Fukuhara et al., 2003). In this 
system, murine MSC co-cultured with rat cardiomyocytes went on to demonstrate 
contractions and myotube formation, associated with the expression of myosin heavy 
chain, troponin I and gap junction connexin-43. However, this study did not exclude 
fusion as a potential mechanism for apparent mouse differentiation; in addition there is 
little evidence for mouse cardiomyocytes inducing cardiomyocytic differentiation in MSC. 
It is noted that co-culture of the dermal cells with cardiomyocytes was dependant on cross-
species communication; previous experiments by other groups have indicated that mouse 
and rat cells of other tissues can communicate in a similar co-culture system. Condorelli 
showed primary endothelial cells from E9 mouse dorsal aorta could communicate with rat 
cardiomyocytes; the endothelial cells differentiated into contracting cardiomyocytes and 
expressed a limited number of cardiac markers as well as contributing to myocardium 
formation in a post ischemic heart (Condorelli et al., 2001). Xu also showed that mouse 
bone marrow stromal cells could communicate with rat neonatal cardiomyocytes; the bone 
marrow stromal cells trans-differentiated into cells with a cardiac phenotype and gap 
junctions between the two cell types (Xu et al., 2004). Although rat and mouse cells are 
therefore capable of communicating with one another, especially in a differentiation 
setting, this may not be suitable for the dermal follicular cells and the mouse 
cardiomyocytes may not be capable of inducing cardiomyocyte expression in a 
mesenchymal-like cell population. In order to determine whether the dermal follicular cells 
are capable of significant differentiation by this method, without the added complication of 
cross-species communication, the DP and DS were co-cultured with embryonic 
cardiomyocytes of the same species. 
When the rat dermal follicular cells were cultured with the rat embryonic cardiomyocytes 
there was detectable increase in expression of some cardiomyocyte-associated genes as 
shown by RT-PCR, the incomplete profile indicated that the embryonic cardiomyocytes 
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failed to induce complete cardiomyogenesis. The expression of Nkx2.5 and GATA4 were 
detectable in some, but not all, co-cultured DP and DS. In addition to the previously 
detected a-MHC expressed in some of the rat DP and DS co-culture samples, and cardiac 
actin in all the DP and DS samples, troponin I was detectable in one of the DP samples. 
However, there was evidence that some induction may be occurring but there was no 
detectable tbx5 expression. It is noted that the number of RT-PCR product bands for 
GATA4 and Nkx2.5 differed when comparing the rat heart to the rat dermal cells after co-
culture. GATA4 has two isoforms which were detected with the primers used here; these 
are shown on figure 4.14. This is consistent with previous findings, as detected by 
immunoblot analysis by Morimoto, where the larger size isoform was predominantly found 
in cellular nuclear extracts and was phosphorylated; GATA4 phosphorylation promotes 
transactivation ability in cardiomyocytes (Moromoto et al„ 2000). This isoform correlated 
with one of the RT-PCR bands in the heart sample in figure 4.1.4; however, this band was 
not detected in the rat dermal cells indicative of an absence of full cardiomyocyte 
commitment. The identity of the second RT-PCR product band associated with Nkx2.5 as 
was detected in one of the dermal co-culture samples in unknown. There are isoforms 
associated with human Nkx2.5 but not yet reported for rat Nkx2.5 therefore this could be 
an, as yet unidentified, isoform. However, the difference in detected gene products between 
the heart and dermal cell samples is supportive of a lack of contamination of 
cardiomyocytes into the cells sorted as being dermal in origin. If this were the case you 
would expect to see the same gene product in both samples. In summary, although a 
number of cardiomyocyte structural genes were detected, the entire dermal co-culture cell 
population were sampled and therefore it is not possible to determine if the genes 
detectable were expressed within the same cells. 
When the mouse DP and DS were cultured with the mouse embryonic cardiomyocytes 
there was a different expression profile detected to that of the rat dermal cells There was 
detectable expression of a number of the structural genes, in one instance expression of all 
of the function-associated cardiomyocyte genes as detected by RT-PCT at low level, 
however there was an incomplete gene expression profile with absence of a number of 
inductive genes indicative of a failure to induce cardiomyogenesis. 
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There was detectable low-level expression of tbx5 in a number of dermal co-culture 
samples no detectable expression of Nkx2.5 and GATA4. Of the structural genes, one 
sample demonstrated expression of all of the genes investigated and a number of these 
were investigated by Q-PCR to determine quantitation of these genes; Q-PCR indicated 
that the level of these genes in the DP and DS samples was so low that if there is indication 
of differentiation it is a very rare event. 
It is noted that the mouse co-culture cells did not express Nkx2.5 but had low level tbx5 
expression while the rat dermal co-culture cells did not express tbx5 but had low level 
nkx2.5 expression. Nkx2.5 and tbx5 synergistically activate cardiac genes and are 
necessary for cardiomyocyte differentiation (Hiroi et al., 2001) and therefore the absence 
of expression of one gene; either tbx5 or Nkx2.5 is suggestive of failure of cardiogenesis in 
the rat dermal cells. 
With the mouse co-culture dermal cells changes in gene expression appeared to be very 
modest except for sca-1 expression. Sca-1, a cell surface antigen which has been implicated 
in cardiac stem cell populations, was expressed in all samples which suggested 
investigation of stem cell markers. Sca-1, Oct4, Sox2, Nanog and Tert were investigated by 
Q-PCR where all of these stem cell markers were apparently up-regulated post-co-culture. 
Nanog, Oct4 and Sox2, all expressed by the mouse dermal follicular cells following co-
culture, are considered markers of pluripotency and are normally expressed by 
undifferentiated E S cells. 
The expression of these genes is consistent with co-culture changing the properties and/or 
numbers of stem cells from the DP and DS. However, it is not possible to determine if all 
the transcripts were detected in the same cells. There is the question of contamination; data 
from FACS experiments indicated that the maximum level of possible spill over, i.e. 
cardiomyocytes collected as being dermal in origin was less than 1 in 10,000. However, the 
level of expression of Oct4 and Sox2 in the embryonic cardiomyocytes could account for 
the detected level of expression in the dermal cells with a contamination level of 1 in 
100,000 cells. Thus contamination cannot be excluded as one explanation. However, such 
very minor levels of contamination cannot explain the sca-1 expression, Nanog (which 
would require contamination levels of near 1 in 6 cells) or Tert (which would require 
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contamination levels of near 1 in 3 cells). In addition, the difference in isoform bands, as 
described for nkx2.5 and GATA4 with rat dermal cells, is not consistent with 
contamination. 
Sca-1 expression cannot be due to contaminative cell types as the expression in the co-
culture cells is greater than the cardiomyocytes as determined by Q-PCR analysis which is 
supported by RT-PCR results with strong evidence of an absence of contamination. It is 
unlikely that this is due to more cells being examined after co-culture compared to before 
cu-culture which are expressing the same amount of sca-1 as the expression change, 
7.5fold for the DS cells, is higher than the number of cells being put into the co-culture. 
This therefore suggests that there is induction of expression of sca-1 in cells and potentially 
an increase in cell number. 
Cells expressing sca-1, as well as c-kit and Isl l , have been identified in the adult heart and 
are suggested to be capable of differentiation into cardiomyocytes, such cells are proposed 
to represent a cardiac progenitor cell sub-population that is capable of self-renewal and 
differentiation into mature, contracting cardiomyocytes (Pfister et al., 2005); sca-1 is 
therefore proposed as a putative marker to identify cardiac progenitor cells (Oh et al., 
2003). In the work of Oh, it is noted that cardiac scal+ve cells express none of the cardiac 
structural genes that were investigated including a-MHC, atrial and ventricular M L C or a-
actin among others, however they did express the cardiac transcription factors GATA4 and 
Mef2c as well as having high levels telomerase activity not detected in the cardiac seal" 
fraction (Oh et al., 2003). This profile may be comparable to the rat dermal follicular cells 
after co-culture with the embryonic cardiomyocytes as shown in figure 4.14. 
Oh also showed scal+ve cells were capable of homing to site of myocardium injury (Oh et 
al., 2003). In addition, bone marrow-derived adult MSC expressing sca-1 have been 
demonstrated to differentiate into cardiomyocytes (Gojo et al., 2003). Skeletal muscle-
derived cells express sea-1 and are capable of differentiating into myogenic cells (Asakura 
et al., 2002) as well as, on over-expression of sca-1, contributing to muscle regeneration 
(Qu-Petersen et al., 2002). Most interestingly, sca-1 has been implicated in cellular 
commitment to myocyte differentiation; using C2Q2 cells, sca-1 was expressed at low 
levels on the surface of proliferating myoblasts but was up-regulated when the cells left the 
144 
cell cycle and differentiated to cardiomyocytes; expression then down-regulated in 
differentiated myotubes. Removing sca-l from the cell surface or blocking it resulted in 
proliferation, interference with myotube formation and persistent expression of early 
markers of myogenic differentiation indicating defective myogenesis (Epting et al., 2004). 
As noted by Epting, mice null for another Ly-6 super family members, of which sea-1 is 
one, resulted in a primary defect of myocardial development and embryo lethality (Zammit 
et al., 2002). These observations suggest an important role for Ly-6 family members in 
muscle development. Sca-l expression in the dermal follicular cells, especially at the high 
levels detected in the mouse DP and DS primary culture cells is therefore very interesting 
and may confer these properties described. 
Nanog requires expression of Oct4 and Sox2 for cardiomyocyte commitment which may 
suggest the detectable expression Oct4 and Sox2, although small and possibly due to 
contamination, may be real. However, this population based study cannot indicate if the 
expression of these three transcripts were in the same cells. In addition, somatic cells do 
not express telomerase and the primary cells used for experimentation here were not 
transformed therefore there is a high probability that the expression of Tert in these cells 
was from cycling stem cells, an increase in the number of stem cells or increasing 
expression levels of Tert in existing stem cells. mTert, expressed in the co-culture samples, 
is a key gene in the investigation of stem cells and their progeny; it is expressed in the stem 
cell compartment of several adult tissues (reviewed by Sarin et al., 2005; Flores et al., 
2006; Siegl-Cachedenier et al., 2007). 
The overall level of expression of gene expression for the DP and DS, as determined by 
quantitative PCR, was generally of a level lower than that detected for the embryonic 
cardiomyocytes but higher than that of the adult heart. For analysis of successful 
differentiation, if the profile of the dermal cells is reminiscent of the adult cardiomyocyte, 
then this is suggestive that these cells if used clinically, having a profile close to that of the 
embryonic cells i.e. a more progenitor, stem cell-like, may indicate they will be capable of 
proliferation and may be recognised in a similar manner to the native stem cell population 
and mobilised more efficiently. 
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In current literature there are a significant number of studies into the differentiation of other 
MSC, as well as various other types of stem cells, into cardiomyocytes. A lot of these 
investigations conclude successful differentiation based on the expression of a small 
number of cardiac associated genes, which are included here, however these genes only 
represent a very small selection of the genes important in the cardiomyocyte. Yoon 
concluded that rat bone marrow MSC had undergone trans-differentiation after co-culture 
with neonatal cardiomyocytes based upon the induction of expression of sarcomeric alpha-
actinin alone (Yoon et al., 2005). Wang also concluded that rat bone marrow MSC had 
differentiated into cardiomyocytes after co-culture with adult rat cardiomyocytes based 
upon the induction of expression of a-actin and troponin T as well as desmin and calponin 
however it is noted these latter two genes are not specific to cardiac tissue (Wang et al., 
2006). Moscoso concluded that pig bone marrow MSC differentiated into cardiomyocytes 
suitable for transplantation, after treatment with 5-azacytizine, based upon induction of 
expression of a-actin in a fraction of the cells (Moscoso et al., 2005). Xu concluded adult 
human bone marrow MSC has differentiated to cardiomyocytes, after treatment with 5-
azacytizine, based upon desmin, {3-MHC, troponin T and a-cardiac actin as well as the 
morphology of the cells (Xu et al., 2004). In all of these cases the number of genes 
investigated is only a fraction of cardiomyocyte-associated functional genes important 
without the inclusion of any transcription factors. If conclusions made in this chapter were 
based upon such a limited gene expression profile, then the dermal follicular cells would be 
deemed capable of differentiating to cardiomyocytes. We detected, by RT-PCR, expression 
of cardiac actin, a-MHC and troponin I in the dermal follicular cells after co-culture with 
species matched embryonic cardiomyocytes, and two of these after cross-species co-culture 
in addition to the genes mentioned above there was also demonstration in once co-culture 
sample of tropomyosin, titin and MLC1A (DP2 in figure 4.15). In same species co-culture, 
particularly with mouse dermal follicular cells and mouse embryonic cardiomyocytes, there 
was evidence of induction of expression of genes by RT-PCR relevant to cardiomyocytes, 
including stem-cell associated genes, which were not significant as determined by Q-PCR. 
However, under this less stringent system of identification and confirmation of cell 
differentiation, as is demonstrated in a number of pieces of current literature, the 
conclusion would be successful differentiation of the dermal follicular cells to 
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cardiomyocytes. Further investigation, as shown here by Q-PCR and indeed a larger gene 
expression profile being examined by RT-PCR, indicates the dermal cells are not 
expressing all the genes expressed by a native cardiomyocyte. Furthermore when the genes 
are detected they are not at comparable expression levels to the cardiomyocyte and in some 
instances could be a result of contamination. This suggests potential for cardiomyocytic 
differentiation, however full differentiation has not occurred. 
It is therefore vital in future studies investigating cardiomyocyte differentiation, especially 
when the cells are cited as having functional and contractile capabilities based on gene 
expression, that an extensive array of genes are probed for. It poses the question: do we 
need to reconsider how cardiomyocyte differentiation is defined and, considering the 
impact of this area of research, revisit a number of pieces of work. It is of concern that the 
investigations by others do not show that this has been taken into consideration and, in a 
number of cases, ongoing clinical trials and in vivo work is based upon such limited results. 
Based on the results presented here, we cannot conclude with confidence that the dermal 
follicular cells have demonstrated full differentiation as they do not express basic genes 
expressed in the embryonic, as well as adult, cardiomyocyte. In summary, when the dermal 
follicular cells are co-cultured with embryonic cardiomyocytes of the same species we see 
the most marked expression profile alteration of cardiac inductive and function associated 
genes, with an increase in the levels of expression to detectable levels or above that 
previously identified. The dermal follicular cells are proposed here as a potential cell type 
for investigating somatic cell differentiation towards a cardiomyocyte lineage. The results 
shown here of gene expressing changes in co-culture are exciting and promote further 
investigation into the dermal follicular cells and their place in cardiomyocyte stem cell 
research. 
These data suggest that there may be a stem cell population resident within the dermal 
follicle. The absence of definitive differentiation of the dermal follicular cells to 
cardiomyocytes may indicate the differentiation potential of the cells only applies to a sub-
population of the DP and DS; the spontaneous differentiation and gene expression changes 
may be attributed to these cells. Population based studies can't be used to examine a sub-
population of stem cells therefore it is necessary to use a method of investigation that will 
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allow for the identification of sub-populations that may be responsible for the gene 
expression changes observed here. Existing stem cell models that use surface antigen 
expression have been demonstrated to not be entirely reliable as there is possibility of loss 
of antigens or presence of contaminating cell types. Therefore, considering there is 
suggestion of up-regulation of Tert in the dermal cells, a phenotypic marker of stem cells, 
the mTert-GFP transgenic mouse was investigated to determine if it could be useful in 
studying stem cells of the dermis and their relationship with stem cells involved in 
cardiogenesis. The mTert-GFP mouse is an animal model that has recently been indicated 
to identify populations of adult cells with stem cell like capabilities (Breault et al., 2008); it 
may allow identification of a stem cell population within the DP and DS structures, or the 
dermis, that is better suited to differentiation. 
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5 The mTert-GFP mouse model 
Complex combinations o f cell surface antigens are used to identify and isolate stem 
cells f rom adult and foetal tissue. This is not always a reliable method o f isolation as 
cell surface antigens can change or be degraded by enzyme activity when dissociating 
cells f rom tissues. An alternative method o f isolation, which defines side population 
cells, is by detecting the functional properties o f stem cells by, for example, their ability 
to efflux Hoechst dye. However, this does come with caveats such as potential 
contaminating cell types. As a result the two methods are often used in combination as 
tools to enrich stem cell populations f rom tissues. 
One common feature o f stem cells is their long term relative resistance to cellular 
senescence despite multiple rounds o f cell division. Telomerase is a ribonucleic protein 
complex that helps maintain the telomeric ends o f chromosomes; these telomeres are 
normally shortened with each cell division in somatic cells, until a critical threshold 
length is reached which induces cellular senescence. Therefore maintenance o f 
telomeres or induction o f telomerase activity is a means o f preventing senescence which 
is associated with the self-renewal o f stem cells. Telomerase is normally undetected in 
most somatic cells but is expressed in adult male germ cells and proliferative stem cells 
o f renewing tissues. 
In the mouse, the transcription o f mTert is tightly regulated and its gene expression 
profile correlates wi th telomerase activity; the expression o f mTert is down-regulated 
with somatic cell differentiation. Furthermore, mTert has been reported to have a direct 
role in regulating adult stem cell proliferation and mobilization. Telomerase regulation 
in stem cells is primarily controlled by Tert. In the mouse a reporter gene system using 
the mTert promoter may allow for the identification o f telomerase expressing cells; a 
biomarker for stem cells in adult tissues. In order to examine this, transgenic mouse 
lines expressing GFP under the control o f the mTert promoter was produced; the mTert-
GFP mouse model (Breault et ai, 2008). Preliminary data showed that, in a manner 
similar to the in vitro studies, cells expressing native Tert also expressed GFP, and that 
when GFP was absent, Tert was also undetectable. In the tissues studies so far (gut and 
blood), somatic stem cells could be identified on the basis o f their expression o f GFP 
using immunofluorescence o f FACS. In the peripheral blood, cells expressing GFP 
included B-cells (-45%), T-cells (-25%), myeloid cells (-25%), as well as a rare 
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population o f circulating haematopoietic progenitor/stem cells, which in culture formed 
GFP+ve CFU-GEMM colonies (Breault et al., 2008). 
Analysis o f the germ cell populations indicated that the largest percentage o f GFP+ve 
cells were found in the mitotically active primary spermatocytes. In comparison, a 
smaller fraction spermatogonia and/or secondary spermatocytes as well as spermatids 
also expressed GFP. These data were consistent wi th previous reports o f telomerase 
activity and validated GFP expression as a marker o f male germ cells in mTert-GFP 
mice. GFP m R N A and protein were localized within the seminiferous tubules and 
corresponded to primary and secondary spermatocytes, consistent wi th the FACS 
analysis (Breault et al., 2008). 
To functionally confirm that GFP expression marked the HSC subset o f mTert-GFP 
B M , the capacity o f high GFP+ve cells from whole bone marrow to exhibit long-term, 
serial, multilineage reconstitution was assessed. Long-term engraftment, defined as 
persistence o f donor cells for more than 5 months fol lowing transplantation, was 
demonstrated in recipient mice receiving GFP+ve cells by FACS analysis o f bone 
marrow. Serial bone marrow transplantation into secondary female recipients was 
performed using GFP+ve bone marrow cells obtained f rom a primary bone marrow 
transplant recipient 5 months after the initial transplantation. The female recipient 
received GFP+ve cells which demonstrated long-term HSC engraftment, surviving 5 
months fol lowing serial transplantation, and peripheral blood chimerism was confirmed 
indicating multilineage reconstitution (Breault et al., 2008). 
The mTert-GFP transgenic mouse is therefore a model system to facilitate the 
identification, isolation and functional characterisation o f putative stem cells using a 
functional as opposed to an antigenic marker. 
5.1 Characterisation of the hair follicle and dermis of the 
mTert-GFP mouse 
The mTert-GFP mouse was used to investigate the DP, DS and bulge region to 
determine i f Tert could identify stem cell populations o f the dermis. The DP and DS 
primary culture cells demonstrated low level detectable expression o f Tert by RT-PCR 
(Chapter 3 figure 3.14), however the end bulb had low level expression and the clonal 
cell lines expressed Tert, therefore the DP and DS were investigated in hair follicle 
sections to determine Tert gene expression in vivo. The theory that a sub-population o f 
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the DP and DS may be more stem cell-like in their properties may be indicated by a 
proportion o f these structures expressing Tert. 
Therefore the initial step in investigating the mTert-GFP mouse model was to consider 
the cells o f interest in the hair follicle, the DP and DS, to determine i f they could be 
located by their GFP expression and distinguished f rom surrounding hair follicle 
structures as well as the surrounding inter-follicular dermis. According to RT-PCR 
analysis (shown in Chapter 3, figure 3.14) the DP and DS primary culture cells 
expressed low level Tert however this expression was higher in the end bulb; the theory 
that a sub-population o f the DP and DS may be more stem cell-like in their properties 
may be indicated by a proportion o f these structures expressing Tert. Identifying cells 
expressing Tert f rom the hair follicle may provide a better method o f isolation o f cells 
for differentiation investigation rather than the manual dissection method that has 
previously been used. 
mTert-GFP status was assigned to adult mice by blood typing for GFP+ve cells; in 
GFP+ve mice there was approximately 4% o f the blood cells positive for GFP-
associated fluorescence which, using the same gating, was 0% for W T mice (data not 
shown). Embryos were assigned GFP status by placenta removal and PCR tissue typing 
(Methods section 2.5.2). 
5.1.1 Histological investigation of the mTert-GFP vibrissae follicles 
Follicles f rom mTert-GFP mice were investigated and compared to W T littermates: 
1. Vibrissae follicles 
Vibrissae follicles were examined initially as they are the largest follicles in the mouse 
and a range o f follicles at different cell cycle stages are typically present simultaneously 
(Davidson and Hardy 1952) as discussed in Chapter 1. 
2. Smaller hair follicles on the face pad 
The bulb region is an area o f the hair follicle which has previously demonstrated Tert 
expression as indicated by its role here in the transition o f hair f rom telogen (resting) to 
anagen (growing) (Sarin et al, 2005). The bulge region o f the vibrissae follicles is 
diff icul t to identify in cross sections o f the follicles; the smaller hair follicles o f the face 
pad, surrounding the vibrissae, were in sagittal sections and thus allowed potential 
identification o f the bulge region in the same plane as the end bulb. 
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3. Developing vibrissae follicles in the El4.5 embryo 
Tert plays an important role in the hair follicle, one which is independent o f its role in 
telomere lengthening. Tert over expression, in the absence o f telomere length changes, 
was found to be associated with stem cell mobilisation, hair growth with promoted 
transition o f hairs f rom telogen to anagen, wi th increased skin thickness and increased 
stem cell proliferation (Flores et al., 2005). Telomerase deficiency was associated with 
a larger number o f stem or progenitor cells in the epidermal and hair follicle 
compartment i.e. the presence o f more inactivated stem cells (Flores et al., 2005). The 
El4.5 mouse was chosen for investigation o f the vibrissa follicles; developing 
embryonic follicles, where the progenitor cells are proliferating and differentiating to 
produce the cells o f the bulge as well as DP and DS structures may represent a time o f 
stem cell mobilisation that requires Tert expression. A t El0-11 there are no vibrissa 
follicles in the face pad; at E l 2 follicle plugs form as epidermal down growths 
surrounded by dermal sheath. The DP is formed at E l 4 and within a day later the hair 
cones form; these are hollow cones that give rise to the inner root sheath which 
develops by hardening o f certain cells f rom the hair matrix. The cone extends upwards 
to form the hair canal at E l 5 (Davidson and Hardy 1952). Therefore, at El4.5 the DP 
and DS are both present wi th the follicles, as the hair canals are formed. Therefore the 
E14.5 mouse embryo was chosen for investigation o f the developing vibrissa follicles. 
4. Neonatal skin 
Recently i t has been reported that Tert triggers a rapid change in gene expression that 
significantly overlaps with the program controlling natural hair follicle cycling; it is 
thought that Tert activates the expression o f hair growth genes and inhibits expression 
o f anti-hair growth genes (Choi et al., 2008). These gene expression changes, which are 
linked to changes in Tert levels, appear to be independent o f alterations in hair follicle 
cycling. This may indicate Tert plays a more important role in the follicle during hair 
growth and, therefore, Tert expression may be associated with hair formation, and 
increase in expression to detectable levels in neonatal skin when the hair is formed and 
growing. Hair emerges through neonatal skin at age 2-3 days old (9-10 days after 
embryonic age E l 4 ) and secondary follicles form at 5-8 days old (Davidson and Hardy 
1952) therefore, the dermis o f the neonatal torso skin was investigated in the mTert-
GFP mouse neonates at 5 days old, when the skin was expected to be particularly 
active. 
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The hair follicles contain a dense network o f blood vessels, therefore discriminating 
between cells that may be present in the circulating blood from the dermal derived cells 
is necessary. CD45 and CD34, identified by antibody labelling, were used for this 
purpose. CD34 is expressed on haematopoietic cells including the HSC where i t 
expressed most strongly on the primitive cells and lost wi th differentiation; it plays a 
role in cell to cell adhesion and signal transduction where i t is involved in regulating 
other haematopoiesis associated genes (Holyoake and Alcorn 1994). CD34 is also 
expressed by vascular endothelial cells (Fina et al., 1990). CD45 is expressed 
exclusively by haematopoietic cells including HSC (Trowbridge and Thomas 1994). 
Co-labelling immunofluorescence techniques are described in method section 2.12.2. 
GFP was detected using an anti-GFP antibody to indicate cells which were Tert+ve at 
the time o f tissue sampling as described in methods section 2.12.1. 
5.1.1.1 GFP epifluorescence of adult vibrissae follicles 
GFP epifluorescence was initially investigated on entire sectioned hair follicles to 
determine i f GFP expression in the hair follicle was detectable above auto-fluorescence. 
Over 20 vibrissa follicles f rom the mTert-GFP mouse were compared to sex matched, 
W T littermate follicles were taken f rom matched vibrissa locations to ensure cell cycle 
staging was also matched. lOum sections were collected from each vibrissa follicle and 
in excess o f 5 sections per follicle were visualised for GFP fluorescence (data not 
shown). 
There was no fluorescence detectable above autofluorescence in the follicles 
investigated (data not shown); autofluorescence is a common problem with the skin and 
the follicles which is overcome by signal amplification with antibody labelling. 
GFP expression may have been present but too low to be detectable above 
autofluorescence; the hair follicles were investigated using antibody labelling which 
would amplify any GFP signal present. 
5.1.1.2 Antibody labelling of adult vibrissae follicles 
The testes o f mTert-GFP mice were antibody labelled as a positive control to confirm 
GFP status o f the mouse, as assigned by blood typing. GFP antibody specificity was 
also confirmed as present to a detectable level in an organ known to be Tert+ve. 
Representative testes sections, from 5 mTert-GFP mice and 5 W T littermates are shown 
in figure 5.1. In mice assigned GFP+ve status, anti-GFP labelling was detectable in the 
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region o f mature sperm heads, spermatids and the stem cells o f the seminiferous 
tubules; the spermatogonium (figure 5.1iv) as described in the analysis o f the germ cells 
when the mTert-GFP mouse was first established (Breault et ai, 2008). 
Wi th confirmation o f the GFP status o f the animals and anti-GFP antibody labelling 
correlating with known stem cells o f the testes, the vibrissa follicles were investigated. 
5 mTert-GFP mice and 5 W T littermates were used. Both face pads were excised and 
sectioned in their entirety; sections o f the end bulb were antibody labelled. Figure 5.2 
shows matched hair follicles. 
Anti-GFP labelling was identified in approximately 10% o f the vibrissae follicles; these 
were the larger o f the vibrissae follicles where the DP and DS were discernable. 
Relatively strong anti-GFP labelling was associated with the DP and DS, wi th less 
intense staining seen in the cortex and medulla. 
5.1.1.3 Antibody labelling of adult face pad 
O f the 5 mTert-GFP mice and 5 W T littermates, where both face pads were excised and 
sectioned, the hairy skin surrounding the vibrissae follicles were assessed for anti-GFP 
labelling. Representative images are shown in figure 5.3. 
The dermis o f the W T mice indicated non-specific binding o f the GFP antibody 
associated with the region o f the sebaceous gland. In the dermis o f the mTert-GFP 
mouse there was positive labelling o f the end bulbs o f developing follicles however the 
DP and DS could not be distinguished within these structures. GFP positive cells were 
visualised in just 10% o f distinguishable follicles present. 
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Figure 5.1: Immunohistochemical labelling fo r GFP cells i n the testes o f the 
mTert -GFP mouse 
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Anti-GFP antibody labelling detected by VIP (purple) (as described in Methods 2.11) 
on testes f rom an mTert-GFP mouse (i,ii,v,vi) and testes f rom a W T littermate (iii.iv). 
VIP was detectable in the region o f mature sperm heads (A) , spermatids (B) and a 
number o f the spermatogonium (C) closely associated with the basement membrane. 
Compared with the W T mouse (Hi, iv), substantive and specific labelling was seen in 
the testes o f the mTert-GFP mouse. Representative phase images. 
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Figure 5.2: Immunohistochemical labelling fo r GFP+ve cells i n vibrissae follicles 
of the mTert -GFP mouse 
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Anti-GFP antibody labelling detected by VIP, counterstained with methyl green, on hair 
follicles from an mTert-GFP mouse (iijv.vi) and developmentally matched follicles 
from W T littermates (i,iii,v). Relatively strong anti-GFP labelling was associated with 
the DP (B) and DS (A) , but less intense staining was seen in the inner root sheath (D) 
and outer root sheath (C). Bright field images at x20 magnification. 
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Figure 5.3: Immunohistochemical labelling for GFP+ve cells in the vibrissae of the 
mTert-GFP mouse 








Anti-GFP antibody labelling detected by VIP, counterstained wi th methyl green, on 
skin surrounding the vibrissa follicles f rom the mTert-GFP mouse (H ) and 
developmentally matched skin o f W T littermates ( f ) , There was relatively strong anti-
GFP labelling o f the end bulb structures (A) o f the mTert-GFP hair follicles. The hair 
shaft (C) o f the mTert-GFP mouse was negative wi th a degree o f labelling in the 
epidermis (B). There was non-specific-labelling in the region o f the sebaceous gland 
(E) as shown on the follicles o f the W T skin. Representative bright f ield images at x20 
magnification. 
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5.1.1.4 Antibody labelling of embryonic vibrissae 
El4.5 embryos f rom two unrelated females were investigated; sagittal sections o f 5 
mTert-GFP embryos and 5 W T littermate embryos were examined. The developing 
vibrissae follicles were apparent in rows and in excess o f 10 sections f rom each embryo 
were antibody labelled. 
There were no GFP+ve cells associated with the follicles or the surrounding dermal 
tissue in any o f the embryo sections investigated (data not shown). 
5.1.1.5 Antibody labelling of neonatal dermis 
Five mTert-GFP neonates and 5 W T littermates were used for dermal cell preparation. 
Approximately 4cm o f skin was removed from each neonate yielding a total o f 20cm 
dermis; in excess o f 200 sections o f skin were antibody treated for both mTert-GFP and 
W T neonates. 
A number o f GFP+ve cells, associated with the hair follicles, were identified in the 
dermis. Representative images are shown in figures 5.5-5.10. Figure 5.4 shows there 
was blue filter autofluorescence, in the absence o f antibody labelling in both mTert-
GFP and W T sections, o f the epidermis and the cell-dense follicles, this was taken into 
account when analysing the mTert-GFP skin sections. 
Figure 5.5 shows W T dermis with CD45 staining; there were no detectable GFP+ve 
cells. A representative image o f a similar mTert-GFP section o f dermis shows the 
identification o f a dermal GFP+ve cell which was CD45-ve, as shown in figure 5.6. 
Figure 5.7 shows W T dermis with CD34 staining; there were no detectable GFP+ve 
cells. A representative image o f a similar mTert-GFP section o f dermis shows the 
identification o f a dermal GFP+ve cell which was CD34-ve, as shown in figure 5.8. 
On occasion GFP+ve cells were identified in the dermis which co-labelled for anti-
CD45 (figure 5.6). These cells were associated with the end bulbs where there was a 
network o f capillaries and appeared to be located in a blood vessel-like structure 
indicative o f HSC. 
GFP+ve cells were identified in one o f two locations in the dermis. The first was the 
dermis surrounding the follicular end bulb as demonstrated in figure 5.9. The second 
was the inter-follicular dermis where cells were located higher up the follicle as 
demonstrated in figure 5.10. These cells were CD45-ve and CD34-ve. 
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Figure 5.4: Neonatal skin of the W T mouse showing epidermal autofluorescence 
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Blue filter autofiuorescence o f the epidermis o f the W T mouse. In the absence o f 
antibody labelling, there was autofluorescence o f the epidermis (A) and the cell-dense 
follicles (B) with the blue fluorescence filter. 
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Figure 5.5: Immunofluorescent labelling f o r GFP and CD45 cells in the neonatal 
skin of the W T mouse 
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Immunofluorescent labelling o f neonatal dermis o f W T mouse. There was no detectable 
anti-GFP expression (2). Anti-CD45 labelling («) indicated a number o f haematopoietic 
cells (A) . Nuclei were identified by Pi labelling (Hi) where the individual hair follicles 
can be seen (B). The epidermis and the dense areas o f the follicles were autofluorescent 
under blue filter fluorescence (C). There were a number o f cells which appeared to be 
CD45+ve (D). Images shown at x40 magnification. 
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Figure 5.6: Immunofluorescent labelling fo r GFP and CD45 cells in the neonatal 
skin of the mTert -GFP mouse 
/. F ITC-GFP //'. A M C A -CD45 
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Immunofluorescent labelling o f neonatal dermis o f mTert-GFP mouse. There were a 
number of GFP+ve cells (i) and CD45+ve cells (A) (ii) in the dermis. A single GFP+ve, 
CD45-ve cell (C) was observed amongst cells that were GFP+ve and CD45+ve (D) 
indicative o f haematopoietic cells in a blood vessel. The GFP+ve cell was located in the 
dermis associated with the hair follicle (B). Antibody specificity was confirmed by a 
no-primary antibody control (v/). Images shown at x40 magnification. 
161 
Figure 5.7: Immunofluorescent labelling fo r GFP and CD34 cells i n the neonatal 
skin of the W T mouse 
i. F ITC-GFP U< A M C A -CD34 
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Immunofluorescent labelling o f the neonatal dermis o f the W T mouse. There was no 
detectable anti-GFP expression (/). Anti-CD34 labelling (ii) indicated a number o f cells 
that were CD34+ve (A) . Nuclei were identified by Pi labelling (I7I) where an individual 
hair follicle can be seen (B). There were a number o f cells, as indicated by Pi+ve nuclei, 
which were CD34+ve (C). Images shown are at x40 magnification. 
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Figure 5.8: Immunofluorescent labelling fo r GFP and CD34 cells in the neonatal 
skin of the mTert-GFP mouse 
/. F ITC-GFP I it. A M C A -CD34 
A 
Immunofluorescent labelling o f the neonatal dermis o f the mTert-GFP mouse. There 
was one GFP+ve cell identified in the dermis (2) as well as a number o f CD34+ve cells 
(A) ( K ) , The GFP+ve cell was CD34-ve (B) and was located in the dermis associated 
with the hair follicle (C). Images shown are at x40 magnification. 
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Figure 5.9: Ant i -GFP labelled cells, of the skin of the mTert -GFP mouse 
associated w i t h the dermis surrounding the fol l icular end bulb 
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Immunofluorescent labelling o f the neonatal dermis o f the mTert-GFP mouse showing 
a GFP+ve cell associated with the follicular end bulb. The phase image (/) shows the 
location o f the hair follicle end bulb (A) , dermis (B), epidermis (C), fat (D) and muscle 
(E) (x5 magnification). Nuclei labelling with DAPI (Hi) showed the GFP+ve cell 
associated with the end bulb o f the hair follicle (F). Images ii.iii.iv and v are at x40 
magnification. GFP+ve cells, associated with the end bulb, were CD45-ve and CD34-
ve. 
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Figure 5.10: Ant i -GFP labelled cells, of the skin of the mTert -GFP mouse, 
associated with the inter-follicular dermis 
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Immunofluorescent labelling o f the neonatal dermis o f the mTert-GFP showing an 
inter-follicular GFP+ve cell associated with the hair shaft region o f the hair follicle. The 
phase image (/) shows the location o f the hair follicles (A) , dermis (B), epidermis (C) 
and fat (D) (x5 magnification). Nuclei labelling with DAPI (Hi) showed the GFP+ve 
cell associated with the hair follicle (A) . Images are shown at x40 magnification. 
GFP+ve cells, associated with the interfollicular dermis, were CD45-ve and CD34-ve 
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The identification of GFP+ve cells in two different locations in the dermis, both of 
which were negative for haematopoietic lineage surface antigens CD45 and CD34, is 
suggestive of two separate dermal cell populations, potentially one associated with the 
end bulb of the follicle and the other with the bulge region. 
Considering there were two GFP+ve cells locations within the dermis, both associated 
with the hair follicle, further analysis of these GFP+ve cells was undertaken by 
investigating the entire dermis by flow cytometry and F A C S isolating the GFP+ve 
populations for further analysis. 
5.1.2 Isolation and characterisation of the mTert-GFP neonatal 
dermis 
GFP+ve cells associated with the hair follicle, as identified in the dermis by 
immunofluorescence, were investigated by flow cytometry as described in methods 
sections 2.3.2 and 2.14. GFP expression was previously identified by antibody labelling 
however, native expression was sufficient to be captured by flow cytometry without the 
need for further amplification of the signal. 
As demonstrated above, GFP+ve dermal cells were identified in the dermal 
compartment of the skin by immunohistochemistry from 5 day old neonatal skin when 
there is appearance of hair on the skin. Freshly isolated dermis from 5 day old neonatal 
skin was investigated by flow cytometry. In addition to this time point, the freshly 
isolated dermis of earlier aged neonates were also investigated; from 2 day old neonates 
and 3 days old neonates to correlate with initial hair appearance and initial secondary 
hair follicle formation. In order to potentially be able to correlate findings from the 
dermal GFP+ve cell population with the DP and DP primary cells in culture, the entire 
dermis was also put into culture and the adherent cells, after 1 week culture and 2 
weeks culture, were F A C S investigated in a similar manner to the "fresh" sorts, which 
were the cells isolated immediately after tissue processing as described above. 
5.1.2.1 Flow cytometric analysis of the dermis 
The dermis from neonates aged 2 days, 3 days and 5 days old were isolated. 10 mTert-
GFP neonates and 10 W T neonates were used for each time point, equating to a 
sampling total of 40cm 2 of dermis for each time point. The fresh dermal samples were 
analysed by flow cytometry for viable cells, 7-AAD-ve, that were lineage-ve and 
GFP+ve (Methods section 2.14). To minimise any effect of F A C S method, the 
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experiment was ran on three separate days with 3-4 mTert-GFP neonates and matching 
W T littermates for each time point run on each day (figures 5.11-5.13). 
The mean proportion of GFP+ve lineage-ve cells identified in the dermis from 2 day 
and 5 day old neonates were similar; the dermis from the 2 day old neonates contained 
0.19% GFP+ve lineage-ve cells (n=10) (representative sample is shown in figure 5.11) 
and the dermis from the 5 day old neonates contained 0.20% GFP+ve lineage-ve cells 
(n=10) (representative sample is shown in figure 5.12). However the mean proportion 
of GFP+ve lineage-ve cells identified in the dermis from 3 day neonates was higher at 
0.45% (n=10) (representative sample is shown in figure 5.13); this may correlate with 
the time of secondary follicle formation and with the GFP+ve cells seen by 
immunofluorescence associating with the end bulb and developing DP. The flow 
cytometric analysis profile was similar for all ages of the dermis with similar 
percentages of viable lineage-ve cells. The GFP+ve cells were gated for lineage 
negativity according to lineage positive control samples. The level of expression of 
lineage cocktail in the GFP+ve cells was re-checked and on every occasion these cells 
were within the range of 10°-10' A P C fluorescence confirming they were well within 
the assigned lineage-ve cells (data not shown). In summary, the flow cytometric profile 
for the mTert-GFP dermis shows there is a clear population of cells that are GFP+ve, 
distinct from the GFP-ve cells and negative for lineage markers, which may represent a 
population of dermal stem-like cells. 
Due to the increased number of GFP+ve cells in the 3 day old neonatal fresh dermis 
sample, this age of neonate was used for further analysis of the dermal cells after a 
period of in vitro culture. The entire dermis from 5 mTert-GFP and 5 W T littermates 
were transferred into a 25cm 2 flask each and adherent cells, after 7 days (figure 5.14) 
and 14 days (figure 5.15), were analysed for viable GFP+ve lineage-ve cells. 
The flow cytometric profile for the 1 week cultured dermis was different to the 2 week 
cultured dermis with 0.30% and 0.13% of cells GFP+ve lineage-ve respectively (fresh 
sorts demonstrated 0.49% GFP+ve lineage-ve as described above). 
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Figure 5.11: Flow cytometric analysis of dermis from a neonatal W T and mTert-
G F P mouse neonates 
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Flow cytometric analysis o f neonatal dermis from 2 day old littermates. Gating for f low 
cytometric analysis was set according to W T neonatal dermis (i and ii) o f matching age 
and sex to the mTert-GFP neonates (Hi and iv). Only cells negative for lineage cocktail 
(method section 2.14) were analysed so to exclude any cells that may be blood derived. 
These gates were corifirmed as negative for lineage positive control samples. O f these 
cells, viability was determined using 7-AAD (methods section 2.14) and viable cells 
positive for GPF (gating A ) were counted and FACS sorted for further investigation. A 
matching GFP-ve population o f cells from the mTert-GFP dermis were also collected 
(B). The number o f viable GFP+ve, lineage negative cells is shown in the gating (A) as 
a percentage o f the entire sorted dermal population o f the mTert-GFP neonates; from 
four experiments the average was 0.19%, in this experiment this was 0.17%. 
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Figure 5.12: Flow cytometric analysis of dermis, from a neonatal W T and mTert-
G F P mouse neonates 
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Flow cytometric analysis o f neonatal dermis f rom 3 day old littermates. Gating for f low 
cytometric analysis was set according to W T neonatal dermis (/ and i f ) o f matching age 
and sex to the mTert-GFP neonates ( H I and iv). Only cells negative for lineage cocktail 
(method section 2.14) were analysed so to exclude any cells that may be blood derived. 
O f these cells, viability was determined using 7 -AAD (methods section 2.14) and viable 
cells positive for GPF (gating A ) were counted and FACS sorted for further 
investigation. A matching GFP-ve population o f cells f rom the mTert-GFP dermis were 
also collected (B). The number o f viable GFP+ve, lineage negative cells is shown in the 
gating (A) as a percentage o f the entire sorted dermal population o f the mTert-GFP 
neonates; f rom four experiments the average was 0.45%; in this experiment this was 
0.49%. 
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Figure 5.13: Flow cytometric analysis of dermis, from a neonatal W T and mTert-
G F P mouse neonates 
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Flow cytometric analysis o f neonatal dermis f rom 5 day old littermates. Gating for f low 
cytometric analysis was set according to W T neonatal dermis (/ and ii) o f matching age 
and sex to the mTert-GFP neonates (Hi and iv). Only cells negative for lineage cocktail 
(method section 2.14) were analysed so to exclude any cells that may be blood derived. 
O f these cells, viability was determined using 7 -AAD (methods section 2.14) and viable 
cells positive for GPF (gating A ) were counted and FACS sorted for further 
investigation. A matching GFP-ve population o f cells f rom the mTert-GFP dermis were 
also collected (B). The number o f viable GFP+ve, lineage negative cells is shown in the 
gating (A) as a percentage o f the entire sorted dermal population o f the mTert-GFP 
neonates; f rom four experiments the average was 0.20%, in this experiment this was 
0.18%. 
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Figure 5.14: Flow cytometric analysis of dermis from 3 day old mTert -GFP mouse 
neonates, cultured in vitro for 7 days 
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Flow cytometric analysis o f the 1 week cultured dermis. Gating for f low cytometric 
analysis was set according to W T neonatal dermis ( i and i f ) o f matching age and sex to 
the mTert-GFP neonates (Hi and iv). Only cells negative for lineage cocktail (method 
section 2.14) were analysed so to exclude any cells that may be blood derived. O f these 
cells, viability was determined using 7 -AAD (methods section 2.14) and viable cells 
positive for GPF (gating A ) were counted and FACS sorted for further investigation. A 
matching GFP-ve population o f cells f rom the mTert-GFP dermis were also collected 
(B). The number o f viable GFP+ve, lineage negative cells is shown in the gating (A) as 
a percentage o f the entire cultured dermal population o f the mTert-GFP neonates; f rom 
four experiments the average was 0.35%; in this experiment this was 0.30%. 
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Figure 5.15: Flow cytometric analysis of dermis from 3 day old mTert -GFP mouse 
neonates, cultured in vitro for 14 days 
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Flow cytometric analysis o f the 2 week cultured dermis. Gating for f low cytometric 
analysis was set according to W T neonatal dermis ( i and ii) o f matching age and sex to 
the mTert-GFP neonates (Hi and iv). Only cells negative for lineage cocktail (method 
section 2.14) were analysed so to exclude any cells that may be blood derived. O f these 
cells, viability was determined using 7 -AAD (methods section 2.14) and viable cells 
positive for GPF (gating A ) were counted and FACS sorted for further investigation. A 
matching GFP-ve population o f cells f rom the mTert-GFP dermis were also collected 
(B). The number o f viable GFP+ve, lineage negative cells is shown in the gating (A) as 
a percentage o f the entire cultured dermal population o f the mTert-GFP neonates; f rom 
four experiments the average was 0.10%; in this experiment this was 0.13%. 
172 
On occasion with flow cytometric analysis, there was a small peak of dermal cells that 
were located within the lineage positive range of cells, as shown in figures 5.11-
5.13(m) and 5.15»/. On every occasion this was observed, these cells also expressed 7-
A A D with a fluorescence of 103 upwards indicating that these cells were dead or dying 
and most likely accumulated the lineage cocktail fluorescent molecules with cell debris 
giving false positive expression (data not shown). The percentage of cells assigned 
lineage-ve decreased between 7 days and 14 days culture from 98.8% to 64.1%; the W T 
samples also decreased in a similar manner. The number of cells in this category was 
amplified in the dermis after 14 days of culture at a time point where the culture flask 
was confluent, and in the absence of passaging, which would lead to increased cell 
death. 
5.1.2.2 Culture of FACS isolated GFP+ve and GFP-ve cells of the 
dermis 
The freshly isolated dermis from 2 mTert-GFP neonates aged 2 days old, 2 mTert-GFP 
neonates aged 3 days old and 2 mTert-GFP neonates aged 5 days with an equal number 
of W T littermates were sorted into three populations of cells: GFP+ve lineage-ve, G F P -
ve lineage-ve and a mixed, lineage-ve population. The mixed population represented 
dermal cells that were passed through flow cytometer with population sorting for 
lineage-ve cells only and therefore contained both GFP+ve and GFP-ve cells at the 
time of sampling. Passing all the cells through the flow cytometer allowed any 
differences between the three populations to not be attributed to the F A C S method. The 
freshly sorted cells were investigated in adherent culture to investigate adherent cell 
morphology, division and to compare to cultures of DP and DS cells. Cells were also 
investigated in suspension culture to investigate aggregation events or proliferation, and 
in hanging drop which encourages aggregation formation. 
Adherent and suspension culture 
Adherent cultures were set up for each of the three, freshly sorted, dermal populations 
from mTert-GFP and W T neonates aged 2 days old, 3 days old and 5 days old. 300 cells 
were plated into 16mm individual adherent culture dishes and observed for 2 weeks in 
vitro culture: 
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GFP+ve lineage-ve sorted population: On every occasion, approximately 2% of cells 
adhered with atypical fibroblastic morphology. These cells did not divide or increase in 
cell size once settled. 
GFP-ve lineage-ve sorted population: On every occasion, approximately 50% of cells 
adhered in culture with atypical fibroblast morphology comparable to the GFP+ve 
population. There was no evidence of substantive proliferation and the dishes did not 
increase in confluency within the 2 weeks of in vitro culture. 
Mixed, lineage-ve population: On every occasion, cells adhered in culture with atypical 
fibroblast morphology comparable to the GFP+ve and GFP-ve populations. The dishes 
were confluent within 1 week of in vitro culture. 
To determine if the sorted cells would aggregate in suspension culture, the sorts were 
repeated and the same groups of cells cultured in petri dishes. After approximately 2 
days the cells no longer appeared refractive, with the presence of a significant degree of 
cell debris, in all populations, none having aggregated. 
Hanging drop culture 
Adherent cultures were set up for each of the three, freshly sorted, dermal populations 
from mTert-GFP and W T neonates aged 2 days old, 3 days old and 5 days old. 300 cells 
were plated into 16mm individual adherent culture dishes and observed for 2 weeks in 
vitro culture: 
Individual hanging drops were set up for each of the three, freshly sorted, dermal 
populations from mTert-GFP and W T neonates aged 2 days old, 3 days old and 5 days 
old. Each cell aggregated contained 300 cells/10ul media; 5 hanging drops were set up 
per sort population for each neonatal age as described above. Hanging drops were 
allowed 5 days undisturbed in vitro culture. 
The cells did not aggregate in any of the hanging drops, including those of the mixed 
dermis. 
5.1.2.3 PCR analysis of FACS isolated dermal populations 
The freshly isolated cells analysed and collected by flow cytometry (as demonstrated in 
figures 5.11-5.13) were sorted into three populations as described above; these 
populations were GFP+ve lineage-ve, GFP-ve lineage-ve and mixed lineage-ve cells, at 
the three neonatal ages. In addition, the adherent cells from the 7 day (figure 5.14) and 
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14 day (figure 5.15) cultured dermis were also sorted into three populations. cDNA 
suitable for R T - P C R (method 2.6.1) and Q-PCR (method 2.6.2) was produced for each 
population, with triplicate samples, apart from the GFP+ve lineage-ve and GFP-ve 
lineage-ve populations of both the 7 day and 14 day in vitro cultured dermis, where 
there was insufficient RNA to produce RT-PCR quality cDNA. 
Figure 5.16 shows R T - P C R analysis of representative samples of the dermal cell 
populations. Included is GFP+ve, GFP-ve and mixed samples (denoted 'unsorted') from 
fresh sorts. Dermal cells from 2 day old, 3 day old and 5 day old neonates all displayed 
a similar gene expression profile; representative bands are shown in figure 5.16. There 
were insufficient cells for RNA amplification for the 7 day and 14 day cultured GFP+ve 
cells therefore only unsorted cells are shown in figure 5.16. 
The GFP+ve population contained all the detectable Tert expression from the mixed 
sample confirming the mTert-GFP model. This which allows properties associated with 
GFP expression to be linked to Tert expression. The GFP+ve population contained all 
the detectable stem cell associated gene expression; Oct4, Nanog and sox2 with c-myc 
expressed in GFP+ve and GFP-ve populations. Cardiomyocyte associated genes were 
also investigated, as previously described when investigating DP and DS cells (Chapter 
3, figures 3.12-3.14). The GFP+ve population of cells was not enriched for detectable 
expression of the cardiomyocyte associated genes. Examination of cardiomyocyte 
associated transcription factors in lineage-ve, dermal cells obtained by this method did 
not express detectable Nkx2.5, GATA4, or Mef2c. Tbx5 was enriched in the GFP-ve 
population. O f the cardiomyocyte associated functional genes troponin I was enriched 
in the GFP-ve cells. Tropoelastin was also enriched to the GFP-ve population. These 
dermal cells did not express detectable a-MHC, cardiac actin and titin. This suggests 
that the expression of the stem cell genes is uncoupled from the expression of the 
cardiomyocyte genes in the dermis. 
Q-PCR was completed on the GFP+ve, GFP-ve and unsorted populations for fresh, 1 
week culture and 2 week culture cells for mTert, Nanog and Sox2 expression to confirm 
the R T - P C R expression profile. These are shown in figure 5.17. 
The GFP+ve populations contained all the mTert, Nanog and Sox2 expression; a 
property maintained from fresh sort samples to 2 weeks in vitro culture samples. 
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Figure 5.16: R T - P C R gene expression profile of F A C S isolated dermal populations 














c - m y c 
GAPDH 
RT-PCR analysis o f mTert-GFP sorted populations for cardiomyocyte and stem cell 
associated genes. The GFP+ve cells contained all the detectable Tert expression which 
confirms the mTert-GFP mouse model. GFP+ve cells contained all the Oct4, Nanog and 
Sox2 detectable expression and was enriched for c-myc expression which was also 
detected in the GFP-ve cells. O f the cardiomyocyte associated genes, tbx5 appeared 
enriched to the GFP-ve population with no detectable expression o f Nkx2.5, Mef2c and 
GATA4. Tropomyosin was detectable in all dermal populations, with detectable 
troponin I and tropoelastin expression enriched in the GFP-ve cells. There was no 
detectable expression o f a-MHC, cardiac actin or ti t in. The gene expression profile for 
the mixed cells (denoted unsorted) appears to remain consistent over the periods o f 
culture investigated. Representative bands are shown. 
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Figure 5.17: Q - P C R gene expression profile of F A C S isolated dermal populations 
for stem cell-associated genes 
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Q-PCR gene expression analysis o f dermal cells freshly isolated, after 1 week culture 
and after 2 weeks culture, samples were then sorted. The graphs show fresh sorted 
samples (/) representative o f dermis from neonates aged day 2, 3 and 5 after 1 week 
cultured dermis (|7) and 2 week cultured dermis (Hi). Gene expression fold changes 
were significant for the fresh and 1 week sorted samples only (p<0.01) when the 
GFP+ve cells were compared to the unsorted samples (mixed population) from the 
same time point. The expression results were relative to GAPDH and normalised with 
respect to mixed (denoted unsorted) samples (mixed GFP+ve and GFP-ve cells). A no-
transcript control ensured detectable gene expression changes were not as a result o f the 
assays used. 
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In summary, GFP+ve cells were identified in the DP and DS adult vibrissae follicles by 
immunohistochemistry. In the smaller pelage follicles, anti-GFP labelling was 
identified in the end bulb. With dual labelling, GFP+ve CD45-ve and GFP+ve CD34-ve 
cells were identified in the dermis associated with the end bulb and the bulge region. 
GFP+ve lineage-ve cells were isolated by F A C S and were found to not adhere or 
proliferate in culture unless in contact with GFP-ve cells. The GFP+ve cells contained 
all detectable Tert expression, by Q-PCR and R T - P C R analysis, and this population was 
also enriched for the pluripotency-associated stem cell genes namely Oct4, Nanog and 
Sox2 demonstrating the mTert-GFP mouse model identifies cells with stem cell 
markers. This suggests that the mTert-GFP mouse model may provide a tool for the 
isolation of a similar stem cell population from the heart. 
5.2 Characterisation of GFP expression of the heart in the 
mTert-GFP mouse 
Having demonstrated a GFP-expressing population of dermal cells in this model that 
contained all the detectable Tert activity and which expressed a pattern of markers 
characteristic of embryonic stem cells, the heart was then examined to evaluate whether 
the mTert-GFP mouse could potentially be a model to identify native cardiac stem cells, 
Furthermore, comparison of selected gene expression between GFP-marked candidate 
stem cells from each of these tissues could aid in identification of molecular markers 
that could involved in cardiomyocyte differentiation. 
There is evidence for the presence of undifferentiated cells with stem cell properties 
within the adult heart (Beltrami et al., 2003; Matsuura et al., 2004; Laugwitz et al., 
2005). However, as outlined earlier, the characteristics, physiology and absolute 
numbers of these cells remains unclear. Some reports indicate that primitive cells with 
stem cell properties make up as much as 2% of all cells, whereas others studies suggest 
that this fraction is as low as 0.005-0.0125% (as reviewed by Anversa et al., 2006); 
differences potentially accounted for by the use of different markers for these cell types. 
One approach to overcome this is to use a marker system that is driven by the 
phenotype of stem cells; such a marker system could be mTert-driven expression of 
GFP. It has been also been suggested that to increase the number of cells with stem-like 
properties to a level more suitable for investigation, such cells types may need to be 
'activated', for example in response to disease or growth. In the heart, the use of 
models of acute injury has been used to investigate the 'activation" of candidate stem 
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cells (Urbanek et al., 2005). The utility of the mTert-GFP mouse in identifying 
candidate stem cells in the heart was thus investigated in both normal adults and in mice 
which received acute cryo-injury to the ventricle. 
5.2.1 Histological investigation of the mTert-GFP heart 
GFP expression in the heart was initially investigated by specific immunofluorescence 
and immunohistochemistry, as with the dermis. Age and sex matched hearts from 3 
mTert-GFP mice and 3 W T neonatal littermates as well as El4 .5 embryonic hearts from 
3 mTert-GFP embryos and 3 W T embryos from the same mating were investigated. 
Despite the examination of more than 30 sections from each individual mouse heart, no 
specific GFP expression was detected. However, given the well described problems 
with non-specific autofluorescence in the heart (Van de les et al., 1995), one 
explanation could be that such specific expression as there is could be masked by the 
background signal. An alternative approach was to examine GFP expression by flow 
cytometry, as proved successful for investigation of the dermis (section 5.1.2.1). 
5.2.2 Flow cytometric analysis of the heart 
Hearts from 3 mTert-GFP mice and 3 W T 3 day old littermates were used. Single cell 
suspensions were prepared from the neonatal hearts by enzyme dissociation according 
to Method section 2.13.1. The cell samples were analysed for viable cells (those that did 
not take up 7-AAD), that were lineage-ve and GFP+ve. A plot of one representative 
flow cytometric analysis is shown in figure 5.18. The number of viable, lineage-ve 
GFP+ve cells was 0.08 + 0.02% of the cells recovered by enzymatic digestion of the 
hearts; a percentage which was smaller than that of the dermal cells which ranged from 
0.17%-0.49% (figure 5.11- figure 5.13). A figure of 0.08 + 0.02% is comparable to 
other reports for candidate cardiac stem cells isolated by other methods as summarised 
in Chapter 1 figure 1.2. These other reports also indicated that the numbers of 
candidate cardiac stem cells increased following injury. In order to determine whether a 
similar population could be identified in the heart following injury, cryo-infarct was 
investigated. 
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Figure 5.18: Flow cytometric analysis of the neonatal heart of the mTert-GFP 
mouse for viable GFP+ve cells that are non-haematopoietic 
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Representative flow cytometric analysis of the neonatal heart for GFP+ve cells. Gating 
was set according to WT hearts (/) of matching neonatal age and sex to the mTert-GFP 
hearts (iV), Only cells negative for lineage cocktail were analysed to exclude any blood 
derived cells. Viability was determined using Pi. The number of viable GFP+ve, lineage 
negative cells is shown in the gating (A) as a percentage of the entire cardiac population 
sorted; for the mTert-GFP population this was 0.08%. 
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5.2.3 Investigation of GFP+ve cells of the myocardium in response 
to cryo-infarct 
Cryo-injury by trans-diaphragm cryoprobe application, which was cooled by liquid 
nitrogen (Method section 2.9), provides a highly reproducible model of anterior MI; the 
damaged myocardium undergoes modest adverse remodelling which is reported to be 
representative of infarcts encountered in clinical practice (Bos et ai, 2005). This model 
of cardiac injury was chosen as it may induce cardiac remodelling through stem cell 
activity and allowed investigation of a well defined area of injury surrounded by 
healthy myocardium. It was important to establish a reproducible injury and be able to 
investigate GFP+ve cells over a cryo-injury induced time course. Therefore a number of 
variables were considered as follows. 
5.2.3.1 Size of probe and placing of injury 
Legend 5.19/ shows the internal organs in-situ; the contact between the diaphragm and 
heart made possible application of the cryo-probe across the diaphragm by intra-
abdominal entry. The injury size was dependent upon the size of the probe. A number 
of probe sizes ranging from 1mm to 8mm were tested (data not shown); a 2 mm was 
small enough to pass through the abdominal incision but large enough to cause a 
notable injury which was well defined as shown in figure 5.19/7. It was possible to 
visualise the heart and lungs during insertion of the probe into the abdominal cavity, 
however this line of vision was blocked during probe application to the heart therefore 
alignment of the probe with the line of the sternum was essential; reproducible injury 
was confirmed by a pilot study of 3 WT mice. The injury was, on every occasion, close 
to the apex of the heart. 
5.2.3.2 Cryo-probe application time 
A 20s application of the cryoprobe (methods section 2.9) produced a reproducible 
injury as was confirmed by a pilot study on 3 WT mice. The cryo-injury was clearly 
apparent on the surface of the myocardium; this injury is shown in figure 5.19i7. 
Previous descriptions using similar cryoprobes also described the option of using two 
10s applications allowing the probe to be re-cooled for the second application. 
However, this was not suitable in creating a reproducible, defined injury as was 
determined by a pilot study on 2 WT mice. 
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Figure 5.19: Cryo-injury of heart as a model of cardiac infarct 
I. Cryo-probe application location 
A = Heart 
B = Diaphragm 
C = Direction of 
cryo-probe application 
D = Cryo-injury 
E = Lungs 
ii. ^ryo-iniu 
The adult mouse heart in-situ after cryo-probe application, i. Ventral view of chest 
cavity illustrating the position of probe application (C) and ii. demonstration of the 
physical damage to the heart after application across the diaphragm. The nitrogen 
dipped probe was applied to the heart (A) for 20 seconds, via intra-abdominal incision, 
across the diaphragm (B) made possible due to the close contact between the two. The 
site of cryo-probe application (D) was immediately starved of oxygen as shown by the 
white coloration. The injury site shown is representative of 5 tested mice, 0.5 days after 
application. 
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A double application resulted in two overlapping injuries due to not being able to 
visualise the first injury during the second probe application (data not shown). 
5.2.3.3 Diaphragm damage 
In all the mice there was injury to the diaphragm. However, the injury was not lethal; 
there were no apparent breathing difficulties in treated mice, when evaluated after 
surgery, nor were there any effects upon the myocardial injury. The diaphragm was 
intact on all mice, observed on post-mortem examination. 
5.2.3.4 Survival Rate 
Cryo-injury was not lethal to treated mice, there were no fatalities in the pilot studies 
described above, which consisted of a total of 5 mice, and in the experimental study, 
described below, which consisted of 24 mice. All mice were monitored daily for cage 
activity, breathing rate and general health which were within acceptable levels. No 
mouse was sacrificed early due to complications post-surgery; this indicated that 
although the damage to the heart was severe the cryo-injury was representative of a 
recoverable myocardial infarction. 
5.2.3.5 Cardiac cryo-injury 
The application of the cryo-probe caused damage to the myocardium as was apparent 
from the initial white pigmentation to the application site as demonstrated in figure 
5.19. In order to sample the myocardium at a time point when the majority of the 
remodelling occurs and when the stem cell population may be activated or recruited to 
the injury site, it was important to determine the time course for the repair of the tissue. 
The appearance of the injury was monitored over the 2 week experiment. 
5.2.3.6 Time course of the appearance of the cryo-injury site 
24 mice received induced cryo-injury and allowed a varying number of days recovery 
before sacrifice. Two groups were set up, the first a pilot study consisting of 2 WT mice 
sacrificed 24hrs post injury and 2 WT mice sacrificed at 3 days post infarct to monitor 
early recovery and ensure animal survival. There were 20 experimental mice consisting 
of 5 mTert-GFP mice with 5 WT mice sampled at 8 days post infarct as well as 5 
mTert-GFP mice with 5 WT mice sampled at 14 days post infarct; time points where 
the infarct appeared to be undergoing a significant change. 
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The hearts of the 2 WT mice analysed 24 hrs after injury demonstrated consistent 
inflammation at the injury with evidence of tissue granulation as shown in figure 5.20. 
At 3 days post-infarct, a degree of inflammation remained present and necrosis was 
apparent as shown in figure 5.21. 
The first 10 experimental mice (5 mTert-GFP mice and 5 WT mice) were sacrificed 8 
days post-infarct; a time point where inflammation was no longer apparent and necrosis 
was limited; the myocardial tissue appeared thinned as the blood within the ventricular 
chamber could be visualised as demonstrated in figure 5.22 This was indicative of a 
degree of remodelling and may have represented the initial increase in GFP+ve cells; as 
cells move to the infarct to aid tissue repair. 
The second time point was one week later at 14 days post-infarct. The myocardial cell 
wall appeared extremely thinned at this time point but with normal tissue pigmentation. 
As shown in figure 5.23 the wall is so thinned it appeared transparent; the ventricular 
chamber could be visualised through the infarct tissue. Legend 5.24 shows sections 
through the day 14 cryo-injured heart at the infarct site demonstrating full depth tissue 
damage. 
The day 8 and day 14 hearts were analysed by immunohistochemistry and 
immunofluorescence. 
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Figure 5.20: Excised cryo-injured heart 24 hrs post-infarct 
/. Cryo-injured heart 1 A= Uninjured ventricular tissue B = Atria 
C = Cryo-injury 
I D = Peri-infarct zone E = Granulation tissue F = Blood vessel infiltration 
ea o f cryo 
E 
Excised mouse heart 24 hrs post-infarct (/') showing cryo-injury (if). The area of cryo-
injury (C) showed evidence of granulation (E), capillary infiltration (F) and 
inflammation as indicated by its raised appearance. The peri-infarct zone (D) was 
apparent and well defined. This photograph is representative of 2 mice; the heart was 
removed 24hrs post-infarct and photographed in PBS. 
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Figure 5.21: Excised cryo-injured heart 3 days post-infarct 
A = Uninjured heart tissue 
B = Atria 
C = Cryo-injury 
D = Peri-infarct zone 
E= Blood vessel infiltration 
/*/. Area of cryo-injury 
\ 
D 
Excised mouse heart 3 days post-infarct (0 showing cryo-injury («). Granulation was 
not apparent however there remained a degree of inflammation and blood on the surface 
of the heart as well as capillary infiltration (E). The peri-infarct zone was less well 
defined (D). This photograph is representative of 2 mice, the heart was removed 3 days 
post-infarct and photographed in PBS. 
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Figure 5.22: Excised cryo-injured heart 8 days post-infarct 
U Cryo-injured heart 
A = Uninjured heart tissue 
B = Atria 
C = Cryo-injury 
D = Peri-infarct zone 
E = Blood vessel infiltration 
F = Blood collecting inside 
ventricular chamber 
Excised mouse heart 8 days post-infarct (i) showing cryo-injury (ii). Granulation was 
not apparent however there remained a degree of inflammation. The ventricle wall at 
the site of injury is thin and the ventricular blood can be seen collecting here (F); 
capillary infiltration remains (E). The peri-infarct zone is less well defined (D). This 
photograph is representative of 10 mice (five mTert-GFP and five WT) the heart was 
removed 8 days post-infarct and photographed in PBS. 
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Figure 5.23: Excised cryo-injured heart 14 days post-infarct 
A= Uninjured heart tissue 
B = Atria 
C = Cryo-injury 
D = Peri-infarct zone 
E = Blood vessel infiltration 
F = Thinned ventricular wall 
. Area of cryo-injury  f v -i j 
m 
Excised mouse heart 14 days post-infarct (i) showing cryo-injury (ii). The ventricular 
wall at the site of necrosis was extremely thinned; bubbles collected in the ventricle, on 
removal of the heart, which could be seen through the myocardium (F). Capillary 
infiltration remained (E) with the peri-infarct zone indistinguishable from normal tissue 




Figure 5.24: Section of a 14 day cryo-infarct demonstrating typical depth of tissue 
damage 
ryo-injured heart 
t _ _ 




Sectioned mouse heart, 14 days post-infarct; a selected section of the cryo-injured tissue 
demonstrating ful l depth tissue damage. This representative section shows the inner 
most part of the infarct; the necrotic tissue penetrated the myocardium (A) through to 
the ventricle (B) and tissue adjacent to the initial contact site (C). This photograph is 
representative of 5 mice, the heart removed 14hrs post-infarct. 
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5.2.3.7 GFP antibody labelling of the cryo-injured heart 
Following cryo-injury, each heart from the day 8 cryo-injury time point; 5 mTert-GFP 
mice and 5 WT littermates, and day 14 time point; 5 mTert-GFP mice and 5 WT 
littermates, were sectioned. GFP+ve cells were identified by immunohistochemical 
antibody labelling on both WT and mTert-GFP hearts. No GFP+ve cells were identified 
in the hearts from mice sacrificed 8 days after cryo-injury (data not shown). 
GFP+ve cells were consistently identified in the mTert-GFP hearts 14 days after cryo-
injury. One (figure 5.25) to two (figure 5.26) GFP+ve cells were identified in 
approximately every other 10pm section visualised; cells were associated with the cryo-
injury area of the heart in, or closely located with, the epicardium. This was the case for 
each of the 5 mTert-GFP hearts where in excess of 50 sections from each heart were 
sampled. 
On occasion there appeared two cells within one section; these cells were located within 
close proximity of one another in the epicardium or within the myocardium, as 
demonstrated in figure 5.27. There were no GFP+ve cells identified in the WT heart 
sections, 8 days or 14 days after cryo-injury, as demonstrated in a representative section 
in figure 5.25. 
To confirm the presence of cells that were identified as GFP+ve by 
immunohistochemical antibody labelling as well as to determine if the cells were of 
haematopoietic or endothelial lineage, the sections from the day 14 cryo-injury hearts 
were dual labelled for anti-GFP and anti-CD45 immunofluorescence. Representative 
GFP+ve cells are shown in figure 5.28. The cells were located in the epicardium, and 
correlated to nuclear Pi labelling and were CD45-ve. 
In summary, figure 5.26 and figure 5.27 demonstrate GFP+ve cells that by 
immunofluorescence, in figure 5.28, were CD45-ve. These cells were associated with 
the epicardium around the infarct zone; in no instance were cells identified within the 
cryo-injured tissue. All labelled cells were clearly distinct from the surrounding GFP-ve 
cells. The frequency of such cells were low at one-two per section and only observed in 
the 14 day post-injury hearts and not detectable in the day 8 samples. 
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Figure 5.25: Immunohistochemical staining for GFP cells in 14 day cryo-injured 
myocardium of the WT mouse 
WT heart 
Immunohistochemistry on WT adult heart, 14 days after cryo-injury, for anti-GFP 
labelling. The area of myocardium shown correlates to the epicardium close to the cryo-
injury zone where GFP+ve cells were identified in the mTert-GFP cryo-injured hearts. 
The WT hearts were removed from the mouse 14 days post-infarct; anti-GFP was 
detected using VIP (purple) and counter stained with methyl green (blue). This 
photograph is representative of 5 WT hearts with 50 sections analysed per heart, image 
shown at x40 magnification. 
192 
Figure 5.26: Immunohistochemical labelling for GFP cells in 14 day cryo-injured 





Anti-GFP antibody labelling detected by VIP (purple), counterstained with methyl 
green, from two separate hearts. 14 days after infarct, of the mTert-GFP mouse. The 
area of myocardium photographed is the epicardium close to the site of infarct showing 
representative GFP+ve cells. 
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Figure 5.27: Immunohistochemical labelling for GFP cells in the 14 day cryo-
injured heart of the mTert-GFP mouse 
t. mTert-GFP heart 
x40 
tt. mTert-GFP heart 
W4 
I k . 
V 
x40 
Anti-GFP antibody labelling detected by VIP, counterstained with methyl green, on two 
separate hearts, 14 days after infarct, of the mTert-GFP mouse. The area of myocardium 
photographed is the epicardium close to the site of infarct, showing two GFP+ve cells. 
Cells were commonly located in the epicardium (/.) and on rare occasions the cells 
appeared in the myocardium associated with the epicardium (//.) 
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Figure 5.28: Immunofluorescent labelling for GFP cells in the 14 day cryo-injured 
heart of the mTert-GFP mouse 




Hi. Pi-nuclei /v. Merge 
x40 x40 
Immunofluorescence labelling for anti-GFP in the heart of the mTert-GFP mouse, 14 
days after cryo-injury, with anti-CD45 co-labelling. The area of the myocardium, close 
to the cryo-injury, is shown where two GFP+ve cells (/) similar to those cells seen with 
immunohistochemistry (as shown in figure 5.27), were identified. These cells were 
CD45-ve as indicated by absence of AMCA fluorescence (ii). A higher magnification 
merge is shown over page. 
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v. Merge 
v/. Pi-nucleus vii. AMCA- CD45 
x 63 x 63 
viii. Merge 
x 63 
The higher magnification merge (v) shows the anti-GFP antibody labelling clearly in 
the epicardium associating with Pi+ve nuclei labelling. 
Figures vi-viii show a CD45+ve haematopoietic cell from the blood of the mTert-GFP 
mouse to demonstrate that the antibody could detect CD45 expression. 
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5.3 Chapter 5 Discussion 
The mTert-GFP mouse was used to determine if there was a population of dermal 
follicular cells that expressed Tert, which have stem cell properties. This model was 
also examined to see if these GFP +ve cells could also be identified in the heart during 
health and disease. 
In the first instance the mTert-GFP mouse was used to determine if there was a 
population of GFP expressing cell types in the dermis. Work described in Chapter 3 
indicated that there was expression of Tert transcripts in the follicular dermis, but that 
this R T - P C R approach could not provide an indication of the numbers of cells 
expressing this gene product in vivo. Histological analysis of the mTert-GFP mouse 
demonstrated expression of the reporter gene in approximately 1 in 10 of the follicles 
examined. Where expression was observed within a follicle, Tert was found in bulge 
region, DS and DP. In no cases was expression exclusive one of these three 
compartments. 
This data appears different that of Sarin et al., (2005), who used immunofluorescence to 
directly detect mTert in mouse hair follicles. In this study, mTert RNA was detectable 
in the bulge region, as demonstrated by co-expression with BrdU labelled cells, and the 
outer root sheath of the follicle, but no expression was detected in the DP. Furthermore, 
expression was not restricted to a sub-population of follicles, but was common to all 
structures examined. There are at least reasons for these differences. The first is that 
with the mTert-GFP transgenic mouse there were multiple copies of the mTert-GFP 
transgene, making GFP easier to detect. Sarin did note that their own data might reflect 
an inability to detect all the Tert expression, as they failed to detect Tert in follicles 
known to express it, such as the DP. Secondly, Sarin was looking at the back skin and 
not the vibrissae follicles. In this study, vibrissae were chosen here as they are allowed 
clear distinction of the DP and DS from surrounding hair follicle structures, however, 
the hair cycle pattern between these two types of follicle can be different (Lavker et al., 
1991). The follicles of the vibrissae may have been in different cycles to the back skin 
follicles as investigated by Sarin. Indeed, this study had no data suggesting that GFP 
expression in the hair follicle followed the hair cycle. 
The DP may have been activated in response to whisker loss, with the formation of new 
hair fibres (Reynolds and Jahoda 1991). During wound healing, the DS is particularly 
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active as DS cells are capable of regenerating the DP and of fibroblastic epidermal 
regeneration (Reynolds and Jahoda 2001). This may then account for the GFP 
expression in these compartments in some, but not all, follicles. 
In an attempt to capture follicles that were inducing hair growth, the embryonic 
vibrissae were investigated. There was no detectable GFP expression in the developing 
vibrissa follicles of El4 .5 embryos. The cells of the follicle, at this stage of 
development, have been reported to be actively involved in the formation of the follicle 
plugs and epidermal down growth (Davidson and Hardy 1952) which suggests these 
cells undergo significant proliferation, suggesting telomere length would need to be 
maintained, as well as differentiation to give rise to the adult hair follicle. However 
these cells may have been committed and therefore not require Tert activity. In 
addition, Human MSC have been reported to have no detectable telomerase even 
though these cells remain capable of differentiation into adipocytes, chondrocytes and 
osteoblasts (Zimmermann et at., 2003). Telomerase activity in haematopoietic cells is 
associated with self renewal potential when telomerase activity was assayed in H S C in 
different stages of differentiation including lineage-committed progenitors and mature 
myeloid and lymphoid cells. The frequency of telomerase-expressing cells appeared to 
correlate with the frequency of cells with self-renewal potential (Morrison et al„ 1996). 
If these stem cells are quiescent in the embryonic vibrissa at this embryonic age, where 
subsequent follicle formation results from differentiation and division of progenitor 
cells, then the actively dividing cells would not require telomere length maintenance if 
they are differentiating down a committed cell lineage, therefore not involved in self 
renewal. These cells would not be identified as GFP+ve with the mTert-GFP mouse as 
they would not be maintaining their telomere length as has been described with the 
M S C and H S C above. The mTert-GFP mouse model may therefore indicate stem cells 
involved in self-renewal, which require longer telomeres. If this were the case, then in a 
highly active tissue the number of cells involved in self-renewal would be limited, as 
the stem cells have already produced cells that are more differentiated and lineage 
committed and these cells then divide to give rise to the specialised follicle components. 
Once the tissue has reached its proliferative capacity, the stem cells are more involved 
in self renewal and entering senescence. In addition, Tert has demonstrated a role in the 
skin that is independent of telomerase and is involved with hair growth (Sarin et ai, 
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2005) therefore it may be detectable when the hair is actively growing and not during 
embryonic follicle formation. 
GFP expression was investigated in the neonatal back skin to attempt to identify cycling 
follicles which would be involved in stem cell mobilisation and new hair growth (Flores 
et al., 2005; Choi et al., 2008). A number of GFP+ve cells were identified in the 
follicular dermis; these cells were CD45-ve and CD34-ve indicating they are not 
derived from the haematopoietic lineage (Holyoake and Alcorn 1994; Trowbridge and 
Thomas 1994). 
GFP+ve cells were associated with two areas of the dermis; the first was the dermis 
surrounding the follicular end bulb and the second was the inter-follicular dermis where 
cells were located higher up the follicle, nearer the bulge region. The anti-GFP labelling 
of cells located in the dermis, associated with the end bulb as demonstrated in figure 
5.9, did not correlate with the region of the DP structure in the end bulb as would be 
seen in a mature anagen hair follicle. There was not co-labelling of anti-GFP with the 
dense nuclei of the discrete hair follicle components. However, their consistent 
appearance in the vicinity of the end bulb suggests that their association with this 
structure is related to the E B components. 
Using the staging as described by Paus et al.,, the follicles photographed show different 
stages of developmental growth as would be expected in neonatal skin, where the hair is 
emerging through the skin for the first time. The staging of the follicles may correlate 
the GFP+ve cells with specific developing dermal compartments. There are 8 stages of 
hair follicle development from stage 0; an accumulation of nuclei termed the pre-germ 
stage, through to stage 8; a maximal length, mature anagen hair (Paus et al., 1999). 10% 
of hair follicles are in stage 8 by day 3 post partum (p.p.), 35% in stage 8 by day 5 p.p. 
and 100% at stage 8 by day 9 p.p.. The skin isolated here was from 5 day old neonates, 
however, as Paus suggests, the hair follicles would be in a variety of stages with only 
35% at full anagen. The follicles, shown here in association with GFP+ve cells, are of 
three different stages; stages 3-6 which are normally associated with the majority of 
hair follicles in neonates aged 2-4 days respectively; this may indicate why limited 
numbers of GFP+ve cells were identified in the 5 day old neonatal dermis by 
immunofluorescence which is also supportive of the concept of the stem cells to be 
entering senescence after self-renewal involved with earlier stages. 
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The first representative follicle, as demonstrated by figure 5.9, was stage 4 which 
normally correlate to follicles in neonates aged 3 days old. This type of follicle is a 
solid, elongated column of epithelial cells, consisting of multiple layers of keratinocytes 
concentrically arranged around the follicular axis; the hair peg is enlarged with a 
concave proximal end where dermal fibroblasts form the rounded, oval DP which is 
partially embedded in the concave end of the hair plug where the hair matrix is 
enclosing the DP by 50% (Paus et al., 1999). The GFP+ve labelling, as shown in figure 
5.9, was directly below the follicle associated with the region of either the remaining 
exposed DP or the hair matrix. 
Figure 5.8 shows a follicle at stage 5 which normally correlate to follicles in neonates 
aged 3-4 days old. This is the advanced hair cone stage or bulbous peg, has elongation 
of the inner root sheath and an enlarged future bulge region, the DP is enclosed by the 
hair matrix and the hair canal has started to develop (Paus et al., 1999). The GFP+ve 
labelling associated with follicles of this stage, as shown in figure 5.8, were situated in 
the developing future bulge region. 
Figures 5.6 and 5.10 both show follicles at stage 6 which normally correlate to follicles 
in neonates aged 4 days old. This is the hair formation stage; the hair follicle end bulb is 
located in the subcutaneous layer of the skin where the DP is thicker and more 
elongated. The hair follicle is at a 40° angle to the epidermis with the inner root sheath 
extended to contain the hair shaft (Paus et al., 1999). Most notable at this stage is the 
elongation of the hair shaft; the GFP+ve cells associated with these stages were deeper 
in the dermis most likely due to the movement of the follicle into the subcutaneous 
layer as the inner root sheath extends. 
In summary, the GFP+ve cells associated with early stage follicles were located with 
the region of the developing DP. When the GFP+ve cells were associated with the later 
stage follicles, they were located in the area of the developing bulge region. This 
suggests that GFP expression was associated with DP development and in bulge region 
development or maintenance. 
F A C S analysis allowed isolation of the dermal-derived GFP+ve cells from a range of 
neonatal ages associated with i) initial hair appearance (day 2 neonates) ii) appearance 
of secondary hair follicle formation (day 3 neonates) and iii) with hairy skin (day 5 
neonates). There was a consistent GFP+ve population present in the dermis which was 
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relatively low; the percentage of cells isolated did not reflect a proliferative population 
of cells; if this was the case the number of GFP+ve cells would be expected to be 
higher. The percentage of GFP+ve cells isolated, that were haematopoietic lineage-ve, 
were similar for the day 2 and day 5 neonates at 0.17% and 0.18% respectively with a 
higher percentage of 0.49% for the day 3 neonatal dermis which may correlate with the 
time of secondary follicle formation (Davidson and Harvey 1952). 
When the mTert-GFP mouse was being initially investigated it was noted that the 
majority of spermatogonial stem cells lining the basement membrane and elongating 
spermatids in the innermost region of the tubule did not express GFP, suggesting that 
the quiescent cells were not identified with this mouse model (Breault et al., 2008). 
This in turn, suggests that the percentage of dermal cells labelled here was consistent 
with the observation of Breault i.e. a population of cells re-entering quiescence. 
Recently, Crigler et al., reported the presence of a mesenchymal population resident in 
neonatal murine dermis which could be repeatedly isolated by a sequence of differential 
centrifugation and selective culture conditions. These cells had potential to develop an 
epidermis in vitro; in monolayer culture the cells had long-term survival capabilities in 
restricted serum and an inducible capacity to produce multiple cell lineages, both 
epithelial and mesenchymal, depending on culture conditions (Crigler et al., 2007). The 
group identified two sub-populations in the dermis which they assigned as fraction D 
and E ; these cells made up 0.4% and 0.7% of the dermis respectively with about 45% of 
these cells being CD34+ve; therefore 0.22% fraction D and 0.39% fraction E were 
CD34-ve, both of which are comparable percentages with the dermal fractions isolated 
by Tert-associated GFP expression. These cells had low labelling for keratin 15, 
associated with the bulge region, with less than 10% of fraction E labelling for c-kit 
which has also been associated with the bulge region. When these fractions were mixed 
with a crude epidermal population of interfollicular basal cells, which did not survive in 
culture when alone; fraction E formed viable monolayers in culture where fraction D 
did not. This is suggestive of fraction E containing epidermal precursors (Crigler et al., 
2007). When fraction D was implanted s.c. (sub-cutaneous) in the skin of immune-
deficient mice, they formed a vascularised fibrotic mass, previously identified as 
precursors to the formation of follicular buds and then pegs (Zheng et al., 2005). 
Fraction E , which expressed the bulge marker keratin 17, integrated with the host 
muscle on s.c. injection into the skin, as described above. Both fractions gave rise to 
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fusiform structures, reminiscent of disorganized muscle, which stained positive for 
smooth muscle actin and desmin. Interestingly, the GFP+ve cells isolated from the 
mTert-GFP mice did not adhere or aggregate in culture when in isolation in both 
hanging drop, suspension and adherent culture which is similar to the fractions isolated 
by Crigler, potentially indicating an overlap of cell populations. The two fractions 
identified by Crigler may correlate with the two different locations of the GFP+ve cells 
in the dermis i.e. fraction D with the end bulb and fraction E with the bulge region. 
The lineage-ve dermal cells were cultured a week and two weeks, using 3 day old 
neonatal dermis; these cultures therefore contained GFP+ve and GFP-ve cells on 
seeding. The percentage of GFP+ve cells in freshly isolated day 3 neonatal skin was 
0.49% which dropped to 0.30% after 1 week culture and furthermore to 0.13% after 2 
weeks. It was not possible to determine if the cells identified as GFP+ve before culture 
were the same cells after 1 week and 2 week culture, however, these percentages were 
within with the range previously identified with freshly isolated dermis. If there were a 
percentage of cells in culture that were stem cell-like in their proliferative properties, as 
indicated by pulse chase experiments in chapter 3, the number of these cells would be 
small and would give rise to a number of more differentiated progeny. Interestingly, as 
demonstrated by figure 3.6 in chapter 3, there were population of DP and DS cells 
which constituted 0.4% and 1.0% of the original population put into culture, 
respectively, that demonstrated the most cell divisions. It would be interesting to 
ascertain if these cells from the DP and DS were comparable to the GFP+ve cells 
isolated from the 1 week and 2 week dermal cultures. 
The GFP+ve and the GFP-ve cells did not adhere well or divide in adherent culture 
when they were separated from one another. When cultured together, with lineage+ve 
cells removed, the cells had fibroblastic appearance in adherent culture and increased in 
confluency indicative of cell division. This suggests the cells assigned GFP+ve status 
require cell-to-cell contact and communication with the GFP-ve cells necessary for 
adherence and propagation of the dermal population; a property observed with the 
maintenance of a number of pluripotent stem cells. There are a number of cells that 
require a feeder layer in order to settle and proliferate including mouse embryonic 
fibroblasts (MEF) for human embryonic stem cells (hESC) (reviewed by Skottman and 
Hovatta 2006) and, for example, umbilical cord blood derived M S C as a feeder layer 
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for umbilical cord derived committed haematopoietic progenitor cells (Jang et al., 
2006). 
R T - P C R analysis of the isolated populations demonstrated all the detectable Tert 
expression in the GFP+ve cells; the in vitro culture results therefore indicate that the 
dermal cells expressing Tert required cell contact with the Tert-ve cells in order for the 
population as a whole to proliferate. The GFP+ve cells also contained all the detectable 
expression of the stem cell associated genes investigated i.e. Oct4, Nanog and Sox2 
which are expressed by pluripotent embryonic stem cells. Q-PCR confirmed that the 
Nanog, Oct4 and Sox2 expression was only detectable in the GFP+ve dermal cells; 
expression of which was maintained even after 2 weeks culture suggestive of the 
maintenance of a stem-cell like population identifiable by Tert expression. These genes 
have not previously been associated with the dermis and their presence here in the 
Tert+ve dermal fraction may indicate their stem cell abilities and differentiation 
potential. 
The majority of the cardiomyocyte-associated genes were not detectable in the dermis. 
Of the cardiomyocyte inductive genes these included Nkx2.5 and GATA4, as was 
undetectable in the DP and DS populations (Chapter 3, figure 3.12). Mef2c was not 
detectable in the GFP+ve, GFP-ve or unsorted cells' suggesting that previous Mef2c 
detection was attributed to the DP and DS. Tbx5, which was previously undetected in 
the DP and DS primary cells, was enriched in the GFP-ve population suggesting the 
cells responsible for this expression are derived from the interfollicular dermis. Of the 
cardiomyocyte functional genes, tropomyosin was expressed in both GFP fractions as 
was detected in the DP and DS cells. a-MHC, cardiac actin and titin were not detectable 
in either GFP+ve or GFP-ve fractions; these genes were undetectable in cultured DP 
and DS (Chapter 3, figure 3.13). The dermis had detectable expression of troponin I and 
tropoelastin in the GFP-ve fractions; elastin highly likely to be associated with the 
elasticity of the skin which is well described (Mithieux and Weiss 2005). 
The general presence or absence of genes in the freshly isolated cells correlated with the 
1 week and 2 week populations indicating although the cells in culture alter their 
expression levels of Tert there remains a consistent population of cells expressing a 
fraction of the genes investigated suggesting these cells as a population are maintained 
in culture. 
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The heart is now considered to contain a population of cardiac stem cells, although the 
markers used for the identification of these cells remains somewhat controversial. The 
identification of these cells has previously required a combination of cell surface 
markers and demonstration of functional capabilities. However, there is no consensus 
on the surface markers to identify a definitive single cardiac stem cell and the molecular 
mechanisms regulating their growth. Expression of Tert may allow the identification of 
a population of cells enriched for cardiac stem cells. 
Flow cytometric analysis of the Tert+ve cells of the heart identified a very low 
percentage of cells, 0.08%, a percentage consistent with previous reported numbers. A 
recent investigation isolated cells by a single-cell clonogenic technique to analyse 
proliferative clonal cell populations from the heart (Tateishi et al, 2007). They set up 
9541 single cells of which 11 produced clones within 7 days; however only 3 grew in 
serum-free media. These 3 clones had significantly elevated telomerase activity and 
formed spherical clusters; interestingly these cells expressed Nanog and Sox2. The 
clonal cells constituted 0.03% of the cardiac cells which is similar to the percentage of 
cells identified by GFP expression here. In addition, Tateishi also produced an mTert-
GFP mouse and F A C S analysed Tert+ve cells. They identified the number of cells 
Tert+ve to be 0.9%+0.2%. Tateishi demonstrated the percentage of cells sca-l-ve (a 
component of the lineage cocktail used here to identify lineage negative cells) which 
was also Tert+ve to be 0.17%. The Tert+ve cells as shown in figure 5.18, constituted 
0.08% of the lineage-ve cardiac cells. Considering a number of other markers were also 
used to identify lineage-ve cells in this study, which were not included in the work of 
Tateishi, the population identified here may overlap with the cells identified by Tateishi 
et al, being in that 0.17%. Tateishi commented that within this 0.17% of cells there 
were cells which were CD45+ve and CD45-ve; a surface marker included in the lineage 
cocktail used here. Tateishi reported sca-1 expression in the majority of intrinsic cardiac 
stem cells in the adult heart which have the characteristics of ES-like and 
mesenchymal-like cells, and that sca-1 expression may play a role in cardiac stem cell 
maintenance and function. The lineage cocktail used here excluded sca-l+ve cells from 
the population, therefore, because the number of Tert+ve, lineage-ve cells identified in 
the heart was so low and to not exclude the possibility of sca-1 being an essential factor 
in the cardiac stem cells, the regenerative heart was investigated by histological 
analysis. 
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A cryo-induced injury is a representative model of a myocardial infarction (Van den 
Bos et al., 2005). The injury to the myocardium was consistent with previous reports of 
cryo-induced myocardial infarctions with extensive areas of coagulation necrosis with 
haemorrhage at the centre of the infarct as observed in figure 5.20 and 5.21. There was 
dense inflammatory infiltrate as observed in fissure 5.20 with granulation tissue (Van 
den Bos et al., 2005). Figure 5.24 showed apparent complete loss of cardiomyocytes of 
normal morphology in the infarct area as reported by Leferovich (Leferovich et al., 
2001) with the appearance of cardiomyocyte remnants (Vandervelde et al., 2006). 
GFP+ve cells, as indicated by immunohistochemistry and confirmed by 
immunofluorescence, were only detectable at day 14. These cells appeared 
morphologically distinct from the cardiomyocytes; they had a small, rounded 
appearance. GFP+ve cells were not observed in the hearts 8 days after infarct, but were 
present at day 14. At that stage the inflammatory cell infiltration is significantly reduced 
compared to earlier time points; there is reduced macrophage and T-lymphocyte density 
at the infarct area (Vandervelde et al., 2006) which is overtaken by regeneration with 
the appearance of cells with stem cell properties as the scar is produced and a degree of 
cardiomyocyte infiltration. 
The GFP+ve cells were mostly associated with the epicardium (figures 5.26); in cases 
when the cells were not in the epicardium they were very closely associated with it 
(figure 5.27) suggesting the GFP+ve cells may be related to the epicardium and its stem 
cells. 
The epicardium is the outermost cardiac epithelial layer that covers the surface of the 
adult vertebrate heart; it is a single-layered flat mesothelium connected to the 
myocardium and is in contact with the fluid of the pericardial cavity (reviewed by 
Wessels and Perez-Pomares 2004). Between the myocardium and the epicardium lies 
the subepicardium, where mesenchymal cells that are epicardium-derived can be found. 
In the mouse at E9.5, there are three cell types in the heart: the cardiomyocytes, the 
endocardial epithelium and the subendocardial mesenchyme which at this stage is 
acellular; at this point of development a new layer of epithelial cells starts to populate 
the myocardial surface of the heart. These cells are derived from the endocardial 
epithelium and they generate the subepicardium as they form the epicardial sheet. 
Therefore the developing epicardium is often considered to be an extra-cardiac cell 
population as is the case with the cardiac neural crest cells (Wessels and Perez-Pomares 
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2004). A subset of these epicardial precursor cells also migrate into the myocardium 
and subsequently differentiate (demonstrated in vitro as well as in vivo) into a variety of 
cell types, including coronary endothelium, coronary smooth muscle cells, and blood 
progenitors, as well as being capable of differentiating into cardiomyocytes (reviewed 
by Wessels and Perez-Pomares 2004). There is also evidence that these cells are 
precursors to the cardiac fibroblasts (Gittenberger-de Groot et al., 1998) however their 
role during postnatal life has not been elucidated. A number of these cells also remain 
in an undifferentiated state, raising the question of whether these cells may be a cardiac 
stem cell population. It has been proposed that these cells remain in position as an 
embryonic fibroblast population with a role in normal development and specifically in 
the formation of the fibrous cardiac skeleton. Under pathological conditions, these cells 
could be involved in the development of abundant fibroelastic tissue that cannot be 
explained simply as ischemic fibrous scar tissue (Gittenberger-de Groot et al., 1998). It 
has been hypothesised that adult human epicardial cells could recapitulate part of their 
embryonic program when transplanted into diseased myocardium where they are 
capable of modifying the surrounding myocardium; epicardial cells transplanted into 
ischemic murine myocardium preserved cardiac function and attenuated ventricular 
remodelling (Winter et al., 2007) indicating they may play a role in the infarcted heart. 
In summary, there were populations of GFP+ve cells in the dermis, which correlate to 
Tert-expressing cells, as well as in the heart. Both cell types appear to be indicative of 
stem cell-like populations of cells which are limited in their number. The mTert-GFP 
mouse model was investigated in its ability to be a better model for the isolation of 
dermal derived cells with differentiation potential and it will be interesting to further 
assess the cells isolated here in comparison to the manually dissected DP and DS as 
proposed in Chapter 4. For the DP, DS or the GFP+ve population from the dermis to 
differentiate to cardiomyocyte-like cells and be used therapeutically, they would most 
likely need to express a gene profile similar to that of the cardiac stem cell population. 
Therefore, using the mTert-GFP mouse as a tool to isolate a stem cell population from 
the heart, although speculative, may allow more understanding of this specialised cell 
population and subsequently determine the best route of differentiation of the dermal 




The end bulb, representative of the DP and DS cells combined, demonstrated 
spontaneous synchronised contractions in vitro, suggestive of cardiomyocyte 
differentiation. The DP and DS, after co-culture in vitro with embryonic 
cardiomyocytes, demonstrated differentiation towards a cardiomyocyte lineage but the 
levels of gene expression were very modest. The results were suggestive of the 
presence of a small population of cells in dermis which may have high potency for 
differentiation and stem cell activity. 
Cells of the DP and DS demonstrated a number of stem cell properties as described in 
chapter 3. In vitro both cell populations maintained their morphology, proliferative rate 
and characteristic gene expression over a number of passages. The presence of 
multipotent cells in the interfollicular dermis has previously been demonstrated in the 
work of Jahoda; the DP and DS were shown to be capable of differentiation towards 
adipocytic and osteocytic lineages (Jahoda et al., 2003A). In addition, ongoing studies 
are investigating the potential of the DP and DS primary cells to populate the embryo 
with blastocyst injections (personal communication with Prof. Jahoda). The bulge 
region of the hair follicle has also demonstrated to give rise to all the epithelial cell 
types of the lower follicle, the epidermis during wound healing as well as cell types 
from lineages unrelated to the hair follicle such as Schwann cells and neurons 
(reviewed by Cotsarelis 2006). Other tissues have also demonstrated multipotency for 
example the bone marrow M S C which have demonstrated differentiation potential to 
osteogenic, adipogenic, chondrogenic and myogenic lineages and potentially neural 
cells also (reviewed by Jackson et al., 2007). Therefore, it is not surprising that if the 
dermal cells represent a population of cells with stem cell properties, as other tissue 
have, that they would be able to give rise to a number of lineages. In addition, a number 
of these cell types have also demonstrated cardiomyocytic differentiation potential as 
discussed in Chapter 1, such as MSC (for example Toma et al., 2002) and H S C (for 
example Kajstura et al., 2005). 
Although a number of stem cell types demonstrate in vitro and in vivo differentiation to 
cardiomyocytes, there is little evidence that exogenous stem cells contribute to the 
heart. A recent study demonstrated that after transplantation of GFP+ve bone marrow 
cells into a c-kit mutant mouse; these cells were subsequently found to reside in the 
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bone marrow as expected. After induction of myocardial infarction, there was a 
dramatic increase in the number of c-kit+ve cells in the heart of which the majority were 
GFP+ve. Although this argues that bone marrow-derived cells have the capacity to 
home to the heart, where they express c-kit, the study does not determine whether these 
bone marrow-derived cells typically reside in the normal heart or whether they were 
recruited only in response to injury (Fazel et al., 2006). In addition, in sex mismatched 
cardiac transplants in humans, the female hearts in male hosts had a significant number 
of Y chromosome-positive myocytes and coronary vessels (Quaini et al., 2002) 
suggesting male cells colonized the female heart after transplantation; cells of both 
donor and recipient origin were found to express c-kit, as well as sca-1, however the 
possibility of fusion was not entirely investigated which may indicate these cells grafted 
but did not differentiate to cardiomyocytes. In vitro animal experiments, whereby cells 
are introduced to the heart by injection directly into the MI heart or into a blood vessel 
after MI, have demonstrated the presence of cells in the myocardium that are donor 
derived as discussed throughout Chapter 1. These grafted cells have demonstrated 
cardiomyocyte properties including gene expression changes, gap junctions with native 
cardiomyocytes and contractions however not all of these studies have investigated 
fusion events with native cardiomyocytes. A number of clinical trials cite functional 
improvement in patients receiving donor cells. However, the degree of functional 
improvement is very modest, 3-5% significant improvement in ejection fraction versus 
controls is typically the range reported (Assmus et al., 2006; Lunde et al., 2006; 
Schachinger et al., 2006). In addition, this range is not proportional to the number of 
cells administered, which is on average approximately l x l O 6 cells, in relation to the 
number of cells in the heart. It raises the question of whether the functional 
improvement is as a result of donor cell integration and differentiation or whether the 
mere presence of the cells induced a paracrine effect irrespective of donor cell type or 
grafting efficiency. In these clinical trials, when there was functional improvement, the 
control for the transplanted cell is normally PBS/saline i.e. the vehicle for the donor 
cells. Should the control be a cell type for example fibroblasts or a population of the 
donor cells that have been irradiated, rendering them unable divide, then the functional 
improvement, if any, may then be able to be attributed to the donor cell type. In 
addition, receptors for granulocyte colony-stimulating factor (G-CSF) , a hematopoietic 
cytokine which induces the mobilization of hematopoietic stem cells and endothelial 
progenitor cells from bone marrow into the peripheral blood circulation, have been 
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identified on cardiomyocytes. G - C S F has been shown to prevent left ventricular 
remodelling and dysfunction after acute MI as well as induce angiogenesis (Takano et 
al., 2006). Therefore functional improvement could be as a result of the cardio-
protective action of G - C S F on the receptors of the viable cardiomyocytes after MI and 
not cellular differentiation of donor cells. 
The evidence of cardiomyocyte differentiation potential of the dermal follicular cells 
suggests the presence of stem cells in the DP and DS population. On potential reason is 
that these are cells that remain in the hair follicle after embryogenesis. The DP and DS 
play a role in hair follicle morphogenesis and wound healing (Jahoda et al., 2001 A; 
Jahoda et al., 2001B). As has been suggested by Jahoda, the dermal cells are considered 
to be embryonic type cells which are retained in an adult system rather than specialised 
adult stem cells. The embryonic-like properties of the hair follicle dermal cells derive 
from the fact that they segregate from intrafollicular dermis relatively early on in 
follicle development at which point they assume characteristic morphological and 
molecular phenotypes distinct from the interfollicular dermis (Jahoda et al., 2002). 
There are suggestions that stem cells from other tissues may be cells left from 
embryogenesis, including cells from the heart. A number of studies into cardiac stem 
cells have identified putative stem cells that express a number of genes associated with 
embryogenesis including Isll (Cai et al., 2003), GATA4, Nkx2.5 and Mef2 (Beltrami et 
al., 2003). 
There are no reported cases of skin spontaneously differentiating to cardiomyocytes 
therefore the ability of the hair follicle DP and DS to demonstrate differentiation to a 
cardiomyocytic lineage is most likely physiologically irrelevant to the skin and the 
follicular dermis. 
The heart has been reported to contain a population of endogenous stem cells, identified 
by a variety of marker combinations not always consistent from one group to another. 
These markers include c-kit, sca-1, Abcg2, Isll as well as a number of functional tests 
including cardiosphere formation and side population properties including Hoechst dye 
efflux, these are discussed individually in Chapter 1. In addition, a number of these cell 
surface markers have been identified in cells collecting in niches in the myocardium. 
There is evidence the heart has degree of cellular maintenance, as demonstrated by the 
presence of a small number of cycling myocardial cells (Soonpaa and Field 1998; 
Kajstura et al., 1998; Beltrami et al., 2001). However, the role of the stem cell in the 
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heart is still not entirely understood. There is little evidence of these cells, in response 
to injury, contributing to myocardial repair and people remain to die of MI and heart 
disease indicating a putative cardiac stem cell population is not able to cope with 
cardiac insult of this magnitude. Understanding potential cardiac stem cells that may be 
functional in MI, or being able to identify prospective stem cells that can be recruited or 
activated to respond to MI, would further out understanding of the heart and lead to new 
avenues of treatment. 
The mTert-GFP mouse is a prospective candidate for identification of proliferating stem 
cell populations by telomerase and, in tracking them thorough homeostasis and in 
response to injury, could be used to elucidate the role and potential for the putative 
cardiac stem cell as well as stem cells form a number of tissues. It is proposed as a 
model to be used in parallel with, or as an alternative to, complex cell surface antigen 
detection. This study describes the isolation of distinct dermal and cardiac-derived cell 
populations using the mTert-GFP mouse model. 
There is evidence this mouse model identifies, by GFP expression, cells with stem-cell 
associated functional properties. Published analysis of the mTert-GFP mouse has shown 
that GFP+ve cells were enriched among bone-marrow derived HSC; telomerase 
expressing GFP+ve cells have also demonstrated long-term, serial, multi-lineage bone 
marrow reconstitution (Breault et al., 2008). In addition, when the cells identified in the 
intestinal crypts are isolated and injected into blastocysts, they are found to give rise to 
the intestine of the embryo suggesting that the cells identified by Tert were stem cells of 
the intestine (personal communication). This study describes Tert+ve cells isolated 
from the dermis which contain all the detectable Oct4, Nanog and Sox2 expression. 
Tert+ve cells were also identified in the cryo-injury, concentrated close to the resultant 
infarct. 
Tert, expressed in stem cells and in progenitor cells, serves to maintain telomere 
function through the de novo addition of telomere repeats to chromosome ends. 
However, Tert has also demonstrated a role, independent of the telomerase RNA 
component, in the mouse skin epithelium where, when over-expressed, it caused rapid 
transition of hairs from telogen to anagen. Tert over-expression promoted this transition 
by causing proliferation of multipotent stem cells in the hair follicle bulge region. This 
new function was reported to operate through a mechanism independent of its activity 
in synthesizing telomere repeats, but instead by promoting proliferation of resting 
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multipotent stem cells in the hair follicle bulge region (Sarin et al., 2005). It is therefore 
a marker for functional stem cells as well as having a role in proliferating cells, making 
it a potential marker for stem cell investigation in many tissues including the skin and 
heart. 
6.1 Future Experiments 
There are a number of experiments that would not only build upon the results described 
here but would provide new avenues of investigation for cells of both dermal and 
cardiac lineage. 
The GFP+ve dermal cells would be a candidate for differentiation experiments. 
Investigating the cardiomyocytic potential of the GFP+ve cells in comparison to the DP 
and DS would be useful in determining if the dermal follicular cells are stem cell-like in 
their potency. The potential of the GFP+ve cells to other lineages, as has been described 
with dermal cells, to determine if these cells are multipotent. GFP+ve cells were 
identified in the heart although at very low levels. F A C S analysis of these cells, namely 
into their expression of sea-1, c-kit, isl 1 and abcg2 would allow them to be compared to 
previously identified potential cardiac stem cell populations. 
Labelling the GFP+ve cells as well as DP and DS cells would allow them to be tracked 
in a number of in vivo experiments. One option would be to cross the mTert-GFP 
mouse with a Zin40 mouse; GFP+ve cells from any tissue of this mouse, once injected 
into a W T mouse, could be identified by lacZ expression. An alternative would be to 
produce a new m T E R T - G F P mouse model with a tamoxifen inducible cre-lox system. 
On administration of tamoxifen the cells expressing Tert, as well as their progeny, 
would be identifiable by P-galactosidase expression. 
Using these transgenic mice, a number of tracking experiments would be possible. For 
the skin, injecting the GFP+ve cells from the dermis into wounds and non-hairy skin to 
determine if they have proliferative properties, demonstrate multipotent differentiation 
and are inductive. Tamoxifen could be administered by injection to the skin at the time 
points investigated here, namely embryonic, neonatal and adult ages, where the hair 
follicle is developing. The dermis would be sampled after varying periods of time 
(pulse chase) to determine which structures the Tert+ve cells give rise to. Tamoxifen 
could be administered to the skin shortly after injury and the skin allowed a period of 
time to heal to determine if the Tert+ve cells identified here contribute to wound 
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healing in a similar manner to bulge cells. Plucking of the hairs would induce new hair 
growth, a different mechanism to wound healing, where tracking Tert+ve cells by cre-
recombinase expression throughout the formation of new hair growth would indicate if 
these cells are involved in hair morphogenesis in a similar manner to the DP and DS. 
Monitoring the Tert+ve cells through normal hair cycling by administering tamoxifen to 
the back skin and allowing the cells a longer period of time before sampling sections of 
the skin may indicate changes in the cells that coordinate with the cycling events. 
If the GFP+ve cells are pluripotent as their gene expression profile suggests then they 
should be capable of giving rise to all of the cells of the body. GFP+ve cells isolated 
from a Zin40/mTert-GFP mouse could be injected into the blastocyst and the resultant 
embryos investigated for lacZ expression. If the GFP+ve cells are pluripotent they 
should give rise to cells of the three germ layers. In comparison, it would also be 
interesting to determine if embryos could be produced from injection of labelled DP 
and DS cells into the blastocyst GFP+ve cells from the heart and skin could be injected 
to determine if they give rise to the heart and skin, respectively, of the embryo in a 
similar manner to the intestinal stem cells. 
Tracking of the cells identified as GFP+ve in the cryo-injury model would help our 
understanding of their role in injury as well as the resting heart. If the GFP+ve cells 
could be labelled as describe above i.e. with tamoxifen inducible cre-recombinase then 
these cells and more importantly their progeny could be tracked in the heart. Tert+ve 
cells labelled during early neonatal life when the heart has a level of proliferation; these 
cells could be tracked out to the adult heart to determine if they are responsible for the 
increase in the heart in transition from neonatal to adult age, as well as if these cells 
eventually congregate in niches. Tert+ve cells labelled in the neonate and the adult 
could be tracked for their response to injury to determine if these cells are responsible 
for remodelling of the injury site and if they correlate to the cells identified in the 
epicardium by GPF expression as demonstrated in chapter 5. Cells could be labelled 
after injury; between day 8 and dayl4 after cryo-injury, time points demonstrated here, 
to determine if these cells are homing, to or originate, from the injury site. 
In summary, the cells of the dermal merit further investigation. They have demonstrated 
a number of stem-cell associated properties as well as modest differentiation potential 
to a cardiomyocytic lineage. The mTert-GFP is an exciting mouse model for the 
potential identification of stem cells, as isolated by a functional marker. There is 
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conflicting evidence for the presence of a cardiac stem cell population; the mTert-GFP 




ACE angiotensin-converting enzyme 
AMCA 7-amino-4-methylcoumarin-3-acetic acid 
ANF atrial natriuretic factor 
ASTAMI Autologous Stem Cell Transplantation in Acute Myocardial 
Infarction 
BM bone marrow 
BOOST Bone marrow transfer to enhance ST-elevation infarct regeneration 
BrdU bromodeoxyuridine 
CFSE Carboxyfluorescein Succinimidyl Ester 
DAPI 4', 6-diamidino-2-phenylindole 
dATP deoxyadenosine triphosphate 
dCTP deoxycytidine triphosphate 
DEPC diethyl pyrocarbonate 
dGTP deoxyguanosine triphosphate 
DMSO dimethyl sulfoxide 
dNTP deoxyribonucleotide triphosphate 
DP dermal papilla 
DS dermal sheath 
DTT 1,4-dithiothreitol 
dTTP deoxythymidine triphosphate 
E e.g. E9 embryonic age e.g. 9 days old embryo 
EB embryoid body 
EC cell embryonic carcinoma cell 
EG cell embryonic germ cell 
eNCSC epidermal neural crest cells 
EPU epidermal proliferative unit 
ES cell embryonic stem cell 
FACS fluorescence activated cell sorter 
FBS foetal bovine serum 
FHF first heart field 
FSC forward scatter 
G-CSF granulocyte colony-stimulating factor 
GMEM glasgows minimal essential media 
HBSS hank's balanced salt solution 
hESC human embryonic stem cell 
HIF-la hypoxia-inducible factor 1 alpha 
HSC haematopoietic stem cell 
HSP-90a heat shock protein 90alpha 
Isll Islet 1 
K-15 keratin 15 
KO knock out 
L-15 leibovitz-15 media 
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LIF leukemia inhibitory factor 
MEF mouse embryonic fibroblasts 
MEM minimal essential Media 
MGB minor groove binder 
MHC myosin heavy chain 
M I myocardial infarction 
min minutes 
MLC myosin light chain 
MLC1A myosin light chain 1A: atrial form 
MLC1V myosin light chain IV: ventricular form 
MSC mesenchymal stem cell 
p.p. post partum 
PAP phthalamidoperoxycaproic acid 
PBS phosphate buffered saline 
PBS-T100 PBS-tritonX-100 buffer 
PCR polymerase chain reaction 
PI Propidium Iodide 
Q-PCR quantitative polymerase chain reaction 
RBC red blood cell 
REPAIR-AMI Reinfusion of Enriched Progenitor Cells and Infarct Remodelling in 
Acute Myocardial Infarction 
RQ relative quantitation 
RT reverse transcriptase 
RT-PCR reverse transcriptase polymerase chain reaction 
s seconds 
s.c. subcutaneous 
SHF second heart field 
SKP skin-derived precursors 
SP side population 
SSC side scatter 
STEMI ST-Elevation acute Myocardial Infarction 
Streptavidin-AMCA streptavidin-7-amino-4-methylcoumarin-3 -acetic acid 
Sv40 simian virus 40 
TERC telomerase RNA component 
TERT telomerase reverse transcriptase 
TOPCARE-CHD Transplantation Of Progenitor Cells And Recovery of left ventricula 
function in patients with Chronic ischemic Heart Disease 
TRAP Telomeric Repeat Amplification Protocol 
TVP Trypsin, Versene, Phosphate 
WT wild type 
xg G force 
a-MHC alpha myosin heavy chain 
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2 Chemicals and Reagents 
0.1% gelatin (Sigma) for coating flasks: Gelatin is provided as a 10% solution in PBS. It 
is diluted 1 in 10, in PBS, for use. 5ml is applied to the flask for 5 min to coat the culture 
flask. Excess gelatin is removed from the flask and cells immediately added in culture 
media. 
4% (w/v) paraformaldehyde: paraformaldehyde is weighed out and slowly added to PBS 
in fume hood with constant agitation. Solution is maintained at 60°C until 
paraformaldehyde is dissolved and solution is transparent. 
Agarose (Sigma): Analytical Grade. Gelling point (1.5%) 36-39°C, Melting point (1.5%) 
87-89°C. 
Collagenase (Worthington): Type 1, A dialyzed, lyophilized powder. Greater than 125 
units/mg dry weight where one Unit releases one micromole of L-leucine equivalents from 
collagen in 5 hours at 37°C, pH 7.5 
DEPC water: water treated with 0.1% DEPC; an inhibitor of RNases, Solution was 
incubated for 12 hours at 37°C then autoclaved to remove any trace of DEPC 
Dispase (Sigma): cell culture tested, ~4 unit/mg solid, where 1 unit will hydrolyze casein 
to produce colour equivalent to l.Oumole (181ug) of tyrosine per min at pH 7.5 at 37°C 
dNTP's (Invitrogen): 2.5mM stock of dATP, dTTP, dCTP and dGTP neutralized to pH 8.0 
with NaOH, and supplied in purified water 
Ethidium bromide (Sigma): powder diluted in water to lOmg/ml for use. Solution is stored 
in the dark in a double sealed container 
Goat serum (Vector): Vecastain ABC Goat IgG kit, PK-4005, used at a 3 in 10 dilution 
(by drops). 
H2O2 (Sigma): provided as a 30% solution in PBS; solution is diluted further for use 
L I F (Sigma): mouse, expressed in Escherichia coli, 10 ug/ml, buffered aqueous solution, 
cell culture tested, supplied as a solution in PBS, pH 7.4 with 0.02% (v/v) Tween 20. 
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3 Buffers 
HBSS (Sigma): HBSS Modified, with phenol red, without calcium, without magnesium, 
liquid. 
PBS (Sigma): One tablet dissolved in 200mL of deionized water yields 0.01 M phosphate 
buffer, 0.0027 M potassium chloride and 0.137 M sodium chloride, pH 7.4, at 25 °C and 
autoclaved before use. 
PBS-T100: (0.025% (v/v) triton X-100 (Sigma) in PBS 
TAE buffer: 50xTAE stock solution is diluted to a 1XTAE solution for use. 50xTAE: 242 
g Tris base in 750ml water; add 57.1 ml glacial acid, 100ml of 0.5 M EDTA (pH 8.0) and 
volume adjusted to 11 with water. 
TVP: - ImM Na2-EDTA (Sigma), 1% (v/v) chick serum, 2.5% trypsin (Sigma) (Sigma) in 
PBS 
4 Kits 
Amnion totally RNA kit: Phenol chloroform, premixed with Isoamyl alcohol, molecular 
biological grade, Purity >99%: Sodium Acetate 3.0M solution, pH 4.5: Acid Phenol 
Chloroform: agarose gel load buffer 
CellTrace CFSE Cell Proliferation Ki t C34554 (Invitrogen): Each vial contained 50ug 
of lyophilized powder. DMSO supplied separate; high quality 0.5ml 
DNA-free kit: DNase-1 enzyme (2units/ul), lOx DNasel Buffer (lOOmM Tris-HCl, 25mM 
MgCb, 5mM CaCy, DNase inactivation reagent 
Gel loading ladder (Fermentas): lkb loading ladder #SM1163, O'GeneRuler™, ready-to-
use, 0.5ug/lane provides the following ladder: 
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High Capacity cDNA Reverse Transcription Kit (Applied Biosystems): lOxRT buffer, 
25xdNTP Mix lOOmM, lOxRT random primers, MultiScribe reverse transcriptase 
(50U/ul), RNase inhibitor, Nuclease free water. 
Streptavidin/Biotin Blocking Kit SP-2001 (Vector): Biotin 4 drops/ml of primary 
antibody. Streptavidin 4 drops/ml of the diluted normal blocking serum. 
Superscript II RNase H- Reverse Transcriptase Kit" (Invitrogen): Oligo(dT) primer 
5pmoles/ul (polyT primer, 500ng/ml): 5xFirst strand buffer (250mM Tris-HCl, pH 8.3 at 
room temperature) 375mM KC1: 15mM MgC^: 0.1M DTT: Reverse transcriptase 200 
units/ul of Superscript™ I I RT where 1 unit incorporates 1 nmole of dTTP into acid-
precipitable material in 10 min.at 37°C using oligo(dT)primer as a template-primer. 
Taq DNA polymerase, recombinant kit (Invitrogen): 10X Tag buffer (500mM KCL, 
lOOmM tris-HCL pH9, 1% (v/v) triton X-100): 50mM MgCl 2: Taq polymerase 5 Units/ul 
in 20% glycerol where 1 unit incorporates 10 nmol of deoxyribonucleotide in 30 minutes at 
74°C. 
TaqMan Fast Universal PCR Master Mix (2x) (Applied Biosystems): PCR Master Mix 
(2x), Nuclease free water. 
TaqMan gene expression assay mix (20x) (Applied Biosystems): contains 18uM 
forward primer, 18uM reverse primer and 18uM TaqMan probe specific to gene of interest 
Vectastain ABC kit (Vector): ABC solution: 2 drops A (Avidin) then 2 drops B 
(Biotinylated Horseradish Peroxidase) in 5ml PBS, mix immediately then 30 mins 
incubation. 
Vector VIP Substrate Kit for peroxidise SK-4600 (Vector): 3 drops reagent 1, 3 drops 
reagent 2, 3 drops reagent 3, 3 drops H2O2 in 5ml PBS mixed well 
5 Cell lines and culture media 
10% GMEM: GMEM with additives and 10% (v/v) FBS 
10% L-15: L-15 with additives and 10% (v/v) FBS 
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10% MEM: MEM with additives and 10% (v/v) FBS 
CGR8 ES cell line: Depositor: Dr A Smith, AFRC Centre for Genome Research, 
Edinburgh, UK (Originator) 
GMEM (Sigma): Sterile filtered, Endotoxin tested, cell culture tested, Supplement with 
0.292 g/L L-glutamine and Tryptose phosphate broth solution (T8159) at 100 ml/L of 
medium used with the following additives: at a final concentration: 0.1 mM non-essential 
amino acids (Sigma), 2mM Glutamine (Sigma) and 0.05mM 2-Mercaptoethanol (Sigma) 
L-15 (Sigma): Sterile filtered, with L-glutamine, endotoxin tested, was always used with 
the following additives: 0.5ug/ml amphotericin B (Sigma), 20mM glutamine (Sigma), 
50ug/ml gentamycin (Sigma) 
MEM (Sigma):Sterile filtered, endotoxin tested with earles salts, L-glutamine and 
NaHC03. MEM was always used with the following additives: 0.5ug/ml amphotericin B 
(Sigma), 20mM glutamine (Sigma), 50ug/ml gentamycin (Sigma) 
6 Primer Design 
ncbi software online: (hup://www.nebi.n 1 m. nili.gov/) 
6.1 RT-PCR Primer Sequences 
Alpha-mvosin heavy chain: Rat forward sequence: TGT GAA AAG ATT AAC CGG 
AGT. Rat reverse sequence: TCT GAC TTG CGG AGG TAT CG. Anneal at 53°C. 93bp 
product size. Mouse forward sequence: CCA CTG TGG TGC CTC GTT C. Mouse reverse 
sequence: GCG TCC GTC ATT CTG TCA CTC. Anneal at 51°C. 89bp product size. 
Atrial myosin light chain 1 (MLC1A): Rat forward sequence: ACC CAA GCC TGA AGA 
GAT GA. Rat reverse sequence: ACT GTG CCG TTG CTT TCT TT. Anneal at 45°C. 
150bp product size Mouse forward sequence: CGG ATA GAA GGC GGG AGC TC. 
Mouse reverse sequence: AGC CTT CAG TGA CCC TTT GCC C. Anneal at 64.1°C. 
325bp product size. 
Cardiac alpha-actin: Rat forward sequence: TAT CAC CAA CTG GGA CGA CA. Rat 
reverse sequence: AAC AAT GCC TGT GGT TCT CC. Anneal at 55°C. 232bp product 
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size. Mouse forward sequence: TGA AGC CCA GAG CAA GCG AGG. Mouse reverse 
sequence: CTG TCG CCA TCT CGT TCT CA. Anneal at 61.6°C. 521 bp product size. 
c-mvc: Mouse forward sequence: GAC ACA GCC ACG ACG ATG C. Mouse reverse 
sequence: GTC GTC AGG ATC GCA GAT. Anneal at 66.5°C. 378bp product size. 
GAPDH: Rat/Mouse forward sequence: ATG GCC CTA CAT GGC CTC CAA GG. 
Rat/Mouse reverse sequence: AGG CCC CTC CTG TTG TTA TTG G. Anneal at 58°C. 
155bp product size (mouse), 184bp product size (rat). 
GATA binding protein 4: Rat forward sequence: GTG CTG CTT CTG GAG CCA CC. Rat 
reverse sequence: GTG GGG AGA GCT TCA GAG CC. Anneal at 6 PC. 1037bp and 
629bp product size. Mouse forward sequence: CCG CTG CAG CTG GAA CCA CC. 
Mouse reverse sequence: GTG GGG ACA GCT TCA GAG CAG. Anneal at 53°C. 1040bp 
product size. 
Lymphoid Enhancer-Binding Factor (LEFD:.Rat forward sequence: CTG TTT TTA TTA 
GCC GAT TAG TGG G. Rat reverse sequence: GCT CAG CAC GTT AAC TCA AAC 
TGG. Anneal at 59.2°C. 190bp product size. 
Mef2c: Rat forward sequence: CAA AGA GGA AAT TCG GAC TG. Rat reverse 
sequence: CCC AGT GAG CTG ACA GGG. Anneal at 55°C. 828bp product size. Mouse 
forward sequence: CGA AGA GGA AAT TTG GAT TG. Mouse reverse sequence: CCC 
AGT GTG CTG ACA GGA. Anneal at 51°C. 423bp product size. 
Nanog: Mouse forward sequence: CGT TCA TCT TCC TGA GGA. Mouse reverse 
sequence: TCC AGA CGC GTT CAT CAG. Anneal at 53.8°C. 305bp product size. 
Nexin: Rat forward sequence: GGG ATC TTG CCA AGG TGA TGC. Rat reverse 
sequence: CCT GTG GTA CAC GGT GTA TGG. Anneal at 60°C. 622bp product size. 
Nkx2.5: Rat forward sequence: GCG CCG AGA GGC GAC GAC. Rat reverse sequence: 
GTA GGC GTT GAG ACC CAG G. Anneal at 57°C. 309bp product size. Mouse forward 
sequence: GCG CCG AGA GAC CAC GCG. Mouse reverse sequence: ATA GGC ATT 
GAG ACC CAC GC. Anneal at 58°C. 349bp product size. 
Oct4: Mouse forward sequence: TGT GCC GAC CGC CCC AAT. Mouse reverse 
sequence: GGG AAT ACT CAA TAC TTG. Anneal at 45.7°C. 532bp product size. 
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Sca-1: Rat forward sequence: GCT ACA ATT GCT TGG GGA. Rat reverse sequence: 
TGC AAA GAT CTC TGG TGC. Anneal at 50°C. 232bp product size Mouse forward 
sequence: CTC TGA GGA TGG ACA CTT CT. Mouse reverse sequence: GGTCTG CAG 
GAG GAC TGA GC. Anneal at 61.5°C. 398bp product size. 
Sox2: Mouse forward sequence: TGCCGT TGC TCC AGC CGT T. Mouse reverse 
sequence: CGC CTT CAT GGT ATG GTC CCG. Anneal at 67.3°C. 370bp product size. 
Tbx5: Rat forward sequence: TAC ACA GGA TGT CTC GGA TG. Rat reverse sequence: 
CAG TCT GAG GCC CGC ATT GC. Anneal at 55°C. 689bp product size. Mouse forward 
sequence: GCG CCT TTA CGT GCA CCC GG. Mouse reverse sequence: CCG AGC 
GAT AGA AGG TGT CT. Anneal at 58.3°C. 670bp product size. 
TERT: Rat/Mouse forward sequence: ACC CAG GAT GTA CTTTGTTAAG. Rat/Mouse 
reverse sequence: AGC AAA CAG CTT GTT CTCCATG. Anneal at 57.8°C. 465bp 
product size. 
Titin: Rat forward sequence: TTA TCA GTG CTG TAG AAC. Rat reverse sequence: GTT 
TTT GTT CTT GTT TAG TA. Anneal at 45°C. 326bp product size. Mouse forward 
sequence: TGA CAC TGG CGC ATA CAC CTG T. Mouse reverse sequence: AGC ACT 
GCC GGC ATC ATT GGT. Anneal at 73.7°C. 327bp product size. 
Tropoelastin: Rat forward sequence: AAA ACC CCC GAA GCC CTA. Rat reverse 
sequence: ACA TTC TCC ACC AAG CAG TA. Anneal at 51°C. 156bp (elastin), 774bp 
and 156bp (tropoelastin) product sizes. Mouse forward sequence: CCA AGT CGG AGC 
TGG CAT CG. Mouse reverse sequence: AGG AAT GCC ACC AAC ACC TG. Anneal at 
62.2°C. 651bp product size. 
Tropomyosin: Rat forward sequence: AGT GAT CTG GAG CGT GCG. Rat reverse 
sequence: TGC ACC TTT CTC TTC TAAGT. Anneal at 53°C. 263bp product size. Mouse 
forward sequence: AGC GAC CTG GAA CGT GCA. Mouse reverse sequence: GCC ACT 
TTC TCT TCT AAG T. Anneal at 49°C. 262bp product size 
Troponin I : Rat forward sequence: GCT TCA GGA CCT ATG CCG. Rat reverse 
sequence: TCG GCC TTC CAT TCC ACT. Anneal at 51°C. 336bp product size Mouse 
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forward sequence: GCT TCA GGA CTT ATG CCG A. Mouse reverse sequence: CGG 
CCT TCC ATG CCA CTC. Anneal at 53°C. 335bp product size 
Ventricular myosin light chain 1 (MLC1V): Forward sequence: AAT CCT ACC CAG 
GCA GAG GT. Reverse sequence: AAC CAT AAC AGT TCC GTT GC. Anneal at 55°C. 
195bp product size 
Versican: Rat forward sequence: GAC TAT GGC TGG CAC AA. Rat reverse sequence: 
GTC CTT TGG TAT GCA GA. Anneal at 53.1°C. 575bp product size. 
6.2 Q-PCR probes and primer sets 
Alpha tropomyosin 1: Mm00600378_ml 
Cardiac muscle alpha myosin heavy chain (a-MHC): Mm00440354_ml 





T-box 5 (tbx5): Mm00803521_ml 
7 Antibodies and Fluorochromes 
7.1 Immunohistochemistry 
DAPI (Vector): Vectasheld Mounting Media with DAPI, l.Sug/ml, excitation 360nm, 
emission 460nm) 
Primary CD34 antibody (Abeam, ab8158): monoclonal Rat anti-mouse CD34 in 0.02% 
sodium azide (w/v) in PBS, O.lmg/ml used at a 1 in 50 dilution 
Primary CD45 antibody (Abeam, ab25386): monoclonal Rat anti-mouse CD45 in 
lOOmM borate buffered saline, 0.5mg/ml used at a 1 in 200 dilution 
Primary GFP antibody (Abeam, ab6556): polyclonal Rabbit anti-GFP, 25% (v/v) 
Glycerol, 50mM Tris-HCl, 0.1% (w/v) sodium azide, 0.5mg/ml used at 1 in 6000 dilution. 
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Secondary antibody (Abeam ab6720): polyclonal Goat anti-rabbit biotin, 0.02M 
potassium phosphate, 0.15M NaCl, 0.01% (w/v) sodium azide, 2mg/ml used at a 1 in 200 
dilution 
Secondary antibody (Abeam, 7086): polyclonal goat anti-rabbit FITC, excitation 495nm 
emission 528nm, lmg/ml used at a 1 in 150 dilution 
Secondary antibody (Abeam, ab6835): biotinylated monoclonal Chicken anti-rat in 
0.01M Na phosphate, 0.25M NaCl, pH7.7, 0.05% (w/v) sodium azide, 0.01% (v/v) 
Thimerisol, 15mg/ml BSA, lmg/ml used at a 1 in 200 dilution 
Streptavidin-AMCA(Vector): lOmM HEPES, 0.15M NaCL, pH7.5, 0.08 (w/v) sodium 
azide, excitation 345-355nm emission 448-454nm, lmg/ml used at a 1 in 50 dilution 
7.2 Flow cytometry 
Flow cytometric analysis on a FACS Aria fluorescence activated cell sorter (FACS) 
(Becton Dickinson) by The Centre for Life flow cytometry unit (University of Newcastle) 
7-AAD (BD Pharmingen): detected in the far red range of the spectrum at 650 nm using a 
long-pass filter. 
Mouse lineage antibody cocktail (BD Pharmingen): APC conjugated in BSA and 0.09% 
(w/v) Sodium Azide. APC fluorochrome is excited at 595-647 nm, and its emission is 
collected in a detector for fluorescence wavelengths at 640-680nm. 
8 Equipment 
Cryostat: Leica CM3050 Research cryostat 
Dissection Microscope: Nikon 
Electrophoresis Tank (CBS Scientific): CBS Scientific MGU 202T 
Gas tight culture tank for low oxygen (Billups-rothernberg): Modular incubator 
chamber 
Haemocytometer (Sigma): Bright-Line Hemacytometer. Cells counted within 5x5 grid 
and population cell count calculated by equation: cell countx3.2xl03 
Incubator: Shell Lab, CO2 incubator 
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Light microscope for phase microscopy: Olympus ckx41 0.2 lens lOx eyepiece 
Power pack (Consort): Electrophoresis power supply Consort E844 440-400mA 
Rocker (Stuart): mini-gyro rocker SSM3 
Rocking incubator : Labnet 21 IDS 
Spectrophotometer (GenQuest): Cecil CE2301 
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